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Abstract 
 
The increased need for macromolecular therapeutics, such as proteins and nucleotides, 
to reach intracellular targets asks for more effective delivery vectors and a higher level 
of understanding of their mechanism of action. Cell Penetrating Peptides (CPPs) have 
been shown to deliver a range of macromolecules into cells either through direct plasma 
membrane translocation or by endocytosis. All known endocytic pathways involve cell-
cortex remodelling, a process shown to be regulated by reorganisation of the actin 
cytoskeleton. Links between actin remodelling and CPP uptake has been shown but 
more information is required to determine the extent of this association and how it could 
influence further research into improving the delivery capacity of these entities. This 
project, by using the CPP octaarginine (R8) investigated how actin disorganisation 
influences the cellular entry of this peptide when attached to a model fluorophore Alexa 
488 or Enhanced Green Fluorescent Protein (EGFP). 
A confocal microscopy technique was initially developed, allowing for high-resolution 
and spatial characterization of the actin cytoskeleton at different cell depths. Analysis 
using this developed method was used to highlight that serum starvation has a strong 
influence on the capacity of R8 to cause membrane blebs and possibly 
macropinocytosis. Using a range of direct or indirect actin inhibitors this work also 
highlighted how they can rapidly cause dramatic cellular deformities beyond the level 
of actin or more subtly affect actin organisation. Further confocal studies revealed that 
choice of cell line significantly affects the effect of actin disruption on CPP entry and 
that this is highly dependent on the nature of the probe. This was exemplified by results 
showing inhibition of EGFP-R8 uptake in HeLa cells treated with cytochalasin D, 
!! ii!
latrunculin B and jasplakinolide but a dramatic increase in uptake in A431 cells when 
they were treated with these drugs.   
The regulation of actin dynamics involves various kinases including Rho–associated 
kinases ROCKs, and Src family kinases. The ROCK inhibitor Y27632 induced the 
formation of actin needles running perpendicular to the plasma membrane of A431 cells 
and increased EGFP-R8 internalisation. By contrast, Src inhibitor PP2 had little effect 
on both the actin cytoskeleton and EGFP-R8 uptake but completely abrogated the 
effects of Cyt D on cellular uptake. This demonstrates for the first time that pre-
treatment of actin with one inhibitor can negate the endocytic effects of another actin 
inhibitor working on a different target.  
Overall this study highlights the importance of analysing actin in detail to identify how 
CPPs and possibly other drug delivery vectors and formulations interact with cells to 
gain entry. Under defined experimental conditions R8 can modify the actin cytoskeleton 
and requires a functional or dysfunctional actin network to allow for maximal cellular 
entry. 
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   PDGFR  Platelet-derived growth factor receptor 
   PEG   Polyethylene glycol 
   PI3K   Phosphatidylinositol-3 kinase 
   PKC   Protein kinase C 
   PRK2  Protein kinase C-related protein kinase 2 
   PtdIns  Phospholipid phosphatidylinositol  
   PtdIns(3,4)P2 Phosphatidylinositol (3,4)-bisphosphate  
   PtdIns(3,4,5)P3 Phosphatidylinositol (3,4,5)-trisphosphate  
   PtdIns(4,5)P2 Phosphatidylinositol (4,5)-bisphosphate 
   PVDF  Polyvinylidene fluoride 
   Rh-P   Rhodamine-conjugated phalloidin  
   RN-Tre  Related protein N-terminal threonine 
   RTK   Receptor tyrosine kinase 
   SDS   Sodium dodecyl sulfate 
   SFK   Src-family kinase 
   SH3   SRC homology 3  
   SNX5  Sorting nexin 5  
   SNX9  Sorting nexin 9  
   SV40  Simian virus 40  
   Tat   Trans-activator of transcription  
   TEMED  Tetramethylethylenediamine 
   TfR   Transferrin receptor  
   TGN   Trans-Golgi network  
   TP10  Transportan 10  
   WASP  Wiskott-Aldrich syndrome protein 
   WAVE  WASP-family verprolin homologue isoforms 
   WASH  WASP and WAVE homologue 
   WH2   WASP homology 2 
   WHAMM WASP homologue associated with actin, membranes and 
microtubules 
   YFP Yellow fluorescent protein  
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Chapter 1: Introduction 
 
1.1 Therapeutic macromolecules and drug delivery vectors (DDVs) 
Therapeutic macromolecules, such as nucleic acids, peptides and high-purity 
recombinant proteins, are a class of clinically applicable compounds with high 
molecular weight that can be defined as macromolecular therapeutics. Also termed 
macro biopharmaceuticals, these are receiving increasing research interest and show 
significant potential in the treatment of acquired diseases such as cancer and also 
hereditary genetic disorders. However, the efficacy of newly discovered 
macromolecules is still impeded by several physiological and cellular barriers, non-
specific bio-distribution and poor bioavailability caused by clearance in the body 
(Wassef et al., 1991). Therefore it is of crucial importance to design and develop new 
approaches for efficient and safe macromolecular delivery to target sites.  
In in vitro studies, the first major obstacle to efficient delivery of macromolecules to 
intracellular targets or locations is the plasma membrane (Cleal et al., 2013). The lipid-
based bilayer of the plasma membrane forms a highly effective barrier that separates the 
intracellular environment from the extracellular space. As a result, the intracellular entry 
of most macromolecules is blocked due to impermeability of the plasma membrane to 
these large entities (Copolovici et al., 2014). The fact that most of the therapeutic 
macromolecules are hydrophilic is also a further hindrance. One of the most widely 
investigated approaches to translocate macromolecules across the plasma membrane is 
to create complexes or conjugates with vectors that have some kind of specific or non-
specific affinity for the plasma membrane that will then allow entry into the cell via 
endocytosis. Such drug delivery approaches include vectors that may be of biological 
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origin such as viruses (Giacca and Zacchigna, 2012), peptides and proteins (Bechara 
and Sagan, 2013) or artificial systems such as polymer-based nanoparticles (NPs) (Cleal 
et al., 2013).  
1.2 Viral delivery vectors  
In 1976, Paul Berg harnessed the modified SV40 virus to deliver DNA segments into 
cultured monkey kidney cells (Goff and Berg, 1976). Since this breakthrough, viral 
vectors have attracted extensive attention in the field of gene therapy. By exploiting 
viral infection pathways, the genetic materials of choice can be co-transported with viral 
DNA or RNA genomes into infected host cells. Certain viral coding regions whose 
subsequent expression in the host accounts for viral replication and toxicity are deleted 
from the original viral genome. The exogenous DNA of interest is then incorporated 
into the viral backbone in place of the deleted sequences. The sequences that are 
essential for encapsulating the vector genes into the viral capsid or integrating vector 
genome into the chromatin of infected cells are, necessarily, kept intact. To reproduce 
recombinant viral vectors in a host cell, a separate helper virus is also required to 
provide the transduced cells with viral genes encoding capsid proteins or replication-
associated proteins (Thomas et al., 2003).  
In the field of gene therapy, the majority of the clinically relevant virus vectors originate 
from five major classes: oncoretroviruses, lentiviruses, adenoviruses, adeno-associated 
viruses (AAVs) and herpes simplex virus type 1 (HSV-1) (Giacca and Zacchigna, 2012). 
As each of these classes holds their own unique set of properties and their disease 
targets are diverse, no single class is suitable for all clinical applications. Although viral 
vectors of different classes have proven to be useful tools for gene transfer in animal 
models and even clinical trials, some characteristics they hold limit their wider 
therapeutic use (Thomas et al., 2003). Oncoretrovirus and lentivirus vectors perform 
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genetic alterations by integrating their genomes into the host cellular chromatin. These 
integrating vectors are preferred if stable genetic modification needs to be maintained in 
proliferating cells, although stable transgene expression from the integrated genomes 
can not be guaranteed due to gradual silencing over time (Pannell and Ellis, 2001). 
However, oncoretrovirus can only access the cell nucleus when the nuclear membrane 
breaks down. Lentivirus can breach the intact nuclear membrane of some cell types, but 
not all non-dividing cells are susceptible to gene transfer by these vectors (Park et al., 
2000). The major obstacle using adenovirus vectors to deliver genes into the cell 
nucleus is their potent immunogenicity. These viruses have been shown to induce 
strong inflammatory responses (Thomas et al., 2003). Another challenge that faces all 
classes of viral vectors is the pre-existing humoral immune responses to the parental 
wild type viruses. These humoral responses lead to the production of virus–specific 
antibodies by B lymphocytes, which impede efficient translocation mediated by viral 
vectors or the subsequent secretion of therapeutic proteins, therefore preclude the long-
term therapy of certain disorders (Sun et al., 2003, Mingozzi and High, 2013, Halbert et 
al., 2000).  Other shortcomings of viral vectors include short-lived transgene expression, 
limited DNA carrying capacity and vector tropism (infectable cell types). These 
limitations necessitate the design and development of new non-viral based approaches 
to introduce exogenous nucleic acids and other macromolecular therapeutics into cells 
with maximum efficiency and minimal toxicity.  
1.3 Non-viral drug delivery methods (NV-DDMs)  
Non-viral delivery methods for drug delivery represent promising alternatives to viral 
vectors since they can offer localised or targeted drug delivery with easier preparation, 
larger drug-load, longer release period and lower immunogenicity (Yin et al., 2014).   
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At present, non-viral drug delivery methods (NV-DDMs) can be generally divided into 
two main classes according to the technology they exploit. Physical methods include 
electroporation, microinjection and magnetofection, and biochemical delivery systems 
engineered by nanotechnology include liposomes, dendrimers, polymeric micelles and 
nanoparticles. Although the physical approaches can offer highly efficient drug or gene 
delivery, these methods also have some significant drawbacks as they can cause damage 
and death to the targeted cells. In the past decades, nanoscale drug delivery systems 
(NDDS) have received widespread attention, and a variety of materials have been 
utilised in their manufacture. The concept of NDDS was derived with the description of 
lipid vesicles (later known as liposomes) in the 1960s along with polymer-drug 
conjugates in the 1970s (Bangham et al., 1965, Ringsdorf, 1975). Liposomes are 
spherical nanostructures that are formed by self-assembly of single or multiple lipid 
bilayers in aqueous systems. This construction allows for entrapment of hydrophilic 
molecules within the internal aqueous phase and hydrophobic compounds in the bilayer 
membrane (Vemuri and Rhodes, 1995). In spite of several desired advantages such as 
biocompatibility and biodegradability, the major problems for liposome vehicles used in 
pharmaceutics are their relatively low stability and short circulation half-life (Mufamadi 
et al., 2011). To combat this, liposomes can be conjugated with biocompatible polymers 
such as polyethylene glycol (PEG). PEGylation protects liposomes from clearance by 
the reticuloendothelial system; otherwise conventional liposomes can be easily 
phagocytosed by specialist cells found within the reticular connective tissue in the liver, 
spleen and lymph nodes (Felice et al., 2014).  
To date, the NDDS family has been undergoing significant expansion and more 
nanotechnology platforms have emerged for drug delivery applications. For example, an 
alternative to covalent binding of cargo to polymer, they can also be physically 
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entrapped in the polymer structures. The resulting products prepared by either method 
may present as polymeric capsules, polymeric nanoparticles, polymeric micelles with 
amphiphilic interior or exterior, or hyperbranched dendrimers (Cho et al., 2008). Carbon 
nanotubes, magnetic nanoparticles and silica nanocarriers have also gained great interest 
as potential drug delivery vehicles (Wilczewska et al., 2012). Currently, there are a 
number of NDDS-based therapeutic agents under preclinical evaluation but only 
relatively few nanotherapeutics have been launched in the pharmaceutical market. A 
variety of limitations have impeded the clinical use and success of nanosized carriers. 
For example, most of the delivery achieved by NDDS relies on the passive 
accumulation of carriers in pathological sites, which leads to low efficiency of cargo 
delivery to specific cells or particular intracellular regions (Koren and Torchilin, 2012).  
1.4 Cell penetrating peptides (CPPs) as drug delivery vectors  
As discussed previously, viral vectors are still considered to be the most efficient 
vehicles for gene delivery, despite the associated negative side effects. This has inspired 
some investigators to develop proteins and peptides that mimic viral cell entry and also 
exploit the mechanisms by which some plant and bacterial toxins can translocate across 
membrane barriers. In the past 15 years, a group of peptides called cell penetrating 
peptides (CPPs) has been discovered and developed for intracellular delivery of genetic 
material, peptides, proteins and other macro entities (Gupta et al., 2005, Raucher and 
Ryu, 2015, Margus et al., 2012).  
The initial observations about the potential of membrane-penetrating proteins or amino 
acid sequences to carry macromolecular cargo and enhance their cellular uptake were 
published in 1965 (Ryser and Hancock, 1965). In this report, histones and poly amino 
acids (polyamines) were shown to be capable of accelerating albumin uptake by 
cultured tumour cells. Very little was then published on the cell-penetrating properties 
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of peptides/proteins until 1988. The transcription-transactivating (Tat) protein of the 
human immunodeficiency virus 1 (HIV-1) and a chemically synthesized version of Tat 
were observed to have the ability to rapidly translocate across the plasma membrane and 
even into the nucleus (Frankel and Pabo, 1988, Green and Loewenstein, 1988). The two 
independent publications triggered great interest in the drug delivery field and are 
generally considered to be the first documented CPPs. In 1991, Prochiantz and 
colleagues reported that Drosophila antennapedia homeodomain, a 60-amino acid 
polypeptide pAntp, could be internalised by mammalian neuronal cells (Joliot et al., 
1991). This work subsequently led to the identification of a shorter polypeptide (16 
amino acid in length), penetratin, corresponding to the third helix of pAntp (Derossi et 
al., 1994). Table 1.1 describes a list of studied CPPs including penetratin and their 
amino acid sequences. In 1997, Vives et al. delineated a minimal amino acid region 
required for Tat protein translocation after intensive studies on different truncated 
versions of Tat (Vivès et al., 1997). These initial descriptions about CPPs have 
subsequently demonstrated significant efficacy in the delivery of biologically active 
entities into cells or various subcellular compartments.  
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Table 1.1 Representative CPPs: sequences, subtypes and origins. 
CPP CPP sequence Subtype Origin  Ref.  
Oligoarginines  R(n) 
Poly-cationic 
Synthetic (Rothbard et al., 2000) 
HIV-1 Tat  
(48-60) GRKKRRQRRRPPQ 
Protein 
derived 
(Richard et 
al., 2005) 
TP10  AGYLLGKINLKALAALAKKIL 
Primary 
amphipathic 
 
Chimeric (Soomets et al., 2000) 
Transportan GWTLNSAGYLLGKINLKALAALAKKIL Chimeric 
(Pooga et 
al., 1998) 
MPG GALFLGFLGAAGSTMGAWSQPKS Chimeric (Morris et al., 1997) 
Pep-1 KETWWETWWTEWSQPKKKRKV Synthetic (Deshayes et al., 2004a) 
Pep-2 KETWFETWFTEWSQPKKKRKV Synthetic (Kurzawa et al., 2010) 
Pep-3 KWFETWFTEWPKKRK Synthetic (Kurzawa et al., 2010) 
CADY GLWRALWRLLRSLWRLLWRA 
Secondary 
amphipathic 
Synthetic (Crombez et al., 2009) 
CADY2 GLWWRLWWRLRSWFRLWFRA Synthetic (Kurzawa et al., 2010) 
MAP KLALKLALKALKAALKLA Synthetic (Oehlke et al., 1998) 
pVec LLIILRRRIRKQAHAHSK Protein derived 
(Elmquist et 
al., 2001) 
Penetratin RQIKIWFQNRRMKWKK Protein derived 
(Derossi et 
al., 1994) 
!
1.4.1 Classifications of CPPs  
More than 100 diverse cell penetrating sequences containing 5-40 amino acids have 
now been described as carriers of various cargos including small entities, 
macromolecules and even nanoparticles (Koren and Torchilin, 2012). Although CPPs 
have a great variety of sequence profiles, it is possible to classify them on the basis of 
specific parameters. According to their origin, CPPs can be broadly distinguished into 
three major groups: protein derived peptides, synthetic sequences that are designed to 
mimic the structures of pre-existing peptides for optimised activity, and chimeric CPPs 
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that are fusion of two natural sequences (usually a hydrophobic and a hydrophilic 
domain of different proteins) (Zorko and Langel, 2005).  
The physico-chemical characteristics of CPP sequences can also be used to 
subcategorize CPPs into three main subclasses: cationic, amphipathic and hydrophobic. 
Most of the known CPPs (~83%) are net positively charged (Milletti, 2012). Among 
them, it has been well accepted that only those that are highly charged without 
displaying any amphipathic arrangement can be classified as cationic CPPs (Figure 
1.1A). There are also some peptides that have both a net positive charge and which are 
hydrophobic. Such peptides are identified cationic if their uptake primarily relies on the 
stretch of positive charges (usually contributed by arginine and/or lysine) at 
physiological pH (Milletti, 2012).  
 
 
Figure 1.1 CPP models showing different structural properties. A) Non-amphipathic/polycationic 
CPPs have no defined secondary structures. B) Primary amphipathic CPPs comprise a hydrophobic and a 
hydrophilic domain. C) The secondary amphipathic CPPs form a secondary structure α-helix with dual 
faces: a hydrophobic and a hydrophilic face. D) In amphipathic β-strand CPPs, β-strands are designated 
as parallel or antiparallel according to the relative direction of the two β-strands associated by hydrogen 
bonding. The side chains (indicated by green or blue dots) of the amino acids of a strand in a β-sheet are 
located on opposite sides of the sheet, leading to the formation of amphipathic regions. 
 
The first described cationic CPP is a short region derived from HIV-1 Tat protein and 
containing both arginines and lysines (Green et al., 1989). Subsequent studies suggested 
that the number of positive charges is crucial for efficient cellular internalisation of 
A B C D 
Non-amphipathic/ 
polycationic CPPs  
Primary 
amphipathic CPPs  
Hydrophobic 
domain  
Hydrophilic 
domain  
Secondary 
amphipathic CPPs  
Hydrophobic face 
of α-helix  
Hydrophilic face of 
α-helix  
Secondary amphipathic 
β-strand CPPs  
Hydrophobic strand 
Hydrophilic strand 
!! 9!
cationic CPPs. In some cases, at least eight positive charges are thought to be required, 
and for polyarginine peptides (Rn), the level of uptake increases with the addition of 
more arginines to the amino acid sequence (Futaki et al., 2001, Tünnemann et al., 
2008). The guanidinium head groups of arginine-rich peptides can electrostatically 
interact with the carboxylates and sulfates provided by cell surface glycosaminoglycans 
(GAGs) or other negatively charged phosphate head groups on the membrane, which 
leads to the formation of bidentate hydrogen bonding (Figure 1.2A). This is thought to 
be responsible for the initial generation of plasma membrane curves or protrusions 
towards the extracellular space (Mishra et al., 2011). However, the amine groups of 
lysine can only form monodentate hydrogen bonding with their counterparts (Figure 
1.2B), which is unfavorable to the formation of membrane curvature (Mishra et al., 
2011). If the correlation between the membrane curvature and membrane perturbation is 
true, it can be considered as a convincing explanation why arginine is more promising 
than lysine in CPP uptake. Additionally, polycationic CPPs were also observed to 
mediate the aggregation of GAGs on cell surface, leading to actin rearrangement and a 
selective activation of protein kinase C and Rho/Rac GTPases to produce an endocytic 
signal (Ziegler and Seelig, 2008, Duchardt et al., 2007). As a membrane destabilisation 
reagent, pyrenebutyrate can insert into the lipid bilayer via its hydrophobic region. Also 
it can electrostatically bind the positively charged head groups of arginine, increasing 
the hydrophobicity of the CPP (Perret et al., 2005). The addition of hydrophobicity to 
the hydrophilic oligoarginine peptides using the hydrophobic counter-anion 
pyrenebutyrate was shown to promote the interactions between the peptides and the 
lipid bilayer, leading to direct cell entry into the cytoplasm and cytosol (Takeuchi et al., 
2006, Guterstam et al., 2009). Such an enhancement on the cellular penetration 
mediated by hydrophobicity was further investigated by adding a penetration 
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accelerating sequence (Pas) to oligoarginine (Takayama et al., 2012). Compared with 
R8 alone, the attachment of the hydrophobic sequence (FFLIPKG) Pas to R8 (PasR8) 
was observed to increase the cellular internalisation of the peptide. Probably, the 
increased hydrophobicity in PasR8 strengthens the interaction between the peptide and 
the plasma membrane, which results in a further membrane destabilisation. Further 
work from our laboratory has shown that adding a phenylalanine group several residues 
away from the CPP sequence can also have quite dramatic effects on cell binding and 
uptake (Watkins et al., 2011, Sayers et al., 2014).  
 
Figure 1.2 Interactions between polyarginine or polylysine and phospholipid head groups. Adapted 
from (Mishra et al., 2011). A) Multidentate hydrogen bonding formed by interactions between the 
membrane’s phosphate head groups and arginine’s guanidinium side chain, induces positive curvature 
strain along the peptide. B) Monodentate coordination of lysine’s amino side chain does not induce 
positive curvature.  
 
The largest subgroup termed amphipathic CPPs can be further identified as primary 
amphipathic, secondary amphipathic and proline-rich amphipathic (Milletti, 2012). 
Primary amphipathic CPPs are formed by the fusion of hydrophobic and hydrophilic 
domains in their primary sequence (Figure 1.1B). Most of the primary amphipathic 
A B 
Plasma membrane Plasma membrane 
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peptides, such as MPG and Pep families (Table 1.1), have hydrophobic sequences of 
different origins but share a common hydrophilic motif, i.e. the nuclear localisation 
sequence (NLS) of Simian virus 40 (SV40) T-antigen: PKKKRKV (Deshayes et al., 
2006). NLSs are short amino acid sequences, rich in arginine and lysine, that tag 
proteins for transportation into the nucleus. NLSs themselves, to some extent, can be 
considered cationic CPPs. However, the lack of sufficient positive charge means that 
most NLSs (alone) are inadequate for cellular uptake (Mueller et al., 2008). NLSs can 
and have been covalently fused with certain highly hydrophobic signal peptides to 
obtain amphipathic peptides that efficiently penetrate the plasma membrane and enter 
cells (Lin et al., 1995, Chaloin et al., 1997).  
Unlike primary amphipathic CPPs, secondary amphipathic peptides only become truly 
amphipathic when in a α-helical or β-sheet confirmation (Figure 1.1C or D). For 
example, in model amphipathic peptides (MAPs) and CADY family of peptides, 
hydrophobic and hydrophilic residues are clustered on separate sides of the peptide 
helix, resulting in one highly hydrophobic face and the other face cationic, anionic or 
polar (Milletti, 2012). β-sheet amphipathic CPPs reveal their amphipathic character 
upon interaction with a phospholipid membrane, through the formation of a 
hydrophobic and a hydrophilic stretch of amino acids. Although the majority of 
amphipathic CPPs are also cationic, there is also a significant body of evidence to 
suggest that the membrane translocation of amphipathic CPPs is actually a result of the 
amphipathic conformation they adopt under certain circumstances, rather than directly 
due to the presence of positively charged residues (Oehlke et al., 1998, Scheller et al., 
1999, Oehlke et al., 2002). However, in some other studies on the mutants of MAP and 
another amphipathic CPP transportan, the ability of the peptides to translocate across 
the plasma membrane was significantly impaired by single mutations or deletions even 
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though some degree of amphipathicity still remained (Scheller et al., 1999, Soomets et 
al., 2000).  Thus, further investigations are required to understand the role and necessity 
of amphipathicity in the cellular uptake of amphipathic CPPs. 
Positively charged residues and amphipathicity are not thought to be obligate for cell 
penetration and efficient internalisation. And recently a few CPP sequences comprised 
of hydrophobic amino acids have been identified. Most of hydrophobic CPPs in this 
class are constructed from natural amino acids. Examples include short sequence 
PFVYLI, a truncated version of the longer peptide C105Y (Rhee and Davis, 2006, 
Watkins et al., 2009) and the signal sequence from integrin beta 3 
(VTVLALGALAGVGVG) (Liu et al., 1996). Recent data indicate that some 
hydrophobic CPPs such as PFVYLI can drive their cellular uptake through an ATP-
independent, non-endocytic pathway (Watkins et al., 2009, Marks et al., 2011). In some 
cases this confers an advantage as CPPs internalised via a non-endocytic route can be 
immediately available in the cytosol and should avoid endo-lysosomal 
entrapment/degradation. Some other hydrophobic CPPs can be produced by chemical 
modifications such as ring-closing olefin metathesis (Schafmeister et al., 2000) and 
prenylation that involved the covalent addition of hydrophobic lipid prenyl (C15 or C20) 
groups onto cysteine residues of peptides (Ochocki et al., 2011). The prenylation 
modification serves to aid peptide penetration via enhancing hydrophobic interaction 
with cell membranes. A number of membrane interacting proteins including Rab 
GTPases are modified via prenylation (Pereira-Leal et al., 2001, Wang and Casey, 
2016). A more recent group of CPPs termed Pepfects, are chemically modified 
derivatives of transportan 10 (TP10). This peptide family are formed through the 
introduction of the stearyl moiety at different positions such as the C-terminus of TP10, 
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and have been shown to efficiently deliver DNA and siRNA in vitro and in vivo without 
the risks of toxicity and inflammations (Ezzat et al., 2011, Suhorutsenko et al., 2011).   
1.4.2 Cellular uptake mechanisms of CPPs  
A key research question in the CPP field is what mechanism(s) do these peptides use to 
enter into cells. Early mechanistic studies in the 1990s suggested that most CPPs 
achieved plasma membrane translocation by non-endocytic, energy- and temperature-
independent, direct passage (Derossi et al., 1994). In most early analysis the cells were 
fixed to allow microscopical analysis of fluorescent CPPs or CPPs attached to GFP in 
cells. This fixing procedure was later found to completely alter the localisation of the 
CPP often towards the negative DNA in the nucleus (Lundberg and Johansson, 2002, 
Richard et al., 2003). Since the publication of these very important papers, a number of 
subsequent studies have led to the general consensus that CPPs under certain conditions 
and with low molecular weight cargo can translocate the plasma membrane in the 
presence or absence of energy (Bechara and Sagan, 2013). However a number of 
endocytic pathways have also been shown to be utilized by CPPs with small and large 
molecular weight cargos to reach the cytoplasm. The mechanism by which they then 
mediate escape from endosomal organelles to reach the cytosol still remains a mystery. 
Despite the significant investment of effort that has been made to unveil the 
mechanisms of CPP translocation across the plasma membrane, the exact uptake 
pathways still remain elusive. It should however be noted that finding one mechanism 
that fits all CPPs with or without attached cargo is impossible to achieve. As mentioned 
earlier it is now well accepted that two modes of cell entry exist to accomplish entry 
into the cytoplasm of cells: direct translocation and uptake via endocytosis. The 
endocytic pathways involved in CPP cell entry relate to the pinocytosis process, which 
can be broadly grouped into four main pathways: clathrin-dependent endocytosis, 
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caveolae/lipid raft-mediated endocytosis, clathrin/caveolae-independent endocytosis 
and macropinocytosis (Doherty and McMahon, 2009, Sigismund et al., 2012). Under 
certain experimental/biological conditions, some CPPs, alone and attached to low 
molecular weight cargo can translocate directly through the lipid bilayer. This is 
initiated by and is thought to depend on the electrostatic interactions between CPP and 
membrane components or via hydrogen bonding (Herbig et al., 2005, Mai et al., 2002). 
The majority of CPPs attached to cargo molecules, especially to those of high molecular 
weight (e.g. proteins, liposomes and nanoparticles) have to utilize single or multiple 
endosomal routes to gain entry to cells and to different subcellular compartments 
(Duchardt et al., 2007). The specific pathway(s) used by a CPP to gain cell entry 
depends on a number of key peptide parameters: the physico-chemical characters of the 
CPP sequences, their concentrations and the properties of the associated cargos. The 
cell type targeted for delivery is also critically important as this determines the plasma 
membrane composition and the cell’s endocytic capacity and profile.  
1.4.2.1 Direct translocation  
The mechanisms of energy-independent direct translocation of CPP cargos have been 
described in several models that include inverted micelle formation, pore formation and 
the carpet-like model (Derossi et al., 1996, Matsuzaki et al., 1996, Pouny et al., 1992). 
Almost all these proposed mechanisms highly depend on the properties of peptide 
sequences, their concentrations (usually above a threshold) and even the membrane 
composition of the studied cells. No matter which of these mechanisms the CPP cargo 
uses to penetrate the bilayer, the first step is thought to involve interactions of the 
positively charged amino acids in the peptide, with negatively charged membrane 
components such as extracellular GAGs, e.g. heparan sulfate and heparin, and 
phospholipids. As a consequence, the plasma membrane may experience stable or 
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transient destabilisation, which provides CPPs with opportunities to pass through into 
the cell (Thorén et al., 2003, Rothbard et al., 2004). Not all the known CPPs are capable 
of direct translocation, however cationic or amphipathic CPPs, such as Tat, R8/9 or 
MPG, have been shown to perform this process under certain conditions (Thorén et al., 
2003, Deshayes et al., 2006, Fretz et al., 2007, Duchardt et al., 2007).  
Following Tat’s first contact with negatively charged phospholipids, part of the plasma 
membrane can be transformed into an inverted micelle structure (Figure 1.3A: I) which 
can open on either the extracellular or the intracellular layer of the membrane (Vivès et 
al., 2003). For the secondary amphipathic penetratin, in addition to the initial 
electrostatic interaction between the peptide and the membrane, the subsequent 
interaction between hydrophobic amino acids of peptide sequence and the hydrophobic 
components of the lipid bilayer also takes part in this inverted micelle mechanism 
(Alves et al., 2008).  
Several more recent studies based on giant unilamellar vesicles (GUVs) indicated that 
the rapid and tight binding of cationic CPPs to anionic extracellular GAGs might not be 
essential for CPP uptake, since effective translocation across GUVs in the absence of 
these components can be observed (Mishra et al., 2011, Swiecicki et al., 2014). 
However, these studies also highlighted the importance of the direct interaction between 
the positive charges of cationic CPPs and phospholipid phosphate groups for efficient 
peptide internalisation via a model phospholipid membrane or biological membrane. 
Cationic CPPs are also thought to induce an internalisation platform in a defined region 
of the plasma membrane that then leads to rapid rush of the peptide into the cytosol 
(Duchardt et al., 2007, Hirose et al., 2012).  
In a theoretical model proposed by Herce et. al (Figure 1.3B), a transmembrane pore is 
formed to facilitate the translocation of highly cationic CPPs such as Tat and other 
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arginine/lysine-rich peptides (Herce and Garcia, 2007, Herce et al., 2009). The charged 
amino acids of the peptides are initially attracted by the phosphate groups of the 
phospholipid bilayer and bind to them, mainly through the side chains of arginines 
and/or lysines. Along with the increase of the surface concentration of the peptides, the 
strength of the peptide-phosphate interactions also builds up. This subsequently leads to 
the distortion of the arrangement of local membrane region compared with their resting 
structure. When the peptide concentration is greater than a certain threshold, which is 
peptide-specific, an arginine/lysine side chain may penetrate into the distal layer and 
nucleate the formation of an aqueous pore. This transient pore then provides an entry 
point for more peptides to diffuse across the bilayer, and the translocation ends with 
pore closure.  
The research group of A.E. Mark described the toroidal model (Figure 1.3A: II) for the 
mechanism of pore formation, which is also applicable to the amphipathic CPP 
penetratin (Yesylevskyy et al., 2009). The initial interactions between penetratin and 
model lipid bilayer depresses the upper monolayer of the plasma membrane while the 
lower monolayer is unaffected. Driven by the increased restraining potential, the peptide 
moves toward the bilayer interior, gradually increasing the deformation of the upper 
monolayer. When the deformation reaches a critical point, a hydrophilic toroidal pore 
appears and its surface is occupied by lipid head groups, which is the major difference 
from the model proposed by Herce et. al.  
The carpet-like model (Figure 1.3A: III) describes a mechanism where peptides 
accumulate on, and bind parallel to, the plane of the lipid bilayer, coating the local 
membrane area with a carpet-like extra layer (Deshayes et al., 2004). When the peptide 
concentration reaches a given threshold, the peptide sheet can initiate the formation of 
micelles or membrane pores, allowing for subsequent peptide translocation.  
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Figure 1.3 A variety of possible models for CPP-mediated direct penetration. The inverted micelle 
(A:I) (Järver et al., 2010) is described as a kind of hydrophilic cavity that forms within the lipid bilayer 
leaflets following interaction between the positively charged residues of CPPs and the phospholipid 
headgroups. This causes membrane distortion. The accommodated CPPs are then released directly from 
the transient micelles to the cytoplasmic region. In the toroidal model (A:II) (Nguyen et al., 2011), the 
peptides insert perpendicular into the sheet of lipid bilayer, with interaction between their hydrophobic 
motifs and the membrane lipid core and association between the polar head groups of phospholipid via 
the hydrophilic regions of the peptides. During such insertion, the membrane is also bent inward to line 
the pore, thus the lipid headgroups form contacts with the transmembrane peptides throughout. The 
formed toroidal structure is then stabilised by the peptides. According to the carpet model (A:III) 
(Nguyen et al., 2011), the peptides accumulate and clustered on the lipid bilayer in a parallel fashion, 
coating the local membrane region with a carpet-like layer. When the coating peptide concentration 
reaches a given threshold, the panel of peptides can initiate the formation of micelles and membrane 
pores to allow cell entry. B) Following the order from a to f, the binding and aggregation of CPPs onto 
the membrane trigger a slight depression within the upper monolayer. The formation of a hydrophilic 
toroidal-like pore structure occurs as a consequence of both the movement of the peptide towards the 
bilayer core and the distortion within the bilayer. Then the peptide passes through the transient pore and is 
pulled out of the structure into the cytosol. The green arrow indicates the direction of the CPP 
internalisation (Yesylevskyy et al., 2009). 
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1.4.2.2 Endocytosis  
Endocytosis is a highly regulated activity by which cells internalise solutes and fluid 
from the extracellular matrix. Endocytosis is an umbrella term that includes 
phagocytosis, a process that is mainly used to internalise large particles such as viruses, 
bacteria and other cells, and several other routes that fall under the classification of 
pinocytosis (Figure 1.4 and legend to this figure). In this introduction a few of these 
pathways are described further and this will then lead to roles that have been proposed 
for them in the uptake of CPPs. 
 
Figure 1.4 Endocytic pathways and the delivery of therapeutic macromolecules using vector 
systems. A variety of (nano) carriers including viruses, liposomes, micelles, dendrimers and CPPs, whose 
sizes vary from low nanometers (peptides) to micrometers, have been shown to facilitate intracellular 
delivery of a wide range of therapeutic macromolecules. All of these pinocytic pathways (clathrin-
mediated endocytosis, caveolae-mediated endocytosis, clathrin/caveolin-independent endocytosis and 
macropinocytosis) have been shown to be involved in the CPP-mediated delivery. Some CPPs are able to 
directly translocate through the plasma membrane. The intracellular endocytic vesicles entrapping the 
CPP complexes may be targeted to recycling endosomes or the endo-lysosomal pathway or CPPs may be 
directed to other locations such as the trans-Golgi Network (TGN). 
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1.4.2.2.1 Clathrin-mediated endocytosis (CME) 
Clathrin-mediated endocytosis is a relatively well-described internalisation pathway that 
occurs constitutively in all known eukaryotic cells. CME involves material uptake 
through clathrin coated vesicles (CCVs) formed as invaginations from the plasma 
membrane; CCVs can also bud from other membrane compartments using different 
adaptor proteins (McMahon and Boucrot, 2011). CME has been reported to be an 
important regulatory process for several cellular activities, such as bringing essential 
nutrients into cells, regulating the activation of signalling pathways, and intercellular 
communication in tissue or organ development (Conner and Schmid, 2003). Based on 
the ultrastructural and biological observations, the formation of CCVs has been clearly 
described, and many adaptor proteins have been identified that, along with clathrin, 
make significant contributions to the formation of clathrin coated pits and vesicles 
(McMahon and Boucrot, 2011). CME utilizes a variety of cargo adaptors and accessory 
proteins serving to package distinct cargos or cargo sets into different cells (Schmid and 
McMahon, 2007). However, it is worth noting that there is overlapping and sharing of 
functions among different cargo adaptors and accessory proteins.  
The CME-mediated uptake usually involves five stages including initiation, cargo 
selection, coat assembly, scission and uncoating. CME can be stimulated by ligand 
binding to specific transmembrane receptors. However, for some other receptors such as 
the transferrin receptor (TfR), their internalisation via CME is constitutive (Hopkins et 
al., 1985). CME internalisation begins with membrane curvature that was originally 
thought to be triggered by local recruitment of the highly conserved Adaptor Protein-2 
(AP2) complex. AP2 binds to the cytoplasmic tails of receptors destined for 
internalisation and to the plasma membrane-specific lipid phosphatidylinositol-4,5-
bisphosphate (PtdIns(4,5)P2) (Ohno et al., 1995, Höning et al., 2005). However, the role 
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of AP2 in initiation of membrane curvature was challenged by some recent studies in 
mammalian cells, which indicate that membrane deformation may result from the action 
of a putative nucleation protein module. The proposed module contains FCH domain 
only (FCHO) proteins, EGFR pathway substrate 15 (EPS15) and intersectins, and is 
suggested to be required for the recruitment of AP2 (Henne et al., 2010). The recruited 
AP2 complex then can bind to cargo to be internalised via its core domain and can 
anchor on the plasma membrane through the binding to PtdIns(4,5)P2); its appendage 
domains (ears) can bind to most of the cargo-specific accessory adaptor proteins and to 
clathrin (Collins et al., 2002). Adaptor proteins are also thought to induce membrane 
curvature effectors that ensure membrane-deformation regardless of the identity of the 
cargo (McMahon and Boucrot, 2011). Clathrin coat assembly proceeds at specific 
regions of the plasma membrane wherein selected cargo is bound to either AP2 or 
adaptor proteins. 
Clathrin is a triskelion-like structure comprising three identical clathrin heavy chains 
(CHCs) and other three tightly associated clathrin light chains (CLCs) (Fotin et al., 
2004). Clathrin triskelia are recruited by AP2 and also by other accessory adaptor 
proteins directly from the cell cytosol to the sites where coated vesicles will mature. The 
recruited clathrin triskelia are then self-polymerised into cage-shaped lattice, which 
consequently stabilises the curvature of the attached membrane. Clathrin assembly itself 
is insufficient to drive membrane deformation as the coated pit invaginates, curvature 
effectors such as epsin family proteins can help mediate membrane bending in the 
assembling clathrin-coated pit for a fully invaginated CCV to form (Ungewickell et al., 
1995, Ford et al., 2002). 
A class of BAR domain-containing proteins such as amphiphysin and sorting nexin 9 
(SNX9) aid in the formation and constriction of the budding vesicle neck (Wigge et al., 
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1997, Ferguson et al., 2009). Another important function of these accessory proteins is 
to recruit the membrane scission protein dynamin to the vesicle neck through the 
binding of their SRC homology 3 (SH3) domains to the pro-rich domain of dynamin 
(Ringstad et al., 1997). The large GTPase dynamin is then concentrated and 
polymerised into helical structures around the vesicle neck. Upon GTP hydrolysis, the 
dynamin polymers induce vesicle scission from the parent plasma membrane, which 
leads to the release of CCVs into cytosol (Praefcke and McMahon, 2004). The clathrin 
coat is subsequently disassembled from lattice back to triskelia by ATPase heat shock 
cognate 70 (HSC70) and its cofactor auxilin (Schlossman et al., 1984, Ungewickell et 
al., 1995). The detached and naked vesicles are then trafficked to and fuse with early 
endosomes. The rapid disassembly of the clathrin coat allows the recycling/reuse of the 
clathrin machinery in further rounds of CCV budding.  
1.4.2.2.2 Caveolae-dependent endocytosis 
It has been observed that certain compounds introduced to cells can be directed into 
lipid rafts and subsequently endocytosed via a pathway distinct from the classical 
clathrin-dependent pathway. Additionally, constitutive uptake of many types of cargos 
in CME-inhibited cells is not negatively affected, providing more evidence for the 
existence of clathrin-independent internalisation pathways (Nichols and Lippincott-
Schwartz, 2001). One such pathway is caveolae-dependent endocytosis. Caveolae are 
membrane invaginations generated from specialized type of microdomain and 
characterized initially by having the presence of caveolin proteins (described later). 
These flask-shaped membrane structures were first observed in the 1950s (Palade, 
1953), but were not extensively investigated until the identification of caveolin proteins 
in 1992 (Kurzchalia et al., 1992, Rothberg et al., 1992). Since then a large number of 
studies have highlighted the importance of caveolae and caveolins in a diverse array of 
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cellular functions ranging from lipid turnover, transport processes, cell growth and 
regulation of signalling molecules (Schnitzer, 2001, Parton and del Pozo, 2013). 
Caveolae have been shown to provide a vehicle for the cellular entry of many entities 
including bacteria, bacterial toxins bound to surface glycolipids, certain viruses such as 
SV40 and glycosphingolipid lactosylceramide (Nabi and Le, 2003, Pelkmans and 
Helenius, 2002, Wolf et al., 1998, Pelkmans, 2005, Vercauteren et al., 2010). However, 
its contribution to cellular endocytosis may be significantly dependent on cell types and 
conditions, implying tissue specific distribution and, probably functions, of caveolae. 
Under the electron microscope, caveolae appear as uncoated flask-shaped invaginations, 
which are typically ~50-100nm in diameter, with spiral or striations around the 
invagination. These bulb structures are invaginated from specific plasma membrane 
microdomains which are rich in cholesterol, glycosphingolipids (GSLs) and 
glycosylphosphatidylinositol (GPI)-linked proteins (known as glycolipid rafts) 
(Anderson, 1998). Caveolae are an abundant feature of many mammalian cell types 
including adipocytes, endothelial cells, smooth muscle and fibroblasts, but have not 
been detected in neurons and leukocytes that lack expression of caveolin proteins (Fra et 
al., 1994). This highlights that the formation of caveolae is dependant on the expression 
of the integral membrane protein caveolin-1 in nonmuscle cells and on muscle specific 
isoform caveolin-3 in myocytes (Drab et al., 2001, Galbiati et al., 2001). Caveolae are 
commonly thought to be specialized, morphologically distinguishable forms of lipid raft 
domains, whose shape is sculpted by caveolin and several other proteins. Although 
caveolin-2 is usually coexpressed and heterooligomerizes with caveolin-1 in many 
nonmuscle cell types and may be involved in some caveolae-like structures, it appears 
not to be obligate for caveolar biogenesis (Razani et al., 2002).   
Caveolin-1 adopts a hairpin-like loop conformation and embeds in the plasma 
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membrane with both N- and C- terminals exposed to the cytoplasm. It binds cholesterol 
and fatty acids and is able to form caveolin homooligomers, which may provide 
attachment sites for caveolin-interacting molecules, concentrating them within caveolae 
(Sargiacomo et al., 1995). Initial reports attributed the assembly of the spiral or striated 
“coat” encircling the cytoplasmic surface of caveolae to the membrane embedded 
caveolin oligomers (Monier et al., 1995). However, a number of recent studies on 
caveolae structure suggest that in addition to caveolin oligomers, polymerised cavin 
proteins are another major component of the unique spiral caveolar “coat” (Kovtun et 
al., 2014, Gambin et al., 2014). The peripheral membrane protein family cavins contain 
four isoforms, cavin 1-4, and are thought to be a key structural component of caveolae. 
The caveolin and cavin families together appear to be sufficient to mediate caveolae 
formation in a cooperative manner (Kovtun et al., 2015). Analysis of the caveolae 
ultrastructure by electron microscopy showed that caveolin proteins are also 
concentrated circumferentially around the narrow neck (Thorn et al., 2003). In addition 
to caveolin, dynamin GTPase, the dynamin-like ATPase EHD2, and the BAR domain-
containing protein Syndapin2 are also enriched at the caveolae neck region, influencing 
the caveolar morphology and dynamics, but these proteins are not essentially required 
for the formation of caveolae (Henley et al., 1998, Morén et al., 2012, Senju et al., 
2011).  
It is commonly thought that the initiation of internalisation via caveolae is induced by 
ligand engagement with various cell surface receptors. In a model proposed by Kovtun 
describing carveolar formation, caveolin oligomers are described as inserting into the 
plasma membrane then clustering with cholesterol and PtdIns(4,5)P2 (Kovtun et al., 
2015). Caveolin-1 is thought not to directly induce membrane curvature but rather to 
stabilise the membrane once deformed (Nabi and Le, 2003). By working in concert, 
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caveolin and the recruited cavin can, together, nucleate membrane curvature, and 
subsequently the coordinated assembly of caveolin-cavin coat remodels membrane to 
shape tubulovesicular structures. Cholesterol is heavily implicated in caveloae 
formation as cholesterol depletion of the plasma membrane causes the caveolae to 
flatten (Rothberg et al., 1990). The invagination and budding of caveolae are also highly 
dependent on the recruitment and the activity of GTPase dynamin (Parton et al., 2006). 
Although caveolin is a functional and structural component of caveolae, its role in the 
formation of caveolae-related vesicular intermediates remains controversial. It has been 
observed that in the absence of caveolin, there is no concomitant inhibition of the 
invagination and budding of vesicular structures sharing fundamental similarities with 
caveolae (i.e. structures which, like caveolae, are specialized forms of cholesterol- and 
sphingolipid-rich lipid raft microdomains and which are dynamin-dependent). This also 
introduces another argument about whether caveolae and equivalent lipid raft-based 
vesicular structures mediate a common or distinct endocytic pathway(s). Unlike CME, 
only a basic understanding of the machinery mediating caveolar endocytosis has been 
obtained. The precise mechanisms by which caveolae form, the role of caveolin, the 
lipid composition of caveolae and the functional relevance of other involved proteins all 
need to be fully explored in the future. This is also the case for caveosomes which are 
the first internalised structures emanating from caveolae at the plasma membrane.  
1.4.2.2.3 Clathrin- and caveolae- independent lipid raft endocytosis 
Many years of extensive examinations on CME and caveolar endocytosis also shed light 
on other types of endocytic pathways. For example caveolae are not essential for 
clathrin-independent lipid raft endocytosis and few markers have been shown to utilize 
caveolae alone for uptake (Parton and Richards, 2003). A number of studies have 
provided evidence for the presence of lipid rafts and the occurrence of lipid raft 
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endocytosis in cells with and without caveolae (Fra et al., 1994, Kirkham et al., 2005).  
Two forms of non-caveolar lipid raft endocytic pathways will be discussed in this 
section: flotillin-dependent endocytosis and CLIC/GEEC (clathrin-independent 
carriers/GPI-enriched early endosomal compartments) - type endocytosis.  
Flotillins are integral membrane proteins that can oligomerise to form discrete 
microdomains in the plasma membrane. Flotillin microdomains have been observed in 
all mammalian cells studied to date, which implies their importance and conserved 
functionality in cellular processes, including endocytosis. A large body of evidence has 
confirmed the involvement of flotillin-rich vesicular structures in the internalisation of 
diverse endocytic cargos, such as GPI-anchored proteins, cholera toxin B subunit 
(CTxB) and also an antibody recognizing CD59/protectin on the plasma membrane 
(Otto and Nichols, 2011). Flotillin -1 and -2 bind each other and colocalise in specific 
plasma membrane regions i.e. flotillin microdomains (Solis et al., 2007, Frick et al., 
2007). The co-assembly of flotillin -1 and -2 may be necessary in the generation of 
membrane curvature and the vesicle budding at the plasma membrane (Frick et al., 
2007).  
Flotillin are found to have topological similarities and homology to caveolin, but the 
two protein families are unrelated in sequence (Bauer and Pelkmans, 2006). Flotillins 
were once thought to be substitutes for caveolin in cell types lacking detectable 
caveolin-1. However, some recent studies discovered that, at least in cultured cells, the 
plasma membrane domains enriched in flotillin are distinct and separate from caveolae 
(Lang et al., 1998, Frick et al., 2007, Glebov et al., 2006). Therefore, flotillin may 
define a unique endocytotic pathway or may function upstream other endocytic 
pathways in the organisation of membrane domains e.g. flotillin was shown to localise 
intensively in the membranes of early CLIC/GEEC intermediates (Lundmark et al., 
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2008a). 
Studies of the internalisation of GPI-anchored proteins, classical markers of lipid raft 
membrane fractions, have revealed the existence of a novel clathrin- and dynamin- 
independent but cholesterol-dependent endotytic pathway. Immediately after 
internalisation GPI-anchored proteins were detected to localise within specific tubular 
membrane structures termed GPI-enriched early endosomal compartments (GEEC) 
(Sabharanjak et al., 2002). This acidic, tubulovesicular membrane structure is seemingly 
responsible for a considerable proportion of internalisation of fluid phase markers 
(Kalia et al., 2006). The GEEC pathway appears to be regulated by Rho family GTPase 
Cdc42, and kinetically separate from the endocytosis of transmembrane proteins 
(Sabharanjak et al., 2002, Chadda et al., 2007). 
In the studies of cholera toxin (CT) cell entry, this protein was found to initially bind a 
ganglioside and marker of lipid rafts, called GM1. CT internalisation was then shown to 
be mediated by clathrin-coated pits and by caveolae (Torgersen et al., 2001). However, 
a remarkable fraction of CT uptake has also been shown to involve a group of novel 
carriers termed clathrin-independent carriers (CLICs) (Kirkham et al., 2005). These 
carriers are clathrin- and dynamin- independent and cholesterol-sensitive like caveolae, 
but have been shown by electron microscopy to be prominently tubular and ring-like in 
morphology (Kirkham et al., 2005). Colocalisation of CT with both fluid phase markers 
and GPI-anchored proteins has been demonstrated, linking CLICs to the previously 
discussed GEEC pathway. This explains why a single CLIC/GEEC pathway is often 
described. Membrane cholesterol is known to be crucial for actively maintaining the 
cluster of GPI-linked proteins on the cell surface. However, the molecular mechanisms 
by which the recruitment of GPI-anchored proteins into these endocytic structures is 
regulated are still poorly understood (Sharma et al., 2004). It has been reported that 
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when the CLIC/GEEC-type endocytic pathway is inhibited or disrupted, CME acts as a 
compensatory pathway to take over the endocytosis of GPI-anchored proteins 
(Sabharanjak et al., 2002). However it is unknown whether the internalised cargos are 
still transported into appropriate intracellular destinations.  
1.4.2.2.4 Macropinocytosis 
Macropinocytosis, a cellular endocytic process for the internalisation of large fluid 
volumes, is characterized by protrusions from the plasma membrane that subsequently 
fuse with themselves or back with the local plasma membrane, resulting in the 
formation of large macropinosomes and the indiscriminate uptake of the entrapped 
extracellular fluid (Jones, 2007, Kerr and Teasdale, 2009). Unlike other pinocytosis 
vesicles, these resulting macropinosomes are irregular in morphology and 
inhomogeneous in size (Mercer and Helenius, 2009). This endocytic pathway has been 
observed in almost all cell types studied to date, usually response to specific stimulation 
of growth factors or other signals. Some specialized cell types can also utilize 
macropinocytosis for the constitutive uptake of extracellular fluid in the absence of 
exogenous stimuli (Jones, 2007, Kerr and Teasdale, 2009). It is difficult to distinguish 
between constitutive macropinocytosis and a term referred to as fluid phase uptake that 
for example will also allow entry of components in the extracellular medium without 
the need for a receptor or binding to the plasma membrane.  
The most unique character that distinguishes macropinocytosis from other pinocytic 
processes is thought to be the formation of membrane ruffles during macropinocytic 
uptake. In most macropinocytic events, the plasma membrane ruffles usually fall into 
three distinct subtypes: planar lamellipodia, circular ruffles and blebs (Figure 1.5), 
depending on the cell type and the ligand. The generation of the lamellipodia-like 
protrusions and the circular ruffles is initiated by actin polymerisation/remodelling, 
!! 28!
whereas the formation of blebs is probably resulted from the destabilisation of local 
actin cortex (Mercer and Helenius, 2009). Actin is critical for macropinocytosis to occur 
and this process is therefore linked closely to actin binding proteins. This is typifies 
when growth factors such as Epidermal growth factor (EGF) is added to cells 
expressing epidermal growth factor receptor (EGFR). Activation of EGFR and other 
receptor tyrosine kinases (RTKs) in turn activate a signalling cascade, for example, Ras 
superfamily GTPases-involved pathways, causing the extension of sheet-like membrane 
ruffles by large-scale localised rearrangement of actin filaments beneath the plasma 
membrane (Kirkham and Parton, 2005). The autophosphorylation of EGF receptors can 
be activated by binding of extracellular EGF or signals inside cells, and the 
phosphorylated receptors then recruit kinases and adaptor proteins which assemble into 
complex near the plasma membrane. The assembled protein complex stimulates 
phosphorylation of certain membrane components (lipids and proteins), which results in 
localised rearrangement of the actin cytoskeleton (Swanson, 2008).  
 
 
Figure 1.5 Different forms of plasma membrane protrusions involved in macropinocytosis. A) 
Planar lamellipodia. B) Circular ruffle. C) Bleb. The red lines represent actin filaments. 
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Upon activation by RTKs, Ras GTPases trigger three parallel signalling pathways 
respectively involving Rho GTPase Rac1, Rab GTPase Rab5 and ARF GTPase Arf6. 
These cell factors work in concert to modulate the formation of membrane ruffles, the 
maturation of macropinosomes and the subsequent membrane trafficking (Lanzetti et 
al., 2004). Rac1 is a well-known regulator of macropinocytosis. Once activated, Rac1 in 
turn switches on the activity of various actin effectors that are involved in actin 
dynamics and stability, and thus initiates the plasma membrane ruffling of all three 
types (Ridley et al., 1992, Mercer and Helenius, 2008). Another Rho family member 
Cdc42 is essentially involved in membrane ruffling during macropinocytic 
internalisation in immature dendritic cells, where macropinocytosis occurs in a 
continuous manner and does not require the presence of external stimulus (Garrett et al., 
2000, Norbury, 2006). However, it is still no evidence to support the role of Cdc42 in 
growth factor-induced macropinocytosis. Rab5 is a well-known molecular marker of 
early endosomes; its increased expression was found to result in increased formation of 
circular ruffles during macropinocytosis. This protein relocalises along circular ruffles 
when cells are activated by platelet-derived growth factor (PDGF). This is in association 
with RN-Tre (related protein N-terminal threonine), a Rab5 effector that interact with 
actin filaments to promote the crosslinking between F-actin and ruffles (Lanzetti et al., 
2004). Another Rab5 effector Rabankyrin-5 was observed to localise to newly formed 
macropinosomes in epithelial cells and fibroblasts, and its overexpression promoted the 
formation of macropinosomes and thereby stimulated fluid phase uptake. In the same 
study, Rabankyrin-5 probably had a role in leading Rab5 to nascent macropinosomes 
(Schnatwinkel et al., 2004). GTP-binding protein Arf6 is best known for its 
involvement in endocytic membrane trafficking and plasma membrane remodelling via 
influence on cortical actin (Radhakrishna et al., 1999, Donaldson, 2005). The activated 
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Arf6 has been shown to recycle Rac1 to the plasma membrane and thus to promote the 
formation of macropinosomes (Radhakrishna et al., 1999). A more recent study 
suggested that Arf6 had a role in stabilising or further facilitating the formation of 
membrane curvature, which was probably conducive to the biogenesis of 
macropinocytosis (Lundmark et al., 2008b).  
In addition to small GTPases, several kinases are also implicated in macropinocytosis. 
One of the most vital is the serine/threonine kinase p21-activated kinase-1 (PAK-1) that 
interacts with and is activated by Rac1 or Cdc42 (Dharmawardhane et al., 2000). 
Extensive studies have shown that PAK-1 is required for all forms of macropinocytosis 
and has a role for all stages of macropinocytosis (Dharmawardhane et al., 2000, Parrini 
et al., 2005, Liberali et al., 2008). After activated, PAK-1 is shuttled to the plasma 
membrane where it activates a number of actin effectors that participate in the following 
membrane remodelling events including ruffling/blebbing and macropinosome 
formation (Mercer and Helenius, 2009). Additionally, some other kinases such as 
protein kinase C (PKC), another serine/threonine kinase, and c-Src, a non-receptor 
tyrosine Src-family kinase (SFK) also contribute to macropinocytosis following ligand 
induced receptor activation. On activation, these kinases are targeted to and associate 
with the plasma membrane and subsequently stimulate membrane ruffling and 
macropinocytosis (Miyata et al., 1989, Amyere et al., 2000, Kasahara et al., 2007). 
Macropinocytosis is also dependent on several other factors. Like PAK-1, Na+/H+ 
exchangers are another key group that are needed for all forms of macropinocytic 
processes. Inhibition of the normal functions of Na+/H+ exchangers [for example by 
amiloride or its derivative 5-(N-ethyl-N-isopropyl) amiloride (EIPA)] has been shown 
to impede the induction of membrane ruffling and thus block the macropinocytic 
internalisation (West et al., 1989, Veithen et al., 1996, Meier et al., 2002). Membrane 
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cholesterol is also important to macropinocytosis. The localisation of Rac1, Arf6 and 
other signalling factors to the macropinocytic membrane is dependent on membrane 
cholesterol (Grimmer et al., 2002, Kwik et al., 2003), and both membrane ruffling and 
macropinocytosis are inhibited by cholesterol depletion (Grimmer et al., 2002). It 
should be noted here that experiments using membrane cholesterol depletion are usually 
designed to examine the role of lipid rafts in cell functions. However, it has been shown 
that the depletion of cholesterol from the plasma membrane has a global effect on actin 
organisation through the loss or redistribution of plasma membrane PtdIns(4,5)P2 (Kwik 
et al., 2003). Thus care must be taken in optimising methods to inhibit specific 
endocytic pathways to avoid disrupting the plasma membrane composition and 
integrity.  
Like other membrane microdomain-dependent pathways, it is presumed that 
concentration/enrichment of specific lipids at heavily activated areas of the plasma 
membrane induces local intracellular changes that are responsible for the morphological 
characters of macropinocytosis. Phospholipid phosphatidylinositol (PtdIns) is abundant 
in the inner leaflet of the plasma membrane. A product of PtdIns phosphorylation 
PtdIns(4,5)P2 can bind to a variety of proteins that are involved in modification of 
membrane chemistry and assembly of actin filaments and enhance their activity. This 
may explain the increased local concentrations of PtdIns(4,5)P2 in membrane ruffles 
during macropinocytosis (Swanson, 2008). Studies have suggested that PtdIns(4,5)P2 
works in concert with activated Rho GTPases including Cdc42 and Rac1 to initiate actin 
polymerisation for the induction of membrane ruffles (Kerr and Teasdale, 2009). As 
macropinocytosis is highly dependent on actin dynamics that mediates the formation of 
actin-based ruffles and blebs, numerous actin effectors controlling/regulating actin 
assembly/disassembly, actin stabilisation and actin connection with membrane are 
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thought to be necessarily involved in this endocytic process. Actin dynamics is central 
to this thesis, therefore a separate section on actin is provided later in Section 1.5. 
Receptor activation by a ligand is not the only mechanism by which macropinocytosis 
can be stimulated as several other entities including bacteria and viruses have been 
observed to induce membrane ruffling and subsequently be internalised together with 
fluid into macropinosomes (Francis et al., 1993, Watarai et al., 2001). In addition, 
CPPs, as small molecules, can also initiate this internalisation process, presumably 
stimulating chemical changes that are otherwise initiated by receptor-ligand interactions 
(Futaki et al., 2007).  
Although substantial efforts have been made to characterize macropinocytosis since the 
first observation of macropinosomes in 1931 (Lewis, 1931), gaps in our understanding 
still remain especially in the context of identifying proteins and lipids that are unique in 
regulating macropinocytosis over other endocytic pathways. These issues in the field of 
macropinocytosis need to be addressed in the future. 
1.4.2.3 Intracellular trafficking after endocytosis 
Cellular uptake via direct translocation allows the internalised cargo to be available 
immediately in the cytosol. If endocytosis is the route of entry then the vector and 
delivered cargo may be trafficked to a number of cell destinations or recycled out of the 
cell (Figure 1.4). There is often the case, especially for nucleotide delivery for escape of 
the cargo into the cytosol and possibly the nucleus.  
The intracellular transport of newly formed, plasma membrane derived endocytic 
vesicles requires the functional participation of a diverse array of membrane-enclosed 
compartments and organelles. These membrane-based structures include early 
endosomes (also called sorting endosomes where cargos are sorted and prepared for 
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future transport), late endosomes or multivesicular bodies (MVBs), recycling 
endosomes, lysosomes, endoplasmic reticulum (ER) and Golgi complex. The basic 
steps involved in vesicular transport can be generally described as: 1) vesicle budding 
from donor compartment or organelle, a process during which selected cargos are 
incorporated into the forming vesicles; 2) vesicle fusion, whereby the entrapped cargos 
are loaded into a specific acceptor compartment or organelle; 3) retrograde transport, a 
retrieval process to return transport machinery components and escaped resident 
proteins from the acceptor back to the corresponding donor compartment (Bonifacino 
and Glick, 2004). As a consequence of a series of tightly regulated movements, the 
cargos can reach their destinations within cells or can be recycled.  
Depending on the cargo and the endocytic pathway(s) used for internalisation, the 
materials that are confined in early endosomal compartments can either be sorted into 
recycling endosomes, or directed into the classical endosome-lysosome pathway, or 
delivered to the ER via the Golgi complex. The significant contribution of actin 
cytoskeleton in coordinating the organisation and dynamics of the mentioned 
intracellular structures will be discussed in Section 1.5. In the classical endosome-
lysosome pathway, a cargo is transported from early to late endosomes and then to 
lysosomes. The cargo may also appear in multivesicular structures that are found within 
late endosomes and may also be delivered to lysosomes or exocytosed as exosomes 
(Raposo and Stoorvogel, 2013). As endocytic cargos proceed through the 
endolysosomal pathway, they experience pH drop from neutral to pH 6.0-6.5 in early 
endosomes, with further decrease from 6.0 to 4.5 during the transport form late 
endosomes to lysosomes (Maxfield and McGraw, 2004). This fall in pH within 
endosomal systems is required for a number of processes including activation of late 
endosomal and lysosomal hydrolases (e.g. cathepsins) and the disassociation of ligands 
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from their co-internalised cell surface receptors, allowing for their recycling and re-use 
at the plasma membrane [e.g. Low Density Lipoprotein (LDL) receptor]. For the 
transferrin receptor (TfR) acidification of endosomes allows for release of iron from 
transferrin, which in turn allows both receptor and ligand (still as a complex) to recycle 
back to the plasma membrane (Maxfield and McGraw, 2004). This does not involve the 
lysosomes but recycling endosomes that coordinate the recycling of both plasma 
membrane components and resident Golgi enzymes back to their sites of action. Most 
often, the return of cargo to the outside of cell generally needs to be avoided in the 
context of drug delivery, thus control of recycling is an important therapeutic 
consideration.  
The classical clathrin-dependent pathway transports most of its contents into late 
endosomes and lysosomes for degradation, whereas some of the materials can be 
recycled back to the plasma membrane (Lakadamyali et al., 2006, Conner and Schmid, 
2003). Material internalised from caveolae as caveosomes have been proposed to be 
delivered to the Golgi apparatus or ER by retrograde transport (Le and Nabi, 2003, 
Nichols, 2002). However, more recent studies suggested that lysosomal delivery could 
also occur from caveosomes (Parton and Howes, 2010, Hayer et al., 2010). 
The cellular destination for macropinosomes is still largely unresolved but is known to 
be cell type- and induction mode- dependent (Wadia et al., 2004, Jones, 2007). The first 
organelle formed from the plasma membrane during macropinocytosis is the 
macropinosome that varies in size from hundreds of nanometers to >2µm diameter. In 
macrophages, macropinosomes undergo a route similar to endosomes, as characterized 
by the gain and loss of classical early/late endosomal markers such as TfR and Rab7 
before fusion with lysosomes (Racoosin and Swanson, 1993). A similar fate of 
macropinosomes was also observed in Dictyostelium discoideum and in mammalian 
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cells with Src kinase overexpression (Maniak, 2001, Kasahara et al., 2007). In HeLa 
cells, macropinosomes rarely interact with other endosomal membrane structures and 
their encapsulated contents appear to return to the extracellular environment through 
recycling pathways (Meier et al., 2002). Similar to the observations in HeLa cells, the 
majority of macropinosomes in human carcinoma A431 cells recycle back to the cell 
surface, although macropinosomes in these cells obtain a number of early endosome 
proteins that are required for homotypic, i.e. macropinosome-macropinosome fusion 
(Hewlett et al., 1994, Roberts et al., 2000, Hamasaki et al., 2004). There was little 
evidence showing the fusion of macropinosomes in A431 cells with other endocytic 
membrane structures (Hewlett et al., 1994).  
1.4.3 CPP uptake via endocytosis 
All the known endocytic pathways have been implicated in the cellular entry of CPPs 
complexed to small cargos such as fluorophores through to large nanoparticles. As 
suggested earlier the choice of cargo is likely to have a major effect on uptake 
mechanism(s) (Jones and Sayers, 2012, Cleal et al., 2013). A major limitation of most 
of the studies on endocytic internalisation of CPPs lies in the fact that they have been 
confined to in vitro analysis using one or several of a range of 
pharmacological/chemical inhibitors of endocytosis. These inhibitors indeed possess 
several advantages over some other molecular biological method in terms of targeting 
endocytic proteins. For instance, the exposure period to inhibitors in vitro studies is 
usually short, which is very likely to preclude the development of side effects and/or 
mechanism compensation. However, one major issue that may undermine the use of 
these inhibitors is the lack of specificity. It is often for a particular inhibitor to interfere 
with not only an endocytic pathway of interest but also alternative entry routes. As these 
inhibitors are notoriously non-specific and also because of the fact that they are usually 
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cytotoxic, it often difficult to interpret the data and make generalizations (Ivanov, 2008, 
Vercauteren et al., 2010). Moreover, the poor specificity of these 
pharmacological/chemical inhibitors makes the specific measurement of the 
contribution of each endosomal route to the uptake of CPP extremely hard to achieve.  
CME has been reported several times to provide for a mean of entry for both CPP alone 
and CPP-protein complex (Richard et al., 2005, El-Andaloussi et al., 2007). However, 
CPP uptake events mediated by clathrin-dependent route may be incidental, because the 
binding of specific ligands to their receptors is thought to be essential for the formation 
of clathrin-coated invagination at the plasma membrane. Several studies have analysed 
the uptake of CPPs when co-incubated with endocytic markers for specific pathways 
such as transferrin for CME. Indeed, in these co-incubation studies, a proportion of 
CPP-conjugates have been found to be co-internalised with transferrin suggesting they 
entered the same pathway (Nakase et al., 2004). But the possibility exists that this may 
be due to extracellular electrostatic interactions between the CPP and the transferrin. 
When they are separately incubated with cells, i.e. at different time points, co-
localisation in endocytic compartments is significantly reduced (Padari et al., 2005). 
Whether certain CPPs can in fact exploit, as-yet-unidentified receptors and trigger the 
subsequent uptake via CME is still to be determined.  
A major focus of work has concentrated on the possibility that CPPs trigger 
macropinocytosis and enter via this pathway. This was initially proposed for CPP-
protein conjugates and also CPPs attached to fluorophores (Nakase et al., 2004, Wadia 
et al., 2004, Kaplan et al., 2005). These studies suggested that CPPs were inducing fluid 
phase uptake similar to growth factor activation and that CPP uptake was dependent on 
actin. Macropinocytosis was not shown to be required for the cellular delivery of 
protein cargo using arginine-rich peptides in the presence of pyrenebutyrate, which is a 
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negatively charged counteranion with high hydrophobicity. Here, addition of 
pyrenebutyrate promoted rapid, direct passage of the CPP-protein cargos and yielded 
cytosolic cargo distribution (Takeuchi et al., 2006). Later work from the Dowdy 
laboratory suggested that macropinocytosis was required for the fraction of CPP that 
escaped into the cytosol over the vast majority that either associated with the plasma 
membrane or was retained inside endocytic organelles (Gump et al., 2010). This study 
also challenged the concept that uptake and intracellular fate of cationic CPPs were 
dependent on the cell surface GAGs. 
Work studying CPP uptake and macropinocytosis has largely been dependent on 
analysing actin dynamics by fluorescence microscopy and flow cytometry. In addition, 
pharmacological/chemical inhibitors of macropinocytosis (e.g. EIPA) and actin 
dynamics (e.g. cytochalasin D) have played a major role in assigning macropinocytosis 
to CPP uptake. Chapter 3 and 4 of this thesis expand on these studies. 
A role for caveolae has been proposed in the cellular uptake of the fusion protein Tat-
GFP (Ferrari et al., 2003, Fittipaldi et al., 2003), and depletion of caveolin-1 from cells 
impaired the cellular delivery of CPP-protein complexes (Säälik et al., 2009). The 
involvement of flotillin-positive endosomes in the cellular delivery of CPP-protein 
complexes has not been firmly confirmed and in certain cell lines including HeLa cells, 
the absence of flotillin does not show any substantial influence on the protein delivery 
by transportans (Säälik et al., 2009). Studies from the Jones laboratory also showed that 
the cellular uptake of polycationic peptides (R8 and Tat) was not affected in flotillin-1 
depleted cells (Al Soraj et al., 2012). 
When detached from the plasma membrane, the endocytic vesicles containing CPP 
cargos move deeper into the cytoplasm and are targeted to different destinations. In a 
model describing common features of the intracellular transport of these vesicles 
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(Räägel et al., 2009, Räägel and Pooga, 2011), the initial small vesicular bodies budding 
from the plasma membrane are usually characterized by low CPP concentrations and 
varied pH values. During the course of internal fusion, more and more entrapped cargos 
accumulated in fewer and fewer vesicular structures, resulting in membrane 
compartments of larger body sizes and higher CPP concentrations. The final destination 
for the internalised CPP cargos is usually dependent on several parameters such as 
cargo properties and/or concentrations (Sigismund et al., 2005), and also the vesicle 
pool in which the cargo reside: in the acidic lysosomes for degradation or in membrane 
compartments with medium pH values that encourage cargo escape before digestion. 
The source of these neutral-pH vesicles is not yet known although the non-acidic 
caveosomal intermediates have been implicated (Pelkmans et al., 2001). Non-acidic 
vesicles, believed to have been formed during the process of caveolar endocytosis, were 
observed by Räägel’s research group. Moreover, in the same study, arginine-rich 
peptides appeared to possess high capacity for inhibiting acidification of the membrane-
bound structures they were contained in (Räägel et al., 2009). 
1.5 Actin cytoskeleton and actin dynamics  
1.5.1 Actin filaments as part of the cytoskeleton  
As one of the most abundant and highly conserved proteins in all eukaryotes, actin is 
involved in a myriad of morphological and functional cell roles. Actin’s cellular 
contributions include: complementing the other cytoskeletal polymers microtubules and 
intermediate filaments (IFs) to establish internal mechanical support, providing actin 
filament “tracks” for the trafficking of intracellular membrane vesicles and driving cell 
movement achieved through actin dynamics (Pollard and Cooper, 2009). Additionally, 
actin is involved in many other important cellular processes including cell division and 
cytokinesis, muscle contraction, establishment and maintenance of cell shape and cell 
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signalling (Dominguez and Holmes, 2011).  
In addition to actin filaments (also known as microfilaments), two other filamentous 
polymers, microtubules and IFs, are also essential components of the cytoskeletal 
network in animal cells. Interactions between these three cytoskeletal elements reinforce 
the cytoskeleton, despite the rapid turnover (on time scales of seconds to minutes) of the 
polymers. To some extent, the cytoskeleton can sense external mechanical features and 
force applied to the cell. Microtubules are hollow cylinders that are comprised of 
polymerised heterodimers of alpha and beta tubulin. The polymerised dimers form 
protofilaments which associate laterally to generate an imperfect helix, each turn of 
which is typically made up of 13 protofilaments (Weisenberg, 1972). Microtubules are 
detectable throughout the cytoplasm and are responsible for the formation of the 
internal structural support of cilia and flagella. Microtubules also participate in the long-
range intracellular transport of certain substances and large vesicles/organelles, and 
chromosome separation during cell division via the formation of mitotic spindles 
(Fletcher and Mullins, 2010).  
Another cytoskeletal component, intermediate filaments (IFs) are commonly observed 
as tetramer structures formed by interaction of two anti-parallel helices (Herrmann et 
al., 2007). The subunits of IFs can be a variety of IF proteins sharing both common 
amino acid sequences and similar structural characteristics. Some examples of IFs 
include keratins in epithelial cells, vimentin in mesenchyme and nuclear lamins. IFs are 
essentially required to maintain the shape of cells and nuclear envelope via the tension 
borne in the network. Additionally, they also provide organelles with anchoring sites 
within cytoplasm and transmit signals from cell membrane to nucleus (Lodish et al., 
2000).  
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1.5.2 Monomeric G-actin and polymeric F-actin  
In eukaryotic cells, globular actin (G-actin) is a 43 kDa monomeric ATP-binding 
protein, which is highly evolutionarily conserved due to its essential role in cellular 
processes and survival (Pantaloni et al., 2001). G-actin can undergo cycles of self-
polymerisation into thin filaments in muscle cells or microfilaments in non-muscle cells 
(Fujita et al., 1996). This assembly process is driven by hydrolysis of the actin-bound 
ATP, and is reversible i.e. the actin filaments can also undergo depolymerisation to 
retain the pool of free G-actin. Actin filaments are right-handed, double-chained and 
single-stranded helix structures that contain highly dynamic barbed ends where new 
actin subunits incorporate and less active pointed ends where formed filamentous actin 
disassembles (Figure 1.6). The barbed end and the pointed end of the same actin 
filament are distinct in structural and biochemical properties (Campellone and Welch, 
2010). 
 
Figure 1.6 Monomeric actin (G-actin) assembly into filamentous actin (F-actin). A) Ribbon diagram 
of G-actin showing the typical four-domain architecture with the ATP binding site and the target-binding 
cleft. B) After activated by ATP-binding, the ATP-bound monomeric actin can then be polymerised into 
actin filaments (F-actin) at free barbed ends. This polymerisation process is driven by hydrolysis of the 
actin-bound ATP to ADP and inorganic phosphate (Pi). Actin filaments can also undergo 
depolymerisation at pointed ends to retain the pool of free G-actin.  
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Structural data indicates that G-actin folds into two lobe-like α/β-domains, which are 
separated by a nucleotide-binding cleft and a target-binding cleft (Figure 1.6A). The 
two major actin domains are defined by their location within the filaments: the small 
outer domain (comprised of subdomains 1 and 2), and the large inner domain 
(composed of subdomains 3 and 4) (Kabsch et al., 1990) (Figure 1.6A). The target-
binding cleft of actin provides the interaction site for a wide variety of actin-binding 
proteins (ABPs) and certain small molecules such as actin disruptors (Dominguez, 
2004). 
Actin filament turnover is mainly regulated by a diversity of ABPs, some of which 
importantly participate in filament dynamics that includes nucleation, elongation, 
capping, severing and disassembly. The nucleotide-binding cleft, as its name implies, 
acts as the binding target for ATP and Mg2+. Here soon after polymerisation of actin 
subunits into filaments, ATP is enzymatically hydrolysed to ADP and inorganic 
phosphate (Pi) (Figure 1.6B). Under physiological conditions, actin monomers can be 
“activated” by ATP-binding. ATP-bound actin can then be polymerised into actin 
filaments (F-actin) at free barbed ends, which can be exposed through uncapping, 
severing pre-existing filaments or ARP2/3 complex and formin-mediated monomer 
nucleation (Zigmond, 2004, Condeelis, 2001). The incorporated actin subunits are all 
orientated in the same direction, resulting in a head-to-tail overall arrangement. This 
gives actin filaments molecular and structural polarity (Pollard and Borisy, 2003).  
1.5.3 Actin dynamics  
The pool of monomeric actin in the cytoplasm is buffered by the actin binding protein 
(ABP) profilin, which prevents actin monomers from spontaneous nucleation to form 
actin dimers and trimeric nuclei (Schlüter et al., 1997). This is thought to partly explain 
the rarity of spontaneous actin assembly. Upon receiving activation from signalling 
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pathways, nucleation-associated factors will directly nucleate actin. In mammalian cells, 
the actin-related protein 2/3 complex (ARP2/3), a number of ARP2/3 activators and 
formin proteins have all been revealed to directly promote actin nucleation (Goley and 
Welch, 2006, Chesarone et al., 2010, Stradal and Scita, 2006). The first identified actin 
nucleator was ARP2/3. This 220 kDa complex contains seven stably associated 
polypeptides including ARP2, ARP3 and five additional subunits ARPC1-ARPC5 
(Goley and Welch, 2006). The ARP2/3 complex is unique among the known filament 
nucleators because of its ability to nucleate branched actin filaments. Based on 
numerous studies on the ARP2/3 complex, all the seven subunits bind to the side of the 
parental filament as a whole. However, only ARPC2 and ARPC4 form intimate contacts 
with the existing filament, whereas ARP2 and ARP3 are presumed to act as the first two 
subunits of the pointed end of the nascent filament (Rouiller et al., 2008) (Figure 1.7A). 
The nascent filament can be subsequently elongated at the free barbed end. The primary 
role of ARP2/3 complex in this event is to join the existing and nascent filaments at an 
angle to form Y-branches (Figure 1.7B). However, the ARP2/3 complex itself is not 
sufficient to initiate actin nucleation. Efficient nucleation also relies on ARP2/3 
activation, which is achieved through ARP2 phosphorylation and interactions with 
WCA domain-containing nucleation-promoting factors (NPFs). A WCA domain 
contains at least one Wiskott-Aldrich syndrome protein (WASP) homology 2 [WH2] 
domain that can bind monomeric actin, plus a connector sequence and an acidic 
segment that binds and recruits the ARP2/3 complex to its action site (LeClaire et al., 
2008, Hertzog et al., 2004, Chereau et al., 2005) (Figure 1.7B).  
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Figure 1.7 The nucleation/assembly of actin filaments mediated by ARP2/3, JMY or formin. A) 
The ARP2/3 complex is composed of seven subunits (ARP2, ARP3, ARPC1-C5), among which ARPC2 
and ARPC4 are responsible for the intimate contacts with the existing filament, whereas ARP2 and ARP3 
are presumed to act as the first two subunits of the pointed end of the nascent filament. WCA domain 
from NPFs bring together the ARP2/3 complex and actin monomers to nucleate new actin branches from 
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the side of preexisting filaments. B) The ARP2/3 complex initially binds to WCA domain from NPFs, 
inducing a conformational change that primes the complex for activation. This activation occurs upon 
binding of the WCA–actin–ARP2/3 complex to the preexisting actin filament near the barbed end. ATP is 
hydrolyzed on ARP2 along with or shortly after nucleation of the nascent filament. The WCA domain 
dissociates from the action site, while the ARP2/3 complex remains at the pointed end of the filament. 
The following elongation of the preexisting filaments and the nascent filaments is driven by ATP 
hydrolysis and phosphate release. C) JMY has the ability to nucleate unbranched actin filaments without 
the presence of ARP2/3 because of its additional WH2 domain and monomeric actin-binding linker. D) 
Two monomeric FH2 domains are joined together by flexible linkers to form an active ring-like FH2 
homodimer, which then binds to actin monomers to initiate unbranched actin filament assembly. This 
process is assisted by additional factors such as APC dimer. The FH1 domains of the formin dimer 
interact with and bind to profilin, and then deliver the profilin-actin complex to the barbed end for further 
actin incorporation. During the process of filament elongation, APC dimer remains at the site of 
nucleation while formin dimer move towards the growing barbed end.  
 
NPFs can be divided into five sub-groups according to their diverse regulatory amino 
acid terminals: 1) WASP and neuronal WASP, which are the best characterized; 2) 
WASP-family verprolin homologue isoforms (WAVE1-3); 3) WASP and WAVE 
homologue (WASH); 4) WASP homologue associated with actin, membranes and 
microtubules (WHAMM) and 5) junction-mediating regulatory protein (JMY) (Stradal 
and Scita, 2006). In contrast to mammalian WASP that is specifically expressed in 
haematopoietic cells, neuronal WASP (N-WASP) can be found in most cell types. 
Unlike the other identified NPFs, N-WASP itself has very little NPF activity due to its 
autoinhibitory GTPase-binding domain (GBD) (Miki et al., 1996). Normally, the 
autoinhibitory portion of the GBD inactivates the connector sequence and acidic 
segment of the WCA domain via intramolecular interaction. The binding and/or 
interaction of a wide range of signalling molecules such as the small Rho GTPase 
Cdc42 with the GBD, causes a conformational change in the GBD and as a 
consequence, WCA domain is free to recruit ARP2/3 for actin polymerisation. The 
absence of active N-WASP is suggested to impair many actin-dependent cellular 
functions including dorsal membrane ruffling, membrane invagination and fission, and 
endosomal trafficking (Campellone and Welch, 2010). In contrast to N-WASPs, the 
WAVE family NPFs are not autoinhibited as they do not contain the GBD. These active 
WAVE isoforms are primarily responsible for ARP2/3 activation during membrane 
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protrusion and cell motility (Suetsugu et al., 2003). NPF WASH has been shown to 
interact with the barbed end capping protein and protein FAM1 that localises WASH to 
endosomes (Derivery et al., 2009, Gomez and Billadeau, 2009). Mammalian WASH is 
associated with early and recycling endosomes: by mediating the local activity of 
ARP2/3, WASH controls the shape of these membrane compartments and regulates the 
trafficking to late endosomes or the recycling to the plasma membrane or the trans-
Golgi (Duleh and Welch, 2010). The recently identified JMY is intensively localised in 
the nucleus of many cell types, but can also assemble in the lamellipodia of migrating 
cells. JMY is unique in its ability to nucleate actin even without the presence of ARP2/3 
because it has an additional WH2 domain and monomeric actin-binding linker 
compared with the other NPFs (Zuchero et al., 2009). However, actin filaments 
polymerised by JMY are unbranched (Figure 1.7C). WHAMM is enriched in the cis-
Golgi and tubulovesicular membrane influencing the morphology of Golgi and the 
trafficking of relevant membrane systems (Campellone et al., 2008).  
Among all the identified actin nucleators, only ARP2/3 complex is known to produce 
branched filaments. The best-characterized nucleator facilitating the assembly of 
unbranched actin is the formin family, which is conserved in all eukaryotes and 
characterized by the presence of formin homology (FH) domains FH1 and FH2 
(Chesarone et al., 2010) (Figure 1.7D). Studies on crystal structures of the formin FH2 
domains showed that two monomeric domains are joined together by flexible linkers to 
form an active ring-like FH2 homodimer (Lu et al., 2007). Unlike the ARP2/3 complex, 
which caps the pointed end of nascent filament, FH2 dimer localises to the barbed end 
and initiates processive filament elongation (Pollard, 2007). The elongating barbed end 
of an actin filament is protected from other capping proteins. Moreover, the competition 
between the formin and its displacement factors for the growing barbed end is crucial 
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for the determination and regulation of filament length (Chesarone et al., 2009). As 
proposed, the FH2 dimer controls actin assembly through adopting alternating 
conformations. Actin incorporation is inhibited in a closed conformation as FH2 dimers 
binds the two terminal actin subunits; while in an open conformation, the addition of 
new actin monomers to the filament is enabled. The proline-rich FH1 domain is 
adjacent to FH2 domain. It binds and delivers profilin-actin complex to the barbed end 
for further actin incorporation (Vavylonis et al., 2006) (Figure 1.7D).  
As previously mentioned, spontaneous actin nucleation and elongation are strongly 
suppressed by the actin monomer-binding protein profilin and the barbed end-capping 
protein. Thus, the presence of actin nucleation factors is essentially required in the 
polymerisation of actin filaments to overcome these barriers. Most of the cellular actin 
assembly requires the collaboration of two or more such factors to trigger the initial 
nucleation. For example, the tumor suppressor adenomatous polyposis coli (APC) 
works with the formin mDia1 to create new actin nucleation sites in cells by forming 
APC-mDia1 complexes. The two components are then separated in the subsequent 
process of filament elongation, but still retain their independent contacts with the 
filament: APC remains at the site of nucleation while mDia1 move towards the growing 
barbed end (Breitsprecher et al., 2012) (Figure 1.7D).  
As a nucleotide exchange factor, the other role of profilin is to promote the exchange of 
ADP-actin (disassociated from the pointed end of the filament) for ATP-actin, which 
allows the recycling of actin subunits for future actin assembly at barbed ends (Didry et 
al., 1998). Another mechanism utilized by cells to maintain a useable pool of 
unpolymerised actin sufficient to sustain necessary actin assembly is the sequestration 
of monomeric actin by thymosin-β4. Unlike profilin, the small protein thymosin-β4 
prevents both actin nucleation at pointed end and filament growth at barbed end. 
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However the association of thymosin-β4 with actin monomer is weaker than that of 
profilin. This allows a competition between profilin and thymosin-β4 for binding to 
actin monomers. As a result, in the pool of free actin subunits, profilin-actin complexes 
are ready for incorporation at the barbed end and thymosin-β4 keeps the remaining actin 
in reserve (Pollard and Borisy, 2003).  
The initial stages of actin polymerisation proceed slowly because the small actin 
oligomers are not sufficiently stable. Once an actin filament reaches a threshold length, 
the elongation at the barbed end can be very rapid. However, the fast filament 
elongation is transient, as the capping proteins, such as heterodimeric CapZ in muscle 
and gelsolin in higher eukaryotes, can bind the barbed end and impede filament growth 
(Cooper and Schafer, 2000, Sun et al., 1999). The growth of barbed ends blocked by 
capping proteins may be recovered by local factors such as PtdIns(4,5)P2, which 
displace capping proteins from barbed ends (Schafer et al., 1996). Rapid elongation at 
barbed ends depletes the monomeric actin pool, which may reduce the elongation rate 
of newly formed actin filaments. By blocking the majority of the barbed ends with high 
affinity, capping proteins limit the length of the growing actin filaments and 
compensate for the consumption of the monomer pool. Another mechanism by which 
the actin monomer pool is replenished utilizes ADF (Actin Depolymerising Factor) 
/cofilin proteins. These proteins bind to the side of ADP-actin filament and accelerate 
the rate of actin depolymerisation at the pointed end (Carlier et al., 1997).  
1.5.4 Myosin motors in actin-based motility  
As a part of the interconnected cytoskeleton, actin filaments not only provide structural 
support and organisation to cells, but also act as tracks for the movement of protein 
motors called myosins. The myosin superfamily are ATPases, which convert chemical 
energy into mechanical energy through ATP hydrolysis and the subsequent 
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conformational changes to generate force and power movements. Thus in addition to 
actin polymerisation, the interactions between myosin motors and actin filaments are 
essential for many forms of cellular movements and also contribute to the transport 
and/or anchoring of organelles, vesicles and other intracellular components (Woolner 
and Bement, 2009).   
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Figure 1.8 Molecular organisation of three types of myosin molecules and their interactions with 
actin filaments. A) Myosin I, II and V share a motor domain on their heavy chains at the amino-terminus 
(the 'head' domain), but differ considerably at the carboxy-terminus (the 'tail' domain). Myosin II is 
composed of two heavy chains that homodimerize via an extended coiled-coil tail. Each heavy chain 
binds a pair of essential and regulatory light chains. These rodlike tail sequences of multiple myosin II 
dimers self-associate in an anti-parallel fashion to assemble into bipolar thick filaments, serving as an 
essential part of the contractile apparatus. The heavy chains of myosin V are bound by identical 
calmodulin light chains and the tail domains only form coiled-coil structure in the region adjacent to the 
neck and leave two tail ends untwisted to provide cargo binding domains. Myosin V can interact with 
different organelles and walk on an actin filament towards the barbed end. Myosin I is a monomer only 
containing a globular head domain and a comparatively short tail. It usually interacts with calmodulin 
light chain to form complex. The tails of myosin I molecules also provide binding domains for some 
adaptor proteins or other binding proteins. Myosin I can either associate with membranes or bind to an 
actin filament, thus mediating actin-based movement – traffic and protrusions. B) In the current model 
describing how myosin molecules power movements along actin, myosin initially binds to actin in the 
absence of ATP. The binding of ATP to myosin causes a rapid disassociation of the myosin head domain 
from actin filament. The subsequent hydrolysis of the bound ATP results in a conformational change in 
the mysoin head and re-anchors myosin on the actin filament at a new position. The release of ADP and 
Pi makes the myosin head regain its original conformation and it is this movement that moves the actin 
for one step.  
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Myosins are the only known molecular motors involved in actin–based motility 
(Hartman and Spudich, 2012). The first myosin (myosin II) was discovered by Kühne in 
1864 in muscle, where in association with actin filaments, it fuels muscle contraction (a 
special form of movement). During 1960s, the presence of myosins (including the 
conventional myosin II) in other nonmuscle cells was confirmed (Hatano and Oosawa, 
1966, Adelman and Taylor, 1969), and their role in a variety of other eukaryotic 
motility processes such as cell movement and vesicle transport has been revealed by the 
subsequent research (Ross et al., 2008). Although all the discovered myosins function 
as motor proteins, a particular myosin, conventional myosin II, is thought to carry out 
specific activities. This protein is mainly responsible for muscle contraction whereas 
myosin I and V primarily participate in the transport of membrane vesicles along actin 
filaments in nonmuscle cells (Krendel et al., 2007, Salas-Cortes et al., 2005, Wang et 
al., 2008). All myosins consist of one or two identical heavy chains and several light 
chains. Moreover the heavy chains are usually arranged into different domains, which 
display distinct structures and functions. For example, myosin II is composed of two 
identical heavy chains and two pairs of essential and regulatory light chains (Figure 
1.8A). Each heavy chain is functionally made up of three major subdomains. The 
globular head domain provides binding sites for actin and ATP. An adjacent α-helical 
neck region is bound by a pair of light chains, and also amplifies head rotations through 
lever arm swinging during energy conversion. Following the neck domain it is a long α-
helical tail sequence that twists around the other one to form the complete myosin II 
dimer (Vicente-Manzanares et al., 2009). These rodlike tail sequences of multiple 
myosin II dimers self-associate to assemble into bipolar thick filaments, which are anti-
parallel arrays of myosin II serving as an essential part of the contractile apparatus in 
muscle cells (Niederman and Pollard, 1975, Svitkina et al., 1995). By contrast, the neck 
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domains of myosin V dimer are bound by two identical calmodulin light chains and also 
its tail domains only form coiled-coil structure in the region adjacent to the neck and 
leave two tail ends untwisted to provide cargo binding domains (Tóth et al., 2005) 
(Figure 1.8A). Unlike myosin II and V dimers, myosin I is a monomer containing a 
globular head domain and a comparatively short tail (Figure 1.8A). Light chains, 
usually calmodulin molecules interact with the α-helical junction of myosin I to form 
complex (Barylko et al., 2000). Like the untwisted ends of myosin V, the tail regions of 
myosin I also possess specific domains that bind to some adaptor proteins or other 
binding proteins. As a result, these unconventional myosins are recruited to their 
specific cellular targets such as membranes of vesicles and organelles and the plasma 
membrane, and then operate movement – traffic and protrusions (Akhmanova and 
Hammer Iii, 2010).  
All the known myosins are thought to use the same basic working model to power 
movements along actin, however the precise molecular mechanisms underlying this are 
still not fully understood. Their highly conserved globular head acts as a specialized 
ATPase whose activity is actin-activated. It means that without the association with 
actin, myosins convert ATP to ADP slowly, and only when the head binds to actin, the 
myosin ATPase works at a much faster rate. Described in a well-accepted model 
(Figure 1.8B), the cycle starts with the binding of ATP to myosin, which causes rapid 
disassociation of the tightly bound myosin-actin complex. The subsequent hydrolysis of 
the bound ATP then initiates a change in myosin conformation. The myosin neck 
domain is consequently affected and acts as a lever arm to displace the myosin head 
domain, which then re-anchored on the actin filament at a new position. This action 
induces the release of ADP and Pi and an event called power stroke, in which the head 
domain regains its original conformation and draws a full stop of one step of movement 
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(De La Cruz and Ostap, 2004). These cyclic interactions fuel myosins to walk along the 
actin filaments toward the barbed end, with the exception of myosin VI (Wells et al., 
1999).  
1.5.5 Roles of actin dynamics in endocytosis  
It is generally accepted that each endocytic pathway is equipped with distinct 
internalisation machinery, despite the overlaps in some of the involved proteins. 
Dynamin, a GTPase, is a good example of a protein that is involved in numerous 
endocytic pathways. However, almost all the known endosomal routes induce cell 
cortex remodelling during internalisation, either via membrane invagination (for 
clathrin/caveolae-dependent routes) or by membrane protrusion (for macropinocytosis 
and phagocytosis). As an important constituent of the cell cortex, there is extensive 
research demonstrating the role of the actin cytoskeleton in these uptake processes. 
There is a growing body of evidence that indicates the actin involvement in downstream 
endocytic pathway events including budding, fission and intracellular movements of 
endocytic vesicles (Mooren et al., 2012).  
1.5.5.1 Actin in Clathrin-Mediated Endocytosis 
It appears that in mammalian cells, actin is not always essential for CME. However, in 
certain settings, such as the internalisation of large cargos or endocytosis at sites rich in 
actin filaments, the involvement of actin becomes necessary. Clathrin and adaptors are 
initially recruited to the plasma membrane, generating the membrane curvature (~80-
100 nm) required for CME to proceed. The accumulated evidence supports the 
functional importance of interactions between many of the endocytic adaptors and the 
actin cytoskeleton. The implication is that the regulation of actin assembly may take 
place in response to endocytosis (Le Clainche et al., 2007). Actin polymerisation in the 
curved membrane region may be inhibited by certain endocytic proteins such as Syp1 
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during early stages of CME (Suetsugu, 2009, Saffarian et al., 2009). As invagination 
proceeds, certain endocytic proteins and ARP2/3 regulators can sense the changes in 
membrane curvature, and gather around the invagination. Following the activation of 
ARP2/3, an actin network is nucleated and established along invagination. During this 
process, the barbed ends of actin filaments point toward the plasma membrane, leading 
to a filament flow-away from the cortex. As the actin filaments are anchored to the 
clathrin-coat of the invagination membrane, the flowing of the network provides the 
force to push the endocytic pit further extruding into the cytoplasm. The dendritic actin 
network remains attached to endocytic membrane to assist vesicle scission and to drive 
the formed vesicle away from the plasma membrane. Our understanding on the 
involvement of actin in CME is still limited as investigations are commonly conducted 
by treating cells with chemical inhibitors, such as cytochalasin D to disrupt actin 
filaments. The results obtained by such methods, have frequently been conflicting and 
so many attempts have been made to explain this clearly very complicated process. 
Kirchhausen and co-workers reported the existence of other clathrin-coated structures, 
distinct from clathrin pits, which were termed as clathrin plaques. These plaques were 
found at the adherent surface of certain cell types (Saffarian et al., 2009). The two 
subgroups of clathrin-coated structures may be responsible for the discrepancies for the 
role of actin in CME.   
1.5.5.2 Actin in Caveolae-Mediated Endocytosis 
Caveolae are flask-shaped plasma membrane invaginations with a width range of 50-80 
nm (See Section 1.4.2.2.2). To facilitate the caveolae fission step, dynamin is recruited 
and concentrated at the neck of membrane invagination. In the internalisation of SV40 
via caveolae, actin filaments were observed to interact transiently with cargo-containing 
caveolae at the stage when dynamin localises to the invagination. Treatment with actin-
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disrupting drugs such as latrunculin A or jasplakinolide, has been shown to reduce the 
translocation of SV40 by ~60%, implying the importance of actin in caveolar pathways 
(Pelkmans and Helenius, 2002). Significant changes in the actin cytoskeleton were also 
demonstrated during virus internalisation in the same study: the depolymerisation of 
actin stress fibres occurred together with the recruitment of actin filament structures to 
virus-containing caveolar invagination (Pelkmans and Helenius, 2002). This indicates 
that like clathrin-mediated internalisation, caveolae-dependent uptake also appears to 
require actin in later endocytotic stages including vesicle fission and/or transport into 
cytoplasm. However, many important questions remain to be answered e.g. those 
concerning which proteins involved in recruiting F-actin to caveolae or/and regulation 
of actin polymerisation/depolymerisation, and whether/how actin functions in the 
uptake of other types of cargos mediated by caveolae. 
1.5.5.3 Actin in macropinocytosis 
In macropinocytosis, the plasma membrane protrudes outwards and engulfs 
extracellular fluid inwards to form large vesicles called macropinosomes. Our 
knowledge about this type of endocytosis in mammalian cells is limited, mainly due to 
the lack of appropriate molecular markers to specifically identify macropinosomes. To 
date, the most commonly used fluid-phase marker is fluorophore-labelled dextrans of 
various molecular weights. Experiments using diverse cell types or even different 
growth conditions may reveal the existence of different macropinosome types and 
macropinocytic pathways. Among the proteins with identified roles in 
macropinocytosis, a number of factors are also necessary in actin regulation, e.g. 
profilin (Engqvist-Goldstein and Drubin, 2003). Actin has a crucial role in the 
formation of macropinosomes by driving membrane protrusion and its subsequent 
closure. In 1999, Merrifield et al. described how the actin associated with pinocytic 
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vesicles in leukemia cells. This study showed that actin could polymerise transiently on 
these endocytic vesicles providing a propulsive force that appeared to push the vesicles 
through cytoplasm (Merrifield et al., 1999). In mouse macrophages, actinin-4, an actin-
binding protein that cross-links actin filaments into thick bundles or links filamentous 
actin to the plasma membrane, were found by immunofluorescence analysis to be 
associated with dextran-labelled macropinosomes, and this linkage was diminished 
during the course of macropinosome maturation (Araki et al., 2000). Additionally, a 
large number of the components of signalling pathways acting as bridge between 
receptor stimulation and actin reorganisation have been reported to regulate 
macropinocytosis. Studies in dendritic cells have showed that small GTPase Cdc42 can 
activate WASP-related proteins and in turn promotes actin assembly for 
macropinocytosis (Rohatgi et al., 1999). In another study, the impaired activity of 
Cdc42 and Rac1 and consequently of their downstream effectors caused by cytosolic 
acidification was suggested to account for the inhibited macropinocytosis (Koivusalo et 
al., 2010). Active phosphatidylinositol-3 (PI-3) kinase that is responsible for the 
production of phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) and 
phosphatidylinositol (3,4)-bisphosphate (PtdIns(3,4)P2) at the plasma membrane, has 
also been reported to make contribution to the actin cytoskeleton remodelling required 
for macropinocytosis (Amyere et al., 2000, Rupper et al., 2001). The activation of PI-3 
kinase was found to induce the kinase activity of PAK-1 via a Cdc42/Rac1-independent 
mechanism and thus to promote actin phosphorylation and cytoskeletal reorganisation 
(Papakonstanti and Stournaras, 2002). A downstream signalling pathway upon EGFR 
activation involves the increased levels of PtdIns(3,4,5)P3 and PtdIns(3,4)P2 that are 
possibly mediated by PI-3 kinase. PtdIns(3,4)P2 in turn recruits sorting nexin 5 (SNX5) 
to the plasma membrane, and the BAR domain of SNX5 was suggested to have a direct 
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role in the generation of membrane curvature and thereby the formation of 
macropinocytic pits (Peter et al., 2004, Carlton et al., 2004, Lim et al., 2008). Evidence 
of the importance of actin in macropinocytosis is growing though the mechanism 
employed by actin to recruit to newly forming pinocytic vesicles has yet to be 
elucidated.  
1.6 Hypothesis and Aims of the thesis 
CPPs as vectors have the capacity to deliver a variety of macromolecules including 
nucleic acids, peptides and proteins into cells. Endocytic pathways are thought to be of 
significant importance for providing CPP-based vector systems with routes for cellular 
entry. All these at some point in time will involve cell-cortex remodelling, a process 
shown to be regulated by reorganisation of the actin cytoskeleton. Tentative links 
between actin remodelling and CPP uptake have been shown but more information is 
required to determine the extent of this association and how it could influence further 
research into improving the delivery capacity of these entities. Therefore this PhD 
project will investigate the hypothesis that actin organisation and disorganisation 
differentially influences the cellular uptake of the CPP octaarginine (R8) when attached 
to a model small molecule fluorophore (Alexa 488) or a much larger biological entity in 
the from of Enhanced Green Fluorescent Protein (EGFP). Overall a deeper 
understanding of the relationship between CPPs and the actin cytoskeleton during the 
process of cell penetration will be achieved by addressing the following major aims: 1) 
optimise a protocol to obtain a high yield of pure EGFP-R8 from E.coli cultures; 2) 
investigate in detail using laser scanning confocal microscopy the effects of a variety of 
actin inhibitors on the actin cytoskeleton; 3) examine the influence of actin 
disruption/reorganisation on cellular uptake levels of the two R8 conjugates.  
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Chapter 2: Materials and Methods 
 
2.1 General materials  
Listed here are details of the general experimental materials used in this project. Other 
more specific materials including CPP conjugates, cell lines, protein expression vector, 
plasmid, antibodies and single siRNAs are indicated in the text, along with their 
sources.  
2.1.1 General chemicals  
Acetic acid: #A/0400/PB17, Fisher Scientific, Loughborough, UK 
Calcium chloride (CaCl2): #C5080, Sigma-Aldrich, Poole, UK 
Citric acid: #C/6160/53, Fisher Scientific, Loughborough, UK 
Dimethyl sulphoxide (DMSO): #D2650, Sigma-Aldrich, Poole, UK 
Ethanol: #E/0650/17, Fisher Scientific, Loughborough, UK 
Glycerol: #G/0600/08, Fisher Scientific, Loughborough, UK 
Methanol: #M/4056/17, Fisher Scientific, Loughborough, UK 
Magnesium chloride (MgCl2): #M8266, Sigma-Aldrich, Poole, UK 
Sodium chloride (NaCl): #S/3120/53, Fisher Scientific, Loughborough, UK 
Sodium hydroxide (NaOH): #S/4880/53, Fisher Scientific, Loughborough, UK 
Tris-base: #BPE152-1, Fisher Scientific, Loughborough, UK 
Tris-HCl: #BPE153-1, Fisher Scientific, Loughborough, UK 
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2.1.2 Protein expression, purification and analysis   
Ampicillin: #A1593, Sigma-Aldrich, Poole, UK 
Benzonase nuclease: #70746, Merck Millipore, Feltham, UK 
Bicinchoninic acid solution: #B9643, Sigma-Aldrich, Poole, UK 
Broad range protein molecular weight markers: #V8491, Promega, Loughborough, UK 
Bovine serum albumin (BSA): #A7906, Sigma-Aldrich, Poole, UK 
Complete protease inhibitor cocktail tablets:  
#11836153001, Roche Diagnostics, Burgess Hill, UK 
Copper (II) sulphate solution: #C2284, Sigma-Aldrich, Poole, UK 
Imidazole: #I5513, Sigma-Aldrich, Poole, UK 
Isopropyl β-D-1-thiogalactopyranoside (IPTG): #I6758, Sigma-Aldrich, Poole, UK 
LB Agar: #A5306, Sigma-Aldrich, Poole, UK 
LB Broth: #L3022, Sigma-Aldrich, Poole, UK 
Lysozyme (hen egg white): #62970, Sigma-Aldrich, Poole, UK 
Ni-NTA Agarose: #30210, Qiagen, Manchester, UK 
Slide-A-Lyzer dialysis cassette: #87736, Life Technologies, Paisley, UK 
S.O.C. (Super Optimal broth with Catabolite repression) medium:  
#15544-034, Life Technologies, Paisley, UK 
Phenol red-free Dulbecco’s Modified Eagle’s medium (D-MEM):  
#31053, Life Technologies, Paisley, UK 
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2.1.3 SDS-PAGE 
40% acrylamide/Bis: #10376643, Fisher Scientific, Loughborough, UK 
Ammonium persulphate (APS): #A3678, Sigma-Aldrich, Poole, UK 
Bromophenol blue: #161-0404, Biorad, Hemel Hempstead, UK  
Dithiothreitol (DTT): #D9163, Sigma-Aldrich, Poole, UK 
Glycine: #G/0800/60, Fisher Scientific, Loughborough, UK 
Isopropanol: #10215331, Fisher Scientific, Loughborough, UK 
Sodium dodecyl sulfate (SDS): #161-0301, Biorad, Hemel Hempstead, UK 
Tetramethylethylenediamine (TEMED): #T9281, Sigma-Aldrich, Poole, UK 
2.1.4 Electrophoresis gel staining reagents  
Ammonia solution: #A/3240/PB15, Fisher Scientific, Loughborough, UK 
Coomassie brilliant blue G-250: #161-0406, Biorad, Hemel Hempstead, UK 
Formaldehyde: #BP531-500, Fisher Scientific, Loughborough, UK 
Glutaraldehyde: #BP2547-1, Fisher Scientific, Loughborough, UK 
Potassium ferricyanide: #702587, Sigma-Aldrich, Poole, UK 
Silver nitrate: #209139, Sigma-Aldrich, Poole, UK 
Sodium carbonate: #S/2880/53, Fisher Scientific, Loughborough, UK 
Sodium thiosulphate: #15219656, Fisher Scientific, Loughborough, UK 
2.1.5 Cell culture   
Tissue culture flasks (25 cm2 or 75 cm2):  
#430641U or #430639, Corning, Fisher Scientific, Loughborough, UK 
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6-well tissue culture plates: #3516, Corning, Fisher Scientific, Loughborough, UK 
Coverslips 16 mm diameter: #12313138, Fisher Scientific, Loughborough, UK 
Dulbecco’s Modified Eagle’s medium (D-MEM):  
#21885, Life Technologies, Paisley, UK 
Fetal bovine serum (FBS): #16000-044, Life Technologies, Paisley, UK 
MatTek glass-bottom imaging dishes (35mm diameter):  
#P35G-1.5-10-C, MatTek Corporation, Ashland, USA 
Penicillin/streptomycin: #15070, Sigma-Aldrich, Poole, UK 
0.05% Trypsin-Ethylenediaminetetraacetic acid (Trypsin-EDTA):  
#25300062, Life Technologies, Paisley, UK 
Epidermal growth factor (EGF): #E9644, Sigma-Aldrich, Poole, UK 
2.1.6 Endocytic probes   
Dextran (10kDa)-Alexa 488: #D22910, Life Technologies, Paisley, UK 
Dextran (10kDa)-Alexa 647: #D22914, Life Technologies, Paisley, UK 
Transferrin-Alexa 647: #T-23366, Life Technologies, Paisley, UK 
2.1.7 Actin inhibitors  
In this thesis the term actin inhibitor or disruptor refers to agent that either directly or 
indirectly interfere with actin functions in cells.      
Cytochalasin D (Cyt D): #C8273, Sigma-Aldrich, Poole, UK 
Jasplakinolide (JAS): #J7473, Life Technologies, Paisley, UK 
Latrunculin B (Lat B): #428020, Merck Millipore, Feltham, UK 
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PP2: #529576, Merck Millipore, Feltham, UK 
Y-27632: #688001, Merck Millipore, Feltham, UK 
2.1.8 siRNA transfection  
Oligofectamine transfection reagent: #12252-011, Life Technologies, Paisley, UK 
Opti-MEM (Minimal Essential medium): #51985, Life Technologies, Paisley, UK 
2.1.9 Cell washing and imaging for confocal microscopy  
Heparin sodium salt: #H3149, Sigma-Aldrich, Poole, UK 
HEPES sodium salt: #H3784, Sigma-Aldrich, Poole, UK 
Roswell Park Memorial Institute (RPMI) 1640 medium:  
#21875, Life Technologies, Paisley, UK 
2.1.10 Cell fixation, permeablisation and staining  
Fluorescence mounting medium Dako oil: #S3023, DAKO, Ely, UK  
Hoechst 33342: #H3570, Life Technologies, Paisley, UK 
Paraformaldehyde (PFA): #P/0840/53, Fisher Scientific, Loughborough, UK 
Rhodamine Phalloidin (Rh-P): #R415, Life Technologies, Paisley, UK 
Triton-X 100: #X100, Sigma-Aldrich, Poole, UK 
2.1.11 Immunoblotting 
Clarity, Western ECL substrate: #170-5060, Biorad, Hemel Hempstead, UK 
Ponceau S solution: #P7170, Sigma-Aldrich, Poole, UK 
Polyvinylidene difluoride (PVDF) membrane:  
#10344661, Fisher Scientific, Loughborough, UK 
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Tween 20: #P1379, Sigma-Aldrich, Poole, UK 
2.2 Expression of histidine tagged (His6) proteins (EGFP-R8 or EGFP 
alone) 
Histidine tagged (His6) CPP-Enhanced Green Fluorescent Protein conjugate, referred to 
here as His6-EGFP-R8 was produced in BL21 (DE3) E.coli, which was transformed 
with a pEV3b plasmid carrying sequences for His6-EGFP-R8 and Ampicillin resistance 
(Figure 2.1). Both non-competent BL21 (DE3) E.coli and pEV3b plasmid were 
provided by Dr Peter Watson, School of Biosciences, Cardiff University following their 
manufacture for a separate project. The harvested recombinant protein His6-EGFP-R8 
was then purified under native conditions exploiting the high affinity of the His tag to 
Ni-NTA (nickel-nitrilotriacetic acid) resin. The same protein expression method was 
used for the expression of His6-EGFP, except for that the competent BL21 (DE3) E.coli 
was transformed with a distinct pEV3b plasmid carrying sequences for His6-EGFP and 
Ampicillin resistance (provided by Dr Peter Watson, School of Biosciences, Cardiff 
University). The obtained protein sample containing His6-EGFP was then purified using 
the same protocol as that used for His6-EGFP-R8. The purity of the expressed protein 
was analysed using SDS-PAGE. Protein concentration was determined by 
Bicinchoninic Protein Assay (BCA). Full experimental details are provided below.  
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Figure 2.1 His6-EGFP-R8 plasmid map. 
 
2.2.1 Preparation of LB agar plates for bacterial growth 
LB agar powder (17.5 g) was dissolved in 500 mL of dH2O and autoclaved at 
120°C/250°F for 50 min. The liquid LB agar was cooled down to ~ 50°C before plate 
setting. For ampicillin LB agar plates, 100 mg/ml ampicillin stock in dH2O was added 
into LB agar liquid to achieve a final concentration of 100 µg/ml. Ampicillin negative 
plates were also prepared. All the LB agar plates were prepared in a biological safety 
cabinet and were stored upside down at 4°C (in the fridge or cold room) until required. 
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2.2.2 Preparation of chemically competent BL21 (DE3) E.coli  
Non-competent BL21 (DE3) E. coli were originally stored in 25% glycerol in a 2 mL 
screw top cryovial at -80°C. To recover bacteria from stock, a sterile loop was used to 
scrape some of the frozen bacteria off of the top and this was then used to streak LB 
agar plates in a safety cabinet. The inoculated plates were then incubated overnight (16-
20 hr) upside down at 37°C, until single colonies (~2 mm in diameter) could be 
visualised. Bacteria on these plates could be immediately used or the plates were sealed 
with parafilm and stored upside down at 4°C until required. To grow competent cells, a 
single bacteria colony was scraped with a sterile loop and used to inoculate a 2 ml 
solution of sterile LB broth (40 mg of LB broth powder dissolved in 2 ml dH2O and 
autoclaved). After overnight (16-18 hr) incubation at 37°C with constant agitation of 
150 RPM, 1 ml of this starter culture was diluted into 100 ml of fresh LB broth and this 
was incubated at 37°C/150 RPM until the OD600 reached ~0.4. The E.coli cells were 
then immediately chilled on ice for 20-30 min and harvested by centrifugation at 
2700 x g for 10 min at 4°C. The cells were maintained at 4°C for the reminder of the 
procedure, and any containers or solutions that came in contact with the cells needed to 
be pre-chilled to 4°C. The supernatant was discarded and the cell pellets were washed 
by vortexing in 60 ml of ice-cold MgCl2-CaCl2 solution (80 mM MgCl2 and 20 mM 
CaCl2 in dH2O). The cells were then fully resuspended in 4 ml of ice-cold 0.1 M CaCl2 
in dH2O. At this point, the CaCl2-treated competent cells can be directly used for 
transformation or be aliquoted into 200 µl and then stored at 4°C in the CaCl2 solution 
for up to 48 hr. For long-term storage, the competent cells prepared in 0.1 M CaCl2 and 
15% glycerol were aliquoted into 50 µl, snap-frozen in liquid nitrogen and stored in a -
80°C freezer.  
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2.2.3 Transformation of competent BL21 (DE3) E.coli  
Competent BL21 (DE3) E. coli cells prepared as above were thawed on ice before 
starting transformation. Plasmid vector pEV3b (15 ng in 10 µl) carrying the sequences 
encoding His6-EGFP-R8 and ampicillin resistance was added to the competent E.coli 
cells and the contents were mixed by pipetting up and down very gently. Negative 
controls containing the competent E.coli cells only and lacking the vector were also 
prepared. All the tubes were incubated on ice for 30 min and then heat-shocked at 42°C 
in water bath for exactly 90 seconds. The tubes were rapidly returned on to ice and the 
cells were chilled for 1-2 min. S.O.C. medium (800 µl) containing 2% tryptone, 0.5% 
yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM 
glucose, was added to each tube and the contents were gently mixed before incubation 
at 37°C/150 RPM for 45 min. The transformed competent cells (20/50/100/200 µl) or 
the non-transformed competent cells (200 µl) were respectively pipetted on to 
ampicillin plates and spread over the surface. The plates were then cultured overnight in 
a 37°C incubator. Additionally, 30 µl of the transformed competent cells or the non-
transformed competent cells were also pipetted onto LB agar plates lacking ampicillin. 
Single transformed colonies growing on ampicillin LB agar plates were then used as the 
source of the recombinant His6-EGFP-R8 protein. 
2.2.4 Expression of His6-EGFP-R8 protein  
Fresh LB broth medium were prepared in 5 L conical flasks and the solution was 
autoclaved. Single transformed E.coli colonies were picked from the selection plate and 
added into a 80 ml of LB broth containing 100 µg/mL ampicillin for overnight culture 
at 37°C with constant agitation of 200 RPM. The following day, 2 L of ampicillin-
containing LB broth medium was inoculated with 40 ml of this E.coli starter culture. 
The diluted culture was then cultured at 37°C/200 RPM to an OD600 of approximately 
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0.6. It usually took ~4 hr to reach this OD if adding 40 ml starter culture to 2 L fresh LB 
medium; the OD600 was carefully monitored after 2 hr incubation and checked every 
half an hour through measuring the culture absorbance using a spectrophotometer - LB 
broth alone was set as reference. Before induction of protein expression, 1 ml of 
bacteria culture was collected from conical flask as non-induction sample and stored at -
20°C. Expression of His6-EGFP-R8 protein was induced by the addition of 1 ml of 1 M 
isopropyl β-D-1-thiogalactopyranoside (IPTG) stock to 2 L LB medium (working 
concentration of IPTG=0.5 mM).  The culture was incubated under the same conditions 
for an additional 3 hr, during which 1 ml of bacteria culture was collected every 1 hr 
and stored at -20°C for subsequent analysis of IPTG induction/protein expression. At 
the end of the induction, the E.coli cells were harvested by 4°C centrifugation at 
4000 x g for 20 min. The cell pallets were snap-frozen in liquid nitrogen and then 
thawed on ice for 5-10 min before resuspending in 40 ml of pre-chilled lysis buffer (20 
mM Tris-HCl (pH7.5), 20 mM NaCl, 20 mM imidazole, protease inhibitor cocktail, 1 
mg/ml lysozyme and 25 U/ml Benzonase nuclease. The cell debris was then removed 
by 4°C centrifugation at 10,000 x g for 30 min, and the clear green strongly fluorescent 
supernatant termed crude E.coli extract was then used for the next purification step.  
2.2.5 Purification of His6-EGFP-R8 protein by affinity chromatography 
The Ni-NTA protein purification system was set up as shown in Figure 2.2 and the 
purification protocol used in this study was according to manufacturers (Qiagen) 
instructions with modifications that were introduced to increase protein purity. It should 
be noted that volumes are not always specified here, as this was dependent on the 
volume of the original E.coli culture. The Ni-NTA resin placed in column was 
equilibrated with 20 ml of equilibration buffer (20 mM Tris-HCl (pH7.5), 400 mM 
NaCl, 20 mM imidazole and protease inhibitor cocktail), pH 8.0. Before loading the cell 
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lysate slowly into the column, the NaCl concentration of the extract was increased from 
20 mM in the original protocol to 400 mM in the optimised protocol and each time the 
pH was adjusted to 8.0. Once the entire sample was passed down the column, the Ni-
NTA resin was washed in order with 10 mL of four different pH 6.3 buffers containing 
20 mM Tris-HCl (pH7.5), 400 mM NaCl and either 20, 30, 40 or 50 mM imidazole as 
part of the optimisation procedure. After the four washing steps, 6×his-tagged EGFP-R8 
protein was eventually eluted with appropriate volume of elution buffer (20 mM Tris-
HCl (pH7.5), 20 mM NaCl, 250 mM imidazole and protease inhibitor cocktail). To 
remove the imidazole and other low molecular weight contaminants, the eluted protein 
fraction was dialysed overnight at 4°C in dialysis buffer (20 mM Tris-HCl (pH7.5) and 
150 mM NaCl) in a 20 kDa molecular weight cut off dialysis cassette. The Ni-NTA 
resin was finally washed with 0.5 M NaOH and stored at 4°C with 30% ethanol to 
inhibit microbial growth.  
 
 
Figure 2.2 Purification of His6-EGFP-R8 with the Ni-NTA protein purification 
system. 
 
His$tag$
Crude E.coli extract 
under native conditions 
Column  
Ni-NTA resin 
Filter 
Wash  
Un-tagged proteins 
WASH OUT 
His-tagged proteins  
BIND 
Elute 
Pure His-tagged proteins 
! 68!
2.2.6 Bicinchoninic acid assay (BCA) 
Bicinchoninic acid assay (BCA) was used in this study to determine protein 
concentrations of samples. Bovine serum albumin (BSA) was used as a protein standard 
and prepared by dissolving a concentration range of 0-1.0 mg/ml in 1× SDS sample 
buffer. In order to make the absorbance measurements of each sample fit in the linear 
range of the assay, the cell lysates were diluted 1:10, 1:20 or 1:50 in the same buffer. 
The BCA working solution was prepared by adding 1 volume copper sulphate 
pentahydrate to 49 volumes bicinchoninic acid. BCA working solution (200 µl) was 
then pipetted into each wells of a 96 well measurement plate containing 10 µl of the 
BSA standards or protein samples. Triplicate measurements for the standards or 
samples were prepared and after incubation at 37°C for 30 min, the absorbance at 562 
nm was measured on a plate reader (Sunrise 96-well Microplate Reader, Tecan) and the 
protein concentration of each sample was extrapolated from the BSA calibration curve.  
2.2.7 Examination of IPTG induction efficacy  
The E.coli cell samples collected before and after IPTG addition were stored at -20°C 
and analysed for protein expression using SDS-PAGE. To prepare cell lysates for this 
procedure, the bacteria samples were thawed on ice and mixed well, and their 
absorbance at 600 nm was measured. The cells were then harvested by centrifugation of 
13,000 x g for 5 min at room temperature. The supernatant was decanted and each cell 
pellet was re-suspended by vortexing in 100 µl of 1×SDS sample buffer (pH 6.8; 20 
mM Tris-HCl; 0.75% (w/v) SDS; 2.75% glycerol; 0.125% (w/v) bromophenol blue and 
0.25 M DTT). These suspensions were then denatured by heating at 95°C for 5 min and 
then centrifuged at 13,000 x g for 5 min. Samples were stored at -20°C or appropriate 
volume of each supernatant (usually 40 µg for crude proteins and 2 µg for purified 
proteins; see section 2.2.6 for protein concentration determination) were loaded onto a 
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12% resolving SDS-PAGE gel (see section 2.3.8 for SDS-PAGE gel preparation). 
Protein standard molecular weight markers (10 µL) were loaded on to one lane. The 
proteins were separated by SDS-PAGE at 100 V for ~ 90 min.  
2.2.8 Preparation of standard denaturing SDS-PAGE gel 
BioRad Mini-Protean II SDS-PAGE kit was used to cast and run the gels. A front and a 
back plate in the clamp frame were assembled, which was then secured into a casting 
stand. The recipes for the stacking (4% acrylamide) and resolving (10% or 12% 
acrylamide) gels are shown in tables 2.1 and 2.2 respectively.  
Table 2.1 Recipe for 10% or 12% resolving gel. 
 
The TEMED should be the last ingredient added into the liquid gel preparation, and 
once added, the liquid mixture was quickly mixed by inversion and poured into the 
casting assembly, leaving a 2-3 cm gap at the top that was immediately filled with 
isopropanol. The resolving gel was left to set for 45 min until solidified. Then the 
isopropanol was descanted and the gap at the top of the resolving gel was washed with 
dH2O ten times and the stacking gel was prepared the same way as the resolving gel.  
 
 
 
 
10% Gel 12% Gel 
Total volume of gel (mL) 10 20 10 20 
40% acrylamide/Bis  (mL)  2.5 5 3 6 
3M Tris pH 8.8 (mL) 1.25 2.5 1.25 2.5 
10% SDS (µL) 100 200 100 200 
dH2O (mL) 6.10 12.2 5.6 11.2 
10% freshly made APS (µL) 75 150 75 150 
TEMED (µL) 7.5 15 7.5 15 
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Table 2.2 Recipe for 4% stacking gel. 
 
The liquid stacking gel was immediately poured on top of the resolving gel. Then the 10 
(or 15)-well comb was inserted into the stacking gel and after 30 min this was removed 
and the gel was transferred into running tank and incubated in running buffer (385 mM 
glycine, 250 mM Tris base and 0.5% SDS).  
2.2.9 Concentrating His6-EGFP-R8 
This was performed using an anisotropic ultrafiltration membrane of centriplus 
concentrator. For this the His6-EGFP-R8 protein sample was centrifuged at 15,000 x g 
for 10 min at 4°C. The green supernatant was saved and transferred to a sterile falcon 
tube and the cell debris in the sample if there was any was discarded. This step was 
included as debris caused blockage of the concentrator. A small amount of dH2O was 
added into the upper centriplus reservoir (~0.6 cm height). The concentrator was then 
centrifuged at 3000 x g for 10 min in order to wash the membrane with water. After the 
water in the filtrate vial was discarded, the protein sample to be concentrated was 
pipetted into the upper reservoir. The sample-containing concentrator was centrifuged at 
3000 x g/4°C until a desired volume of clear liquid (solvents and low-molecular-weight 
solutes) had accumulated in the filtrate vial. Solutes larger than membrane pore size 
such as His6-EGFP-R8 were retained in the sample reservoir. The final protein retained 
4% Gel 
Total volume of gel (mL) 10 15 
40% acrylamide/Bis  (mL)  1 1.5 
1M Tris pH 6.8 (mL) 1.3 1.95 
10% SDS (µL) 100 150 
dH2O (mL) 7.22 10.82 
10% freshly made APS (µL) 75 112.5 
0.1% Bromophenol blue (µL)  300 450 
TEMED (µL) 10 15 
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at the top of the concentrator was collected and the protein concentration determined via 
the BCA assay.  
This concentration procedure was problematic due to blockage of the membrane and it 
was very difficult to obtain protein at concentrations >200 µM. This was not of 
sufficient concentration to be used as a stock solution for subsequent cellular uptake 
assays using confocal microscopy. Therefore larger E.coli volumes were used (5 L 
total) keeping all purification volumes described above the same. This resulted in much 
higher concentration of His6-EGFP-R8 that following purification from the Ni matrix. 
The eluted protein solution was firstly dialysed overnight at 4°C in dialysis buffer and 
then dialysed against phenol red-free D-MEM in 20 kDa molecular weight cut off 
dialysis cassette and this could then be incubated directly with cells after adjusting the 
concentration with more D-MEM. 
2.2.10 Staining SDS-PAGE gels with Coomassie blue 
Gels following SDS-PAGE were incubated and stained in Coomassie blue stain (0.25% 
Coomassie blue G-250, 50% methanol and 10% acetic acid) for 2-4 hr, until the gel was 
a uniform blue colour. The staining solution was then decanted and the protein gel was 
de-stained overnight in 5% methanol and 7.5% acetic acid until the background was 
clear. Gels were then imaged on a BioRad ChemiDoc system.   
2.2.11 Silver staining SDS-PAGE gels  
In some cases, following Coomassie blue staining, protein gels were subjected to a 
silver staining procedure. All required solutions needed to be freshly prepared prior to 
use. The gel was rehydrated by washing twice in dH2O for 20 min and incubated in 10% 
glutaraldehyde solution for 30 min, followed by three 20-min washes in dH2O. Staining 
was performed with silver diamine solution prepared by adding 21 ml of 0.36% (w/v) 
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NaOH, 1.4 ml of 35% ammonia to 73.6 ml of dH2O and then adding 4 ml of 20% (w/v) 
silver nitrate drop by drop with constant stirring. Gels were stained for 30 min and then 
washed three times in dH2O for 5 min. To visualise protein bands, the gel was soaked in 
developing solution containing 2.5 ml of 1% (w/v) citric acid and 0.26 ml of 36% 
formaldehyde in 500 ml of dH2O for 1-10 min. Stopping solution (40% ethanol and 
10% acetic acid in dH2O) was added onto the gel to terminate further development. To 
reduce background staining, Farmer’s reducing agent (0.3% w/v potassium ferricyanide, 
0.6% w/v sodium thiosulphate and 0.1% w/v sodium carbonate) was added onto gels for 
7-10 min, after which it was removed and replaced with stopping solution.  
2.3 Labelling of CPP octaarginine (R8) with Alexa488 
Peptide octaarginine (R8), extended with GC at its C-terminal (RRRRRRRR-GC), was 
synthesized by American Peptide Company (California, USA). Alexa Fluro® 488 C5 
maleimide salt was purchased from Invitrogen (Paisley, UK).   
The extended GC at the C-terminal of R8 allows conjugation to Alexa Fluro® 488 C5 
maleimide salt. The labelling reaction was performed by Dr Edward Sayers in the 
laboratory and production of the fluorescent peptide was monitored by HPLC. Fractions 
corresponding to R8-GC-Alexa488 were freeze dried and resuspended in dH2O and 
characterized by mass spectrometry. All peptides analysed in this thesis were labelled, 
purified and characterized by Dr Edward Sayers.  
2.4 Cell culture   
2.4.1 Cell lines and growth medium  
HeLa (cervical carcinoma, epithelial) cells: ATCC Code CCL-2. 
A431 (skin epidermal) cells: ATCC Code CRL-1555.  
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Dulbecco’s Modified Eagle’s medium (D-MEM) supplemented with fetal bovine serum 
(FBS, 10% final volume) and penicillin/streptomycin (100 units/ml and 100 µg/ ml 
respectively) 
The two cell lines used in this project were chosen due to the fact that they had already 
been particularly characterised with respects to cellular uptake of R8-Alexa 488 and 
had shown major differences in both the organisation of their actin network and 
internalisation of dextran and R8-Alexa488 in the presence of the actin inhibitor 
cytochalasin D (Al Soraj et al., 2012).   
2.4.2 Cell recovery from liquid nitrogen storage  
The frozen cell vials were removed from liquid nitrogen and thawed in a 37°C water 
bath for ~1-2 min. Cells (1 ml) were then transferred into a 15 ml falcon tube that 
contained 9 ml of growth medium and centrifuged at 1000 x g for 5 min. The 
supernatant was discarded and the cell pallet was resuspended in 5 ml of growth 
medium and transferred into a 25 cm2 tissue culture flask prior to incubation at tissue 
culture conditions (37°C/5% CO2). The growth medium was changed every 2-3 days 
until the cells were confluent. Cells were then washed twice with PBS and trypsinised 
with 1 ml of 0.05% Trypsin-EDTA at 37°C/5% CO2 (usually 3-4 min for HeLa cells 
and 7-8 min for A431 cells). Then growth medium (4 ml) was added into flask to stop 
trypsinisation and the detached cells (5 ml) were transferred into a 75 cm2 tissue culture 
flask containing 15 ml growth medium for routine maintenance.  
2.4.3 Cell maintenance  
HeLa or A431 cells were maintained in growth D-MEM at 37°C/5% CO2. Medium was 
regularly changed every 2-3 days and cell passaging was done as previously described 
in section 2.4.2 when cells reached 80-90% confluency. Passage numbers between 5-25 
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were used for all cell assays in this study to avoid high passage number-related effects 
such as cellular morphology changes and genomic instability.  
2.5 Cell transfection with siRNA 
Three autoclaved coverslips were placed into each well of 6-well tissue culture plate. 
HeLa (0.1 × 106 cells/well) or A431 (0.3 ×106 cells/well) cells were then seeded in 2.5 
ml D-MEM containing 10 % FBS and allowed to adhere for 24 hr at 37°C/5 % CO2 and 
then grown to a confluence of ~50-60%. Single siRNA sequences targeting different 
endocytic proteins are shown in Table 2.3.  
Table 2.3 siRNA sequences and stock concentrations.  
siRNA target Concentration  Sequence  
Non-targeting 
control (GFP) 100 µM 5’-GGCUACGUCCAGGAGCGCAdTdT-3’ 
AP2µ2 50 µM 5’-GUGGAUGCCUUUCGGGUCAdTdT-3’ 
Caveolin-1 100 µM 5’-AGACGAGCUGAGCGAGAAGdTdT-3’ 
 Flotillin-1 100 µM 5’-AGAUGCACGGAUUGGAGAAdTdT-3’ 
 PAK-1  100 µM 5’-AUAACGGCCUAGACAUUCAdTdT-3’ 
 Cdc42 100 µM 5’-GACUCCUUUCUUGCUUGUUdTdT-3’ 
The siRNA sequences listed here were dissolved in 6 mM HEPES, 20 mM KCl and 0.2 mM MgCl2 (pH 
7.4).  
 
On the day of cell transfection, the transfection reagent was prepared by mixing 2 µl of 
oligofectamine in 13 µl of Opti-MEM to a final volume of 15 µl. Diluted siRNA 
solution was prepared by adding 1 µl of 100 µM siRNA stock (or 2 µl of 50 µM siRNA 
stock) into 184 µl (or 183 µl) of Opti-MEM to a final volume of 185 µl. The diluted 
siRNA and oligofectamine solutions were gently mixed and incubated at room 
temperature for 30 min. During this incubation period, the cells were washed three 
times with serum free D-MEM and then the medium was replaced with 800 µl of fresh 
serum-free D-MEM. The siRNA:oligofectamine complex was added to each well and 
incubated with cells for 4 hr at 37°C/5 % CO2. Using this method a final siRNA 
concentration of 100 nM in the transfection mixture has been previously shown to 
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silence expression of flotillin-1 and caveolin-1 in both HeLa and A431 cells (Al Soraj et 
al., 2012). Then 500 µl of D-MEM containing 30% FBS was added to each well without 
removing the transfection mixture and the cells were further incubated 37°C/5 % CO2 
for 48 hr. Cell lysate collection or live cell assays could be then conducted.  
For live cell imaging experiments the same transfection procedure was employed on 
cells plated on 35mm MatTek dishes. See section 2.8.5. 
2.6 Cell lysate collection and preparation for Western blotting  
Culture plates (6 well) prepared as above but without coverslips were placed on ice and 
the medium in each well was aspirated. The cells were then washed three times with 
ice-cold PBS before addition of 100 µl of lysis buffer (150 mM NaCl, 50 mM Tris base 
(pH 8.0) and 1% Triton-X 100 including protease inhibitors) to each well. The cell 
plates were kept on ice and placed on a lateral, circular shaker for 5 min before cells 
were scraped and the cell lysate were transferred to pre-cooled eppendorfs. Samples 
were then centrifuged at 4°C/13,800 x g for 10 min. The supernatants (crude protein 
samples) were finally transferred to fresh, pre-cooled eppendorfs.  
The concentrations of the collected crude protein samples were determined by BCA as 
described in section 2.2.6, and then were equalised by addition of appropriate volumes 
of lysis buffer. The samples were mixed with appropriate volumes of 4× loading buffer 
(8% sodium dodecyl sulphate [SDS], 40% glycerol, 0.08% bromophenol blue, 250 mM 
Tris-HCl and 2 M freshly-made DTT) at a ratio of 3:1 and denatured by heating at 95°C 
for 5 min, followed by centrifugation at 13,000 x g for 5 min. Samples were stored 
overnight at -20°C before analysis by SDS-PAGE.  
2.7 Protein detection by Western blotting 
Collected cell lysates from each experiment (15 µg) were loaded onto a 12% SDS-
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PAGE gel alongside 10 µl of protein molecular weight markers. SDS-PAGE gel was 
prepared as described in section 2.2.8. The proteins in each sample were separated by 
SDS-PAGE at 100V for ~ 90 min, and then transferred to a polyvinylidene fluoride 
(PVDF) membrane at 100V for ~ 60 min at 4°C.  
The membrane with transferred proteins was then washed briefly in dH2O, placed in 
Ponceau S solution for ~1 min and then returned to dH2O for a confirmation of protein 
transfer. The unwanted membrane regions were cut out and the membrane strips 
containing proteins of interest were retained. The Ponceau solution was recycled and the 
membrane strips were washed thoroughly in PBS to remove all traces of stain. 
For immunoblotting, the membrane strips were blocked in 5% milk in PBS containing 
0.025% Tween20 (PBST) for 1 hr at room temperature. Then the blocking solution was 
discarded and the membrane was incubated with relevant primary antibodies diluted in 
2% milk in PBST for 1 hr at room temperature. Primary mouse anti-β-tubulin antibody 
purchased as a HRP conjugate was diluted in 5% milk in PBST and no secondary 
antibody was required for it. The primary antibodies and the corresponding secondary 
antibodies are listed in Table 2.4.  
Table 2.4 Primary and secondary antibodies and dilutions for immunoblotting. 
Primary antibody  Dilution  Secondary antibody Dilution  
Mouse anti-AP50 (#611351, BD Biosciences) 1:200 Goat anti-mouse HRP 1:2000 
Rabbit anti-Caveolin-1 (#3238S, Cell Signaling) 1:1000 Goat anti-rabbit HRP 1:2000 
Mouse anti-Flotillin-1 (#610820, BD Biosciences) 1:500 Goat anti-mouse HRP 1:2000 
Rabbit anti-PAK-1 (#2602S, Cell Signaling) 1:200 Goat anti-rabbit HRP 1:2000 
Rabbit anti-Cdc42 (#2462S, Cell Signaling) 1:200 Goat anti-rabbit HRP 1:2000 
Mouse anti-β-tubulin HRP conjugated  
(#AB21058, Abcam) 1:50,000 -  
Rabbit anti-GAPDH (#2118S, Cell Signaling) 1:1000 Goat anti-rabbit HRP 1:2000 
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The membrane was then washed three times with PBST for 15 min prior to incubation 
with appropriate secondary antibody diluted in 2% milk in PBST at room temperature 
for 1 hr. 
The membrane was washed three times in PBST for 5 min before development. Equal 
volumes of ClarityTM Western enhanced chemiluminescence (ECL) reagents were 
mixed, applied to the PVDF membrane and left for 5 min. After incubation with the 
ECL mixture, excess solution was removed from the membrane. Subsequently the 
membrane was wrapped in cling film and then imaged on a BioRad ChemiDoc system. 
Band intensities were quantified using ImageJ software. The values were exported to 
excel where they were normalised against the loading control. For full quantification 
method see Wymant, Ph.D thesis 2014. Accessible from orca.cf.ac.uk/72275.   
2.8 Confocal fluorescence microscopy  
Fluorescence images shown in Chapter 3 and 4 are representatives of at least 2 
independent experiments. For fluorescence quantification and the following statistical 
analysis some experiments in Chapter 5 were performed three times. 
2.8.1 Cellular uptake of CPP conjugates  
HeLa or A431 were seeded on MatTek dishes at respective densities of 0.5 × 106 
cells/dish and 1.0 × 106 cells/dish and maintained in 2.5 ml D-MEM containing 10 % 
FBS. Cells were then allowed to adhere for 24 hr at 37°C/5% CO2 to reach a confluence 
of ~80 %. Alternatively cells on MatTek dishes had been transfected for 48 hr with 
siRNA as described in Section 2.5. On the day of experiment cells were washed twice 
with PBS and then either 2 µM CPP conjugate R8-Alexa488 or EGFP-R8 or EGFP 
alone prepared in 100 µl serum-free D-MEM was carefully added on to the central 
glass-bottom microwell drop by drop. This volume (100 µl) was used for all microscopy 
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experiments employing MatTek dishes. The cells were then incubated for 1 hr at 
37°C/5% CO2. Cells were washed three times with 0.5 mg/ml heparin in PBS to reduce 
the plasma membrane-associated R8 conjugates and then once with PBS, prior to the 
addition of 2 ml of imaging medium [RPMI with 20 mM HEPES (pH 7.4)]. Cells were 
then subjected to analysis by confocal microscopy.  
2.8.2 Uptake of CPP conjugates in Cyt D-treated cells  
HeLa or A431 cells were seeded on MatTek dishes as described in section 2.8.1 and 
cultured for 24 hr. Cells were washed with PBS before addition of diluent control 
(DMSO) or 10 µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. Then 
CPP conjugates at 2 µM concentration in serum-free D-MEM were added to the cells in 
the absence (control) or presence of 10 µM Cyt D for 1 hr at 37°C/5% CO2. The cells 
were then washed three times with 0.5 mg/ml heparin and once with PBS, and 
incubated in 2 ml imaging medium prior to analysis by confocal microscopy.  
2.8.3 Uptake of EGFP-R8 in control or Cyt D-treated cells at 4°C or 37°C 
A431 cells were seeded on MatTek dishes as described in section 2.8.1 and cultured for 
24 hr. Cells were washed with PBS before addition of diluent control (DMSO) or 10 
µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. For control cells, EGFP-
R8 (2 µM) was added to the cells for 1 hr at 4°C/5 % CO2 or at 37°C/5% CO2. For Cyt 
D-treated cells, 2 µM of EGFP-R8 in serum-free D-MEM was incubated with the cells 
in presence of 10 µM Cyt D for 1 hr at 4°C/5% CO2 or at 37°C/5% CO2. Then cells 
were washed three times with 0.5 mg/ml heparin and once with PBS, and incubated in 2 
ml imaging medium prior to analysis by confocal microscopy.  
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2.8.4 Uptake of CPP conjugate EGFP-R8 in cells treated with other actin 
inhibitors 
A431 cells were seeded on MatTek dishes as described in section 2.8.1 and cultured for 
24 hr. Cells were washed with PBS before incubation with diluent control (DMSO or 
dH2O) or actin inhibitor prepared in serum-free D-MEM at 37°C/5% CO2. Table 2.5 
lists the inhibitors used along with working concentrations and cell incubation time used 
in this study. Then 2 µM of CPP conjugate EGFP-R8 prepared in serum-free D-MEM 
was added to the cells in the absence (control) or presence of relevant actin drug for 1 hr 
at 37°C/5% CO2. Cells were washed three times with 0.5 mg/ml heparin and once with 
PBS, and incubated in 2 ml imaging medium prior to analysis by confocal microscopy.  
Table 2.5 Actin inhibitors, concentrations and cell incubation period used to disrupt/modify the 
actin cytoskeleton in section 2.8. 
Actin inhibitor Concentration(s) Incubation 
time Lat B 0.5 µM 30 in 
JAS 2 µM, 4 µM, 8 µM 45 min 
*Y-27632 1 µM, 10 µM, 50 µM, 100 µM 4 hr 
PP2 1 µM for HeLa cells; 10 µM for A431 cells 48 hr 
*The diluent control was dH2O 
 
2.8.5 Uptake of EGFP-R8 in siRNA-transfected cells  
HeLa (0.1 × 106 cells/well) or A431 (0.3 × 106 cells/well) cells were seeded on MatTek 
dishes in 2.5 ml D-MEM containing 10 % FBS and allowed to adhere for 24 h at 37°C/5 
% CO2 and then grown to a confluence of ~50-60%, before transfection with siRNA for 
48 hr as described in section 2.5. Cells were then washed with PBS before incubation 
with 2 µM of EGFP-R8 in serum-free D-MEM for 1 hr at 37°C/5% CO2. Cells were 
washed three times with 0.5 mg/ml heparin and once with PBS, incubated in 2 ml of 
imaging medium prior to analysis by confocal microscopy. Untransfected cells were 
also investigated. 
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2.8.6 Cyt D effects on EGFP-R8 uptake in cells transfected with si-Cdc42 
A431 cells seeded and cultured as described in section 2.8.5 were transfected with 
control si-GFP or si-Cdc42 for 48 hr as described in section 2.5. After washing with 
PBS, they were incubated with either diluent control (DMSO) or 10 µM Cyt D at 
37°C/5% CO2 for 15 min prior to a further incubation with 2 µM EGFP-R8 in serum-
free D-MEM for 1 hr at the same conditions in the presence or absence of Cyt D. Cells 
were then washed three times with 0.5 mg/ml heparin and once with PBS, and 
incubated in 2 ml of imaging medium prior to analysis by confocal microscopy. 
Untransfected cells were also investigated. 
2.8.7 Uptake of transferrin-Alexa 647 in Cyt D-treated cells  
HeLa or A431 cells were seeded on MatTek dishes as described in section 2.8.1 and 
cultured for 24 hr. Cells were washed with PBS before addition of diluent control 
(DMSO) or 10 µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. Then 5 
µg/ml transferrin-Alexa 647 (TF-647) prepared in serum-free D-MEM was added to the 
cells in the absence (control) or presence of 10 µM Cyt D for 30 min at 37°C/5% CO2. 
The cells were washed three times with PBS before addition of 2 ml imaging medium 
and a further incubation at 37°C/5% CO2 for 10 min to deplete the plasma membrane 
labelling by TF-647.  
2.8.8 Uptake of dextran (10kDa)-Alexa 647 in Cyt D-treated cells  
HeLa or A431 cells were seeded on MatTek dishes as described in section 2.8.1 and 
cultured for 24 hr. Cells were washed with PBS before addition of diluent control 
(DMSO) or 10 µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. Then 0.1 
mg/ml dextran (10kDa)-Alexa 647 (dextran10-647) prepared in serum-free D-MEM 
was added to the cells in the absence (control) or presence of 10 µM Cyt D for 1 hr at 
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37°C/5% CO2. Then cells were washed three times with PBS and incubated in 2 ml 
imaging medium prior to analysis by confocal microscopy.  
2.8.9 Endosomal co-localisation of EGFP-R8 and dextran  
2.8.9.1 Co-localisation of dextran (10kDa)-Alexa 488 and dextran (10kDa)-Alexa 
647 
A431 cells were grown on MatTek dishes, as described in section 2.8.1, for 24 hr. They 
were then washed twice with PBS before addition of diluent control (DMSO) or 10 µM 
Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. Dextran (10kDa) labelled 
with different fluorophores Alexa 488 (dextran10-488; 0.2 mg/ml) and Alexa 647 
(dextran10-647; 0.1 mg/ml) prepared in serum-free D-MEM were co-incubated with the 
cells in the absence (control) or presence of 10 µM Cyt D for 1 hr at 37°C/5% CO2. 
Then the cells were washed three times with PBS and incubated in 2 ml imaging 
medium prior to analysis by confocal microscopy.  
2.8.9.2 Co-localisation of EGFP-R8 and dextran10-647 
HeLa or A431 cells were cultured on MatTek dishes, as described in section 2.8.1, for 
24 hr. They were then washed twice with PBS before addition of diluent control 
(DMSO) or 10 µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% CO2. EGFP-R8 
(2 µM) and dextran10-647 (0.1 mg/ml) prepared in serum-free D-MEM were co-
incubated with the cells in the absence (control) or presence of 10 µM Cyt D for 1 hr at 
37°C/5% CO2. Then cells were washed three times with 0.5 mg/ml heparin and once 
with PBS, and incubated in 2 ml imaging medium prior to analysis by confocal 
microscopy.  
2.8.9.3 Co-localisation of EGFP-R8 and lysosome-located dextran10-647 
HeLa or A431 cells were seeded on MatTek dishes, as described in section 2.8.1, and 
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cultured for 24 hr. They were then washed with PBS before incubation with 0.1 mg/ml 
dextran10-647 for 2 hr (pulse) in serum-free D-MEM at 37°C/5% CO2. Dextran 
containing medium was removed and the cells were washed again with PBS prior to a 
further 4 hr chase in growth medium at 37°C/5% CO2. Then cells were treated with 
diluent control (DMSO) or 10 µM Cyt D for 15 min in serum-free D-MEM at 37°C/5% 
CO2. EGFP-R8 (2 µM) in serum-free D-MEM was added to the cells in the absence 
(control) or presence of 10 µM Cyt D for 1 hr at 37°C/5% CO2. Then cells were washed 
three times with 0.5 mg/ml heparin and once with PBS, and incubated in 2 ml imaging 
medium prior to analysis by confocal microscopy. 
2.8.10 Confocal fluorescence microscopy  
Confocal fluorescence microscopy analysis was performed on a Leica SP5 confocal 
laser scanning microscope, equipped with laser lines 405 Blue Diode (Excitation 
wavelength 405 nm) for visualisation of Hoechst 33342, Argon (Excitation wavelength 
488 nm) for visualisation of fluorophore Alexa 488 and fluorescent protein EGFP, 
Helium Neon 1 (Excitation wavelength 543 nm) for visualisation of Rhodamine 
Phalloidin (Rh-P) and Helium Neon 3 (Excitation wavelength 633 nm) for visualisation 
of fluorophore Alexa 647. All images presented in this study were obtained using a 
HCX PL APO 63× 1.4 NA oil immersion objective with Leica Type F immersion oil. 
Parameters “Gain” and “Off-set” of the individual photomultiplier tubes need to be 
adjusted within an experiment in order to obtain optimal image acquisition avoiding 
saturation. For multi-channel image acquisition, the channels were scanned in a 
sequential recording mode to avoid spectral cross-talk caused by overlapping excitation 
and/or emission spectra of fluorophores. The acquisition mode “XYZ” and the image 
resolution (pixels/image) of 1024×1024 were selected to use. Pinhole size was set to 1 
Airy Unit, and scan speed was set as 700 Hz. For single section images, the same 
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optical section is scanned three times to generate a line average image. Captured images 
were then analysed using ImageJ.  
2.9 Actin cytoskeleton visualisation  
2.9.1 Cell culture for actin labelling  
Three autoclaved coverslips were placed into each well of 6-well tissue culture plate. 
HeLa (0.5 × 106 cells/well) or A431 (1.0 × 106 cells/well) cells were then seeded in 2.5 
ml D-MEM containing 10 % FBS and allowed to adhere for 24 hr at 37°C/5% CO2 and 
to reach a confluence of ~80–90 %. 
2.9.2 Actin cytoskeleton labelling  
HeLa or A431 cells were prepared on coverslips as described in section 2.9.1. Then 
cells were washed three times with PBS and fixed with 3 % PFA in PBS at room 
temperature for 15 min. Cells were washed three times again with PBS and 
permeabilised with 0.2 % Triton-X 100 in PBS at room temperature for 5 min. After 
three washing with PBS, cells were stained for cell nuclei with 1.0 µg/ml Hoescht 
33342 in PBS and for polymerised actin with 1.0 µg/ml Rhodamine-conjugated 
phalloidin (Rh-P) in PBS through incubation at room temperature for 15 min. The cells 
were finally washed three times with PBS and once with distilled water (to remove salt 
from the coverslip), and the coverslips with cells were mounted onto a clean glass 
microscope slide containing 12 µl of DAKO mounting medium. 
2.9.3 Actin cytoskeleton visualisation in actin inhibitor-treated cells   
HeLa or A431 cells were seeded on coverslips as described in section 2.9.1, and 
cultured for 24 hr. Cells were then washed three times with PBS before addition of 
diluent control (DMSO or dH2O) or actin inhibitor prepared in serum-free D-MEM at 
37°C/5% CO2. Table 2.6 contains a list of various actin inhibitors used in this study and 
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their incubation time with cells. Following incubation with actin drug, cells were 
washed with PBS, fixed with 3% PFA, permeabilised with Triton-X 100 and stained for 
cell nuclei and for F-actin as described in section 2.9.2. Finally the coverslips with cells 
were mounted onto a clean glass microscope slide containing 12 µl of DAKO mounting 
medium, prior to actin visualisation on confocal microscopy as described in section 
4.2.1. 
Table 2.6 Actin inhibitors, concentrations and cell incubation period used to disrupt/modify the 
actin cytoskeleton for visualisation in section 2.9.   
Actin inhibitor Concentrations Incubation 
time Cyt D 20 nM, 200 nM, 2 µM 15 in 
Lat B 0.1 µM, 0.5 µM, 1.0 µM 30 min 
JAS 0.2 µM, 0.8 µM, 2 µM, 4 µM 45 min 
*Y-27632 1 µM, 10 µM, 50 µM, 100 µM 4 hr 
PP2 1 µM for HeLa cells; 1 or 10 µM for A431 cells 48 hr 
* The diluent control was dH2O 
* For each actin inhibitor, a wide range of concentrations, selected on the basis of published literature, 
were tested. Based on this information, the appropriate concentration(s) of compound to use was 
determined by its visual effects on actin and acceptable cytotoxicity.  
 
2.9.4 Actin cytoskeleton visualisation in serum-starved cells treated with R8 or 
EGF   
HeLa and A431 cells were seeded at respective densities of 0.25×106 and 0.5×106 
cells/well as described in section 2.9.1, and cultured for 24 hr at 37°C/5% CO2. For 
serum starvation, the cells were washed three times with PBS and placed in fresh D-
MEM lacking serum. For control cells the medium was replaced with fresh D-MEM 
supplemented with 10 % FBS. After a further culture at 37°C/5% CO2 for 16 hr, the 
cells were washed three times in PBS and then incubated with serum-free DMEM 
containing 10 or 20 µM R8 (HeLa cells) or 20 µM R8 or 50 nM EGF (A431 cells) at 
37°C/5% CO2 for 2.5 min only. The cells were then quickly washed, fixed, labelled for 
the nucleus and actin, and finally imaged by confocal microscopy as described in 
section 2.9.2 and 4.2.1. 
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2.9.5 EGFP-R8 effects on the actin cytoskeleton in cells treated with actin 
inhibitors 
A431 cells were seeded on coverslips as described in section 2.9.1, and cultured for 24 
hr. They were washed three times with PBS before pre-treatment of either diluent 
control (DMSO or dH2O), 10 µM Cyt D for 15 min, 0.5 µM Lat B for 30 min, 0.8 µM 
JAS for 45 min or 50 µM Y27632 for 4 hr at 37°C/5% CO2. All actin inhibitors used 
here were prepared in serum-free D-MEM. Cells were then incubated with 2 µM EGFP-
R8 in the absence (control) or presence of relevant actin inhibitor for 1 hr and washed 
three times with 0.5 mg/ml heparin and once with PBS. Following several wash steps, 
cells were fixed with 3% PFA, permeabilised with Triton-X 100 and stained for cell 
nuclei and for F-actin as described in section 2.9.2. Finally the coverslips were mounted 
onto a clean glass microscope slide containing 12 µl of DAKO mounting medium, prior 
to actin visualisation by confocal microscopy as described in section 4.2.1. 
2.9.6 Actin cytoskeleton visualisation in si-Cdc42-treated cells   
A431 cells were seeded on coverslips as described in section 2.5 and cultured for 24 hr 
before being transfected with si-GFP (control) or si-Cdc42 for 72 hr as described in 2.5. 
Following siRNA transfection, cells were washed with PBS, fixed with 3% PFA, 
permeabilised with Triton-X 100 and stained for cell nuclei and for F-actin as described 
in section 2.9.2. Finally the coverslips with cells were mounted onto a clean glass 
microscope slide containing 12 µl of DAKO mounting medium, prior to actin 
visualisation on confocal microscopy as described in section 4.2.1. Untransfected cells 
were also investigated. 
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Chapter 3: Examination of the effect of Cytochalasin D on the 
uptake of CPP conjugates and endocytic probes 
 
3.1 Introduction 
As discussed in the general introduction, the actin cytoskeleton is believed to play a role 
in different endocytic pathways, and most especially in macropinocytosis. The 
subsequent intracellular trafficking of endosomal vesicles has also to a certain extent 
been shown to be dependent on actin. Widely used tools to examine the roles of the 
actin cytoskeleton in various cellular processes including endocytosis are 
pharmacological/chemical inhibitors such as cytochalasin D (Cyt D) that influence actin 
dynamics through different mechanisms. Cyt D is a member of a class of fungal 
metabolites known as cytochalasins, which were discovered in 1967 and have been 
shown to affect a variety of motile functions of eukaryotic cells (Carter, 1967, Casella et 
al., 1981, Wessells et al., 1971). Cyt D disrupts actin cytoskeleton in vitro by binding to 
the fast-growing ends of actin nuclei and filaments with high affinity. Consequently, the 
addition of monomeric actin to these sites is prevented. Therefore, Cyt D has become a 
popular reagent in research of actin-dependent cellular uptake mechanisms.  
In the previous studies performed in the Jones’ laboratory (Al Soraj et al., 2012), Cyt D 
inhibited the uptake of cell penetrating peptides R8 and Tat in two different cell models: 
HeLa and A431 cells. But interestingly, the effect of actin disruption with Cyt D on the 
uptake of the fluid phase marker dextran was highly dependent on the choice of cell line 
as it was found to reduce uptake in HeLa cells and stimulate uptake in A431 cells. This 
indicated that in A431 cells, these CPPs utilized a different pathway from that used by 
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dextran. This novel finding in A431 cells (enhanced dextran uptake by Cyt D) has been 
described before in opossum kidney cells (Gekle et al., 1997) and inspired us to ask 
more questions on the role of actin in endocytosis. Normally macropinocytosis requires 
functional actin rearrangement close to the plasma membrane to facilitate the formation 
of membrane protrusions that mediate the engulfment of fluid. Less is known about the 
un-stimulated fluid phase uptake processes that also allow dextran to be internalised 
into cells (Al Soraj et al., 2012). Cyt D has been extensively used to study 
macropinocytosis and is a powerful inhibitor of this process. The effect of this drug on 
fluid phase uptake is less characterized and merits further study. 
Several CPPs have demonstrated an ability to deliver intact proteins into cells either as 
fusion proteins or as non-covalent complexes [reviewed in (Kristensen et al., 2016)]. 
Most importantly the biofunctionality of specific proteins has been shown to be 
maintained to influence intracellular processes (Futaki et al., 2004, Wadia and Dowdy, 
2003). This is one reason why these peptides are interesting candidates for delivery of 
therapeutic proteins. Efforts have been focused on understanding the internalisation 
mechanisms of these CPP-protein conjugates, as it is fundamental for improving their 
therapeutic potential. Among the different subtypes of endocytosis, macropinocytosis is 
one of the most frequently suggested pathways to be involved in the cellular entry of 
these CPP-protein conjugates (Wadia et al., 2004a, Liu et al., 2002) and much of this is 
due to studies using Cyt D. 
Green fluorescent protein (GFP) traditionally refers to the ~ 27 kDa bioluminescent 
protein that was first isolated from Aequorea jellyfish by Shimomura et al (Shimomura 
et al., 1962, Johnson et al., 1962). GFP has become one of the most widely exploited 
proteins in cell and molecular biology due to its ability to generate green fluorescence 
when it absorbs light in the blue to ultraviolet range (maximally excited at 395 nm and 
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emitting with a peak at 509 nm) (Tsien, 1998). In order to gain greater potential for 
widespread usage, a variety of mutants of GFP including enhanced GFP (EGFP), which 
is a popular humanized version of GFP and color mutants such as yellow fluorescent 
protein (YFP) derivatives have been engineered.  
GFP has also been attached to CPPs to monitor how the peptides are able to deliver a 
protein cargo to the inside of cells (Nischan et al., 2015, Jo et al., 2014). The first study 
showing artifacts on the cellular location of CPPs due to fixation was in fact performed 
using a variety of GFP-attached CPPs (Lundberg and Johansson, 2002). Typically GFP 
extended with CPPs are first purified from E.coli lysates after the bacteria have been 
transfected with plasmids encoding the fluorescent protein in frame at the N- or C- 
terminus of the CPP. These fusion proteins can then be added to cells in medium and 
using live cell imaging confocal microscopy the fate of the fluorophore in cells can be 
monitored under different conditions. A variety of CPP-GFP constructs have been used 
to evaluate the translocation efficiency and intracellular protein uptake of these CPP 
delivery systems in a wide range of cell lines including stem cells and primary cells (Jo 
et al., 2014, Simon et al., 2009, Jones, 2010). GFP has also incorporated into more 
complex delivery systems such as Tat mediated cell delivery of DNA complexed with a 
second protein called p50. Here p50 was expressed in frame with Tat and GFP that 
acted as a reporter for cell entry into mammalian PC12 (a clonal cell line derived from a 
transplantable rat pheochromocytoma) cells (Gao et al., 2009). The delivery of large 
cargos such as full-length proteins mediated by arginine-rich CPPs (for example Tat) 
usually shows that they are effectively internalised but entrapped in endocytic vesicles, 
which quite possibly also deliver the cargo to lysosomes for degradation. In a recent 
study, the internalisation efficiency of Tat-GFP conjugate into live cells was 
significantly increased by peptide cyclization, and the internalised conjugates were 
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rapidly visible in the cytosol and the nucleus. Meanwhile the linear Tat analogue did not 
confer evident GFP escape into the cytosol (Nischan et al., 2015). The fusion of pH-
sensitive E(1)GFP to the HIV-Tat protein enabled the monitoring of pH changes during 
endocytosis and allowed for real-time tracking of multiple steps in endocytosis from 
initial cell surface binding (Serresi et al., 2009). As previously discussed the 
internalisation modes of CPPs include direct entry across cell membranes and a variety 
of endocytic pathways. Arginine-rich peptides such as R8 may utilize either or both 
mechanisms to gain the cell entry, depending on physicochemical properties of the 
peptides and/or the attached cargo and the administration conditions. However, when 
attached with cargo of high molecular weight such as GFP (27 kDa), the fusion protein 
R8-GFP employed endocytosis to transduce through the plasma membrane, usually 
followed by confinement in punctate membrane vesicles (Futaki et al., 2004). The 
addition of pyrenebutyrate prior to the loading of R8-EGFP led to direct membrane 
translocation of the R8 conjugate into the cytosol within a few minutes (Takeuchi et al., 
2006). Although numerous cell uptake studies have been published using a range of 
CPP-GFP fusion proteins, there is almost no general agreement regarding the exact 
mechanisms of their uptake and the details remain unclear. 
Aims  
A major focus of this thesis was to perform comparative analysis of the cellular uptake 
of R8 attached to a fluorophore (Alexa 488) or a small protein (EGFP) in different cell 
lines. The aims of this chapter were to 1) optimise a protocol to obtain a high yield of 
pure EGFP-R8 from E.coli cultures and 2) investigate and compare the cellular uptake 
mechanism(s) of R8-Alexa 488 and EGFP-R8 in HeLa and A431 cells using actin 
disruptor Cyt D. This may shed new light on the role of actin in endocytic pathways and 
gain a better understanding of how protein attached CPPs enter into cells. 
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3.2 Results 
3.2.1 Expression and purification of His6-EGFP-R8 
The initial objective of this chapter was to purify His6-EGFP-R8 from BL21 (DE3) 
E.coli to allow subsequent cell uptake studies. BL21 (DE3) E.coli is a widely used 
expression vector and suitable for expression of many non-toxic and soluble proteins. 
This strain contains the lambda DE3 lysogen, which carries the gene for T7 RNA 
polymerase under the control of the modified lacUV5 promoter and a lac operator. In 
the absence of lactose, the lac repressor binds in a sequence-specific manner to the lac 
operator sequence of DNA in the host chromosome and prevents E.coli RNA 
polymerase from binding the lacUV5 promoter, which consequently blocks the 
expression of T7 RNA polymerase. As soon as the lac repressor disassociates from the 
lac operator, T7 RNA polymerase will be transcribed and translated. Therefore it is 
ideal for use with T7 promoter-based expression systems such as pEV3b plasmid, 
encoding His6-EGFP-R8 and conferring ampicillin resistance. 
Without lactose, the lac repressor also binds to the lac operator sequence on the plasmid 
DNA and thus blocks the access of T7 RNA polymerase to the T7 promoter. IPTG, a 
molecular mimic of allolactose can bind to lac repressor and release the repressor from 
lac operator, allowing the gene transcription in the lac operon. The T7 RNA polymerase 
will be first expressed and binds to the T7 promoter sequence upstream of the gene of 
interest on the plasmid to trigger the subsequent transcription of the target gene His6-
EGFP-R8. Unlike lactose, IPTG is not involved in any metabolic pathways and thus 
unlikely to be broken down or used by cells. This makes IPTG a more useful inducer of 
lac operon than lactose itself as the concentration of IPTG added could remain constant 
during the induction period.  
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E.coli was successfully transfected with the plasmid that then allowed growth on 
ampicillin LB plates. As expected no growth was observed from E.coli controls lacking 
the pEV3b vector (data not shown). As written in the Materials and Methods (section 
2.2.4), samples were removed from cultures following inoculation of LB media with the 
starter culture. This allowed for analysis of protein expression before and after adding 
IPTG.  
Following culture the E.coli cells were lysed and efficacy of IPTG induction on 
expression of His6-EGFP-R8 was estimated by SDS-PAGE and visualised with 
Coomassie blue staining (Figure 3.1). Before IPTG addition, some basal level 
expression of His6-EGFP-R8 in E.coli cell culture was seen to occur showing as a weak 
band at ~30 kDa. In BL21(DE3) cell lines, binding of the lac repressor with operator 
sites is never 100% efficient, and thus gene transcription from the lac operon promoter 
can not be completely shut off. This always leads to some basal expression of T7 RNA 
polymerase from the E.coli genome (often termed leaky expression) in the absence of 
inducer such as IPTG and the subsequent basal expression of target gene located 
downstream of the lac operator on the plasmid. With the addition of IPTG, EGFP-R8 
expression was significantly boosted, as indicated by the detection of the more intense 
bands at ~30 kDa in +IPTG samples.  
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Figure 3.1 Expression of His6-EGFP-R8 in BL21 (DE3) E.coli cell cultures before and after IPTG 
induction. Crude E.coli extracts (40 µg) from non-IPTG induced sample (-IPTG; lane 2) and samples 
induced with 0.5 mM IPTG for 1-3 hr (+IPTG; lane 3-5) were loaded onto a 12% SDS-PAGE gel and 
electrophoresis was performed at 100V for 90 min. Gel was then stained using Coomassie blue. His6-
EGFP-R8 is highlighted with a blue frame. Marker (lane 1): protein molecular weight markers.  
 
EGFP-R8 was tagged with six consecutive histidine residues (6×His) at its C-terminal, 
and the purification of the target protein was performed on Ni-NTA resin. NTA 
(nitrilotriacetic acid) has four metal-chelating sites and can tightly bind metal ions. In 
the purification resin used here, four of the six ligand binding sites in the coordination 
sphere of the nickel ion are occupied by NTA, leaving two sites free to interact with two 
imidazole rings of the 6×His tag respectively. Therefore, Ni-NTA matrices have high 
selectivity and affinity for biomolecules that have been tagged with six histidine 
residues. 
The purification of His6-EGFP-R8 is composed of four main steps: cell lysis, protein 
binding, resin washing and protein elution. When passing the crude cell lysate slowly 
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through the resin column, proteins lacking this His affinity tag will be eluted but the 
6×His tagged EGFP-R8 will strongly bind to the nickel ions immobilised by the NTA 
groups on the resin. However, under native conditions there is still potential for binding 
background contaminants. To reduce nonspecific, low affinity binding of untagged 
proteins, low concentration of imidazole (20 mM) was added into crude cell lysate and 
column equilibration buffer. The imidazole ring is part of the histidine structure; 
therefore imidazole itself can also bind to the nickel ions and consequently shield the 
matrix in the first place and disrupt the binding of dispersed histidine residues in 
background proteins. Although Ni-NTA resin offers high binding capacity to the tag, a 
small fraction of the target protein was observed to pass through the column (lane 3 in 
Figure 3.2). This loss might be partly due to the presence of imidazole (20 mM) in cell 
lysate. Imidazole rings of different sources including imidazole itself compete for the 
binding sites, which may interfere with the binding of the 6×His tag to column.  
By adding imidazole in the washing buffer at 20 mM, a large number of unrelated 
endogenous proteins that interacted with the Ni-NTA groups were eluted and appeared 
in the washes (lane 4-7 in Figure 3.2). However, at the same time, the interaction of the 
target protein with the Ni-NTA matrix also seems to be disturbed by washing steps, 
which could be reflected by appearance of the weak bands around 30 kDa in lane 4-7 
(Figure 3.2).  
Imidazole of a much higher concentration (250 mM) was utilized to elute the his-tagged 
protein from the matrix. Apart from His6-EGFP-R8, a number of other proteins 
especially the one(s) at ≤10 kDa, were observed in the final preparation (lane 8 in 
Figure 3.2). To remove imidazole in the purified protein preparation, dialysis was 
performed using a 20 kDa MWCO (molecular weight cut off) membrane cassette. Most 
of the contaminating proteins including the ones under 10 kDa were still remained in 
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the purified protein sample (lane 9 in Figure 3.2). It should be noted that truncated 
products of the original full-length fusion protein are common contaminants as they 
may have His tag attached to them. The source of these contaminants could be 
premature translation termination or protein degradation during protein expression or 
purification steps. On the other hand, proteins that are linked to or non-specifically 
associate with the tagged protein can also appear as unwanted contaminants in the final 
product. R8 is known to bind non-specifically to proteins such as BSA (MW=66.5 kDa) 
(Kosuge et al., 2008). 
 
Figure 3.2 Purification of His6-EGFP-R8 from BL21 (DE3) E.coli lysate using Ni-NTA resin. All the 
protein samples from crude cell lysate (lane 2), flow-through (lane 3), four washes (lane 4-7) and purified 
products before and after dialysis (lane 8 or 9) were loaded onto a 12% SDS-PAGE gel and 
electrophoresis was performed at 100V for 90 min. Gel was then stained using Coomassie blue. The band 
of His6-EGFP-R8 is pointed out with a black arrow. Marker (lane 1): protein molecular weight markers. 
For experiments more than one lane were run for each protein sample and shown are specific lanes from 
these merged together omitting a number of duplicate lanes. The original gel is presented as Appendix 1. 
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Though a high purity product was obtained it was decided to further optimise the 
protocol in an attempt to remove some of these contaminants. Optimisation was based 
on using the product obtained from the first large (2L E.coli culture) preparation and 
after dialysis subjecting it to “repurification”. Optimisation was performed on the basis 
of three different strategies.  
Strategy 1: The concentration of NaCl in the crude cell lysate, column equilibration 
buffer and washing solutions was increased from 20 mM to 400 mM (recommended by 
Qiagen on www.qiagen.com). The higher ionic strength has been shown to prevent 
nonspecific ionic interactions between proteins and the Ni-NTA resin during binding 
and washing steps. Another benefit using NaCl of higher concentration is to reduce 
hydrophobic interactions between the target protein and the other background 
contaminants. Additionally, the concentration of imidazole in washing solutions was set 
as a gradient (20-50 mM) to gradually disturb the binding of dispersed histidine 
residues in non-tagged background proteins. 
Strategy 2: The pH in washing buffers was lowered to 6.3 to disturb the interaction 
between histidine residues of endogenous proteins and the Ni-NTA matrix. Here the 
imidazole concentration in washing buffers was also prepared as a gradient of 20-50 
mM, but the NaCl concentration in all the working buffers was kept as 20 mM as 
described in the original protocol.  
Strategy 3: Heparin was utilized here to shield the R8 tail. Heparin is highly negative 
and will interact with cationic R8 thus reducing its tendency to bind to negative charges 
on other background proteins. Here 1 mg/ml heparin dissolved in dH2O was added to 
the protein sample prior to column loading and the column equilibration buffer 
respectively. Imidazole (20-50 mM) was also present in the washing buffers used in this 
heparin–based strategy. 
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Increasing the concentration of NaCl (Strategy 1; Figure 3.3) in the purification process 
(except for the elution buffer) improved the purity of the sample especially with 
respects to the band at ~5 kDa. This was observed on both Coomassie blue (Figure 
3.3A) and Silver stained gels (Figure 3.3B) that were included in the experimental set 
up as a more sensitive method to detect proteins on gels. However, NaCl of increased 
concentration caused the loss of the target protein during washing steps (shown in lane 
4-7 of Figure 3.3). This protein loss became more striking when the imidazole 
concentration reached 50 mM (lane 7 in Figure 3.3). Lowering the pH (Strategy 2; 
Figure 3.4) was also an effective method to gain purity of the final product. The 
addition of heparin (Strategy 3; Figure 3.5) into the column equilibration buffer and the 
protein sample before passing through the Ni-NTA resin also resulted in significant loss 
of His6-EGFP-R8 into the elute (lane 4-7 in Figure 3.5A and B). Moreover, low 
molecular weight proteins were still retained on the column and only eluted upon high 
imidazole elution. 
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Figure 3.3 Strategy 1. Optimisation of the purification of His6-EGFP-R8 by increasing NaCl 
concentration. Previously prepared EGFP-R8 (1.0 ml of 2.5 mg/ml) was applied to an equilibrated Ni-
NTA resin column, followed by four washes (1 ml washing buffer for each) containing 20-50 mM 
imidazole respectively and then elution with 1 ml elution buffer. Sample (10 µl) from each fraction was 
loaded on to 12% SDS-PAGE gel. Electrophoresis was performed at 100V for 90 min. Proteins were 
visualised initially by Coomassie blue staining (A) and further by Silver staining (B). Protein bands 
corresponding to His6-EGFP-R8 are highlighted with black arrow.  
 
Figure 3.4 Strategy 2. Optimisation of the purification of His6-EGFP-R8 by lowering pH. Previously 
prepared EGFP-R8 (1.0 ml of 2.5 mg/ml) was applied to an equilibrated Ni-NTA resin column, followed 
by four washes (1 ml washing buffer for each) containing 20-50 mM imidazole respectively and then 
elution with 1 ml elution buffer. Sample (10 µl) from each fraction was loaded on to 12% SDS-PAGE 
gel. Electrophoresis was performed at 100V for 90 min. Proteins were visualised initially by Coomassie 
blue staining (A) and further by Silver staining (B). Protein bands corresponding to His6-EGFP-R8 are 
highlighted with black arrow.  
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Figure 3.5 Strategy 3. Optimisation of the purification of His6-EGFP-R8 by adding heparin. 
Previously prepared EGFP-R8 (1.0 ml of 2.5 mg/ml) was applied to an equilibrated Ni-NTA resin 
column, followed by four washes (1 ml washing buffer for each) containing 20-50 mM imidazole 
respectively and then elution with 1 ml elution buffer. Sample (10 µl) from each fraction was loaded on to 
12% SDS-PAGE gel. Electrophoresis was performed at 100V for 90 min. Proteins were visualised 
initially by Coomassie blue staining (A) and further by Silver staining (B). Protein bands corresponding 
to His6-EGFP-R8 are highlighted with black arrow.  
 
For all further protein purification, low pH (6.3) and imidazole gradients were 
employed. Additionally NaCl concentration of the column equilibration buffer and the 
protein sample to be purified was also increased to 400 mM, in order to prevent 
hydrophobic association between the target protein and the other unrelated background 
proteins. Figure 3.6 shows a representative gel using this final amended protocol and 
here the final eluate (lane 8) was also dialysed against phenol red-free D-MEM through 
a 20 kDa MWCO cassette. This then allowed the protein sample to be directly loaded 
on to HeLa and A431 cells for endocytosis studies. Analysis of this gel using the 
BioRad chemidoc system showed a purity of >99% for the main protein band from 
Coomassie blue stained gel. The purified protein following D-MEM dialysis was 
aliquoted (20 µl each) and snap frozen in liquid nitrogen and stored at -80°C. With this 
procedure a 5 L E.coli preparation resulted in obtaining ~21 ml of a 50 µM solution of 
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His6-EGFP-R8. This same procedure was also used to purify protein His6-EGFP lacking 
the R8, and a preparation of ~98% purity was obtained (Figure 3.7 for final product). 
 
 
Figure 3.6 Optimised protocol for His6-EGFP-R8 purification. Optimisation was performed on the 
basis of three different strategies that were higher NaCl concentration, stringent lower pH and imidazole 
gradients. Crude cell lysate (40 µg; lane 1) obtained from a 5 L E.coli preparation was applied to an 
equilibrated Ni-NTA resin column, followed by four washes (25 ml washing buffer for each) containing 
20-50 mM imidazole respectively and then elution with buffer of 250 mM imidazole. Sample (20 µl) 
from each wash (lane 4-7) and 2 µg of the eluted His6-EGFP-R8 protein sample (lane 8) were loaded on 
to 12% SDS-PAGE gel. Electrophoresis was performed at 100V for 90 min. Proteins were visualised by 
Coomassie blue staining (A). Marker (lane 3): protein molecular weight markers. Protein bands 
corresponding to His6-EGFP-R8 are highlighted with black arrow. Insert (B) shows the final purified 
product.  
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Figure 3.7 His6-EGFP purification. The same optimised purification protocol including higher NaCl 
concentration, stringent lower pH and imidazole gradients was used to purify His6-EGFP. Crude cell 
lysate (40 µg; lane 1) obtained from a 1.5 L E.coli preparation was applied to an equilibrated Ni-NTA 
resin column, followed by four washes (10 ml washing buffer for each) containing 20-50 mM imidazole 
respectively and then elution with buffer of 250 mM imidazole. Sample (20 µl) from each wash (lane 4-7) 
and 2 µg of the eluted His6-EGFP protein sample (lane 8) were loaded on to 12% SDS-PAGE gel. 
Electrophoresis was performed at 100V for 90 min. Proteins were visualised by Coomassie blue staining 
(A). Marker (lane 2): protein molecular weight markers. Protein bands corresponding to His6-EGFP are 
highlighted with black arrow.  
 
3.2.2 Studying the role of actin in the uptake of R8-Alexa 488 and EGFP-R8 in 
HeLa and A431 cells  
Due to quite extensive differences in endocytosis of dextran and to a lesser extent of 
CPPs like R8- and Tat-Alexa 488 between HeLa and A431 cells (Al Soraj et al., 2012), 
it was decided to focus on these two cell lines for analysing the cellular uptake of both 
EGFP-R8, EGFP alone and also R8-Alexa 488 as model for a CPP conjugate with a low 
molecular weight (720 Da) cargo. This fluorescent peptide was prepared by Dr Edward 
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Sayers in the laboratory (See Section 2.3 for more details). In the absence of R8, work 
from our laboratory has shown that the fluorophore alone (as Alexa488-Cysteine) 
exhibits no cell penetrating capacity (Fretz et al., 2007). The cells were plated into 35 
mm MatTek dishes and cultured overnight before washing in PBS and adding 100 µl 
serum-free D-MEM containing 2 µM of either R8 conjugates (R8-Alexa 488 or EGFP-
R8) or EGFP alone. It should be noted that cell confluency has been shown to be 
important in endocytic uptake of CPPs in epithelial MDCK cells (Foerg et al., 2007). In 
that study, higher cell confluency led to reduced uptake and this was attributed to down-
regulation of endocytosis by Rho GTPases. The cells were then incubated under tissue 
culture conditions (37°C/5% CO2) for 1 hr before performing live cell confocal 
microscopy. In HeLa cells, fluorescent vesicular structures were clearly observed 
scattered in the cytoplasm for both R8 conjugates but not for EGFP alone  (Figure 3.8). 
This conformed the vital role of R8 in mediating cellular uptake. Similarly, EGFP alone 
did not show the capacity to enter A431 cells but again the R8 conjugates were 
internalised (Figure 3.9). These representative images were collected at the same day 
using identical microscopy setting and A431 cells appeared to be more efficient at 
internalising both R8 cargos. 
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Figure 3.8 Verification of the importance of R8 in cellular uptake in HeLa cells. Cells were washed 
and incubated with 2 µM of either R8 conjugates (R8-Alexa 488 or EGFP-R8) or EGFP alone in serum 
free D-MEM for 1 hr, and analysed by confocal microscopy. Images were taken as single sections and 
shown with green fluorescence, DIC or merge. Scale bars 10 µm.  
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Figure 3.9 Verification of the importance of R8 in cellular uptake in A431 cells. Cells were washed 
and incubated with 2 µM of either R8 conjugates (R8-Alexa 488 or EGFP-R8) or EGFP alone in serum 
free D-MEM for 1 hr, and analysed by confocal microscopy. Images were taken as single sections and 
shown with green fluorescence, DIC or merge. Scale bars 10 µm. 
 
To examine the effect of Cyt D on the cellular uptake of R8-Alexa 488 and EGFP-R8 in 
the two chosen cell lines, cells were washed with PBS and pre-treated with or without 
10 µM Cyt D for 15 min. Then 2 µM of R8-Alexa 488 or EGFP-R8 was loaded onto the 
cells in presence or absence of 10 µM Cyt D for 1 hr. The cells were then washed three 
times with 0.5 mg/ml heparin in PBS to reduce the plasma membrane-associated 
fluorescence (Lundberg et al., 2003) and analysed by confocal microscopy.  
As shown by DIC microscopy, 10 µM Cyt D had dramatic morphological effects on 
both HeLa and A431 cells (Figure 3.10-3.13). There was also clear evidence of 
EGFP 
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membrane blebbing following Cyt D treatment. This drug strongly inhibited the 
internalisation of R8-Alexa 488 in HeLa cells (Figure 3.10) to the point that only very 
low cell associated fluorescence was observed. There was no clear evidence of Cyt D 
mediated inhibition of EGFP-R8 uptake but treatment with this drug caused a scattering 
of punctate fluorescence compared to untreated cells that displayed strong perinuclear 
labelling (Figure 3.11).    
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Figure 3.10 Cyt D effects on the cellular uptake of R8-Alexa 488 in HeLa cells. Cells were incubated 
with 2 µM R8-Alexa 488 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr before 
heparin washes and analysis on confocal microscopy. Shown are single projection images of fluorescence 
only (R8-Alexa 488), DIC and merges of fluorescence and DIC of the same cells. B and D represent 
zoomed images from different fields of view of A and C respectively in order to provide more 
information on the heterogeneity of fluorescence labelling. Scale bars 10 µm.  
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Figure 3.11 Cyt D effects on the cellular uptake of EGFP-R8 in HeLa cells. Cells were incubated with 
2 µM EGFP-R8 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr and washed thoroughly 
using heparin. Cell associated fluorescence was analysed on confocal microscopy. Shown are single 
projection images of fluorescence only (EGFP-R8), DIC and merges of fluorescence and DIC of the same 
cells. B and D represent zoomed images from different fields of view of A and C respectively in order to 
provide more information on the heterogeneity of fluorescence labelling. Scale bars 10 µm.   
 
In contrast to HeLa cells, the Cyt D treatment did not evidently reduce the 
internalisation of R8-Alexa 488 by A431 cells (Figure 3.12). But the drug indeed 
altered the distribution pattern of the cargo significantly. The green vesicular structures 
DIC Merge EGFP-R8 
A 
B 
C 
D 
(-)
 C
yt
 D
 
(+
) C
yt
 D
 
! 107!
observed in normal untreated A431 cells were relatively evenly scattered throughout the 
cytoplasm (Figure 3.12A and B), whereas most of the punctate structures found in the 
drug-treated A431 cells were largely clustered (Figure 3.12C and D). The insensitivity 
of R8 uptake to Cyt D treatment may imply that R8 has at least one alternative 
endocytic pathway to utilize to enter into A431 cells, when its routine actin-dependent 
pathway is blocked. Therefore, by following different uptake route(s), the intracellular 
location or destination of the delivered cargo may also be changed. Surprisingly, the 
same experiment but adding EGFP-R8 onto A431 cells revealed that Cyt D dramatically 
enhanced the internalisation of this cargo into vesicular structures and affected their 
distribution throughout the cell (Figure 3.13) as previously had been observed in HeLa 
cells. Instead of scattered in cytoplasm (Figure 3.13A and B), a large number of the 
observed green fluorescent punctae were aggregated and enriched in small “islands” or 
U-like structures mainly surrounding the nucleus (Figure 3.13C and D). A major 
difference in the behaviour of these two cell lines to actin disruption was also 
previously noted by us for uptake of the fluid phase endocytic probe dextran (Al Soraj 
et al., 2012). The actin cytoskeleton in A431 cells interestingly appears to act as a 
hindrance to the cellular uptake of protein attached R8, which challenges our previous 
thoughts about the positive role of actin in endocytic pathways.    
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Figure 3.12 Cyt D effects on the cellular uptake of R8-Alexa 488 in A431 cells. Cells were incubated 
with 2 µM R8-Alexa 488 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr before 
heparin washes and analysis on confocal microscopy. Shown are single projection images of fluorescence 
only (R8-Alexa 488), DIC and merges of fluorescence and DIC of the same cells. B and D represent 
zoomed images from different fields of view of A and C respectively. Scale bars 10 µm.   
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Figure 3.13 Cyt D effects on the cellular uptake of EGFP-R8 in A431 cells. Cells were incubated with 
2 µM EGFP-R8 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr and washed thoroughly 
using heparin. Cell associated fluorescence was analysed using confocal microscopy. Shown are single 
projection images of fluorescence only (EGFP-R8), DIC and merges of fluorescence and DIC of the same 
cells. B and D represent zoomed images from different fields of view of A and C respectively. Scale bars 
10 µm.  !
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3.2.3 Studying the role of actin in the uptake of transferrin and dextran in HeLa 
and A431 cells 
To further explore the role of actin in endocytosis in these two cell lines the effects of 
Cyt D was similarly assessed on the clathrin-mediated endocytosis marker transferrin 
(transferrin-Alexa 647) and the fluid phase/macropinocytosis probe 10 kDa dextran 
(dextran10-Alexa 647). HeLa or A431 cells were pre-incubated in the absence or 
presence of 10 µM Cyt D for 15 min, and then further incubated with 5 µg/ml 
transferrin-Alexa 647 (TF-647) for 30 min or 0.1 mg/ml dextran10-Alexa 647 (Dex-647) 
for 1 hr in the absence or presence of 10 µM Cyt D. Cells were then washed with PBS 
and the cell-associated fluorescence was analysed by confocal microscopy as previously 
described.  
As shown in Figure 3.14, Cyt D treatment did not seem to result in noticeable inhibition 
or enhancement of TF-647 internalisation in either A431 (Figure 3.14A and B) or HeLa 
(Figure 3.14C and D) cells. In Cyt D treated HeLa cells, the transferrin appeared to be 
more prominent on the plasma membrane (Figure 3.14D).  
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Figure 3.14 Cyt D effects on the internalisation of transferrin-Alexa 647 (TF-647) in A431 (A, B) 
and HeLa (C, D) cells. Control cells or cells pre-treated with Cyt D were incubated with 5 µg/ml TF-647 
in the absence (A or C) or presence (B or D) of 10 µM Cyt D for 30 min and washed with PBS. Cell 
associated fluorescence was analysed using confocal microscopy. Shown are single section images of 
fluorescence only (TF-647), DIC and merges of fluorescence and DIC of the same cells. Scale bars 10 
µm.  
 
Our previous work demonstrated that whereas dextran uptake was inhibited in Cyt D 
treated HeLa cells it was increased in A431 cells treated with the same drug (Al Soraj et 
al., 2012). This was confirmed using flow cytometry and data in Figure 8F of the 
manuscript was generated as part of this thesis. Experimental details and results are 
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shown in Appendix 2. In this thesis the same experiments were performed but confocal 
microscopy was used to visualise the fluorescence. Figure 3.15 and 3.16 clearly 
demonstrate the marked difference in Cyt D effects on dextran uptake between these 
two cell lines. In Hela cells (Figure 3.15) there was evidence of inhibition of uptake as 
previously described (Al Soraj et al., 2012) but in A431 cells a very large increase in 
fluorescence was noted and here again it was aggregated in the cells (Figure 3.16). The 
images here were taken as single sections inside the cells and these fluorescent 
structures were not clusters on the plasma membrane.  
These results suggested that EGFP-R8 and dextran use the same endocytic route(s), 
especially macropinocytosis, for their uptake in A431 cells. Interfering with actin-
dependent pathway(s) could stimulate the activity of other pathways leading to 
increased uptake levels.   
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Figure 3.15 Cyt D effects on the internalisation of dextran10-Alexa 647 (Dex-647) in HeLa cells. 
Control cells or cells pre-treated with 10 µM Cyt D were further incubated with 0.1 mg/ml dextran10-
Alexa 647 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr and washed with PBS. Cell 
associated fluorescence was analysed using confocal microscopy. Shown are single section images of 
fluorescence only (Dex-647), DIC and merges of fluorescence and DIC of the same cells. B and D 
represent zoomed images from different fields of view of A and C respectively. Scale bars 10 µm.  
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Figure 3.16 Cyt D effects on the internalisation of dextran10-Alexa 647 (Dex-647) in A431 cells. 
Control cells or cells pre-treated with 10 µM Cyt D were further incubated with 0.1 mg/ml dextran10-
Alexa 647 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr and washed with PBS. Cell 
associated fluorescence was analysed using confocal microscopy. Shown are single section images of 
fluorescence only (Dex-647), DIC and merges of fluorescence and DIC of the same cells. B and D 
represent zoomed images from different fields of view of A and C respectively. Scale bars 10 µm.  
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3.2.4 Endosomal co-localisation of EGFP-R8 and dextran !
The data presented above with Cyt D suggested that dextran and EGFP-R8 utilize the 
same endocytic pathway(s), to enter into A431 cells. Experiments were then performed 
to compare the subcellular distribution of these two molecules in the two cell lines. 
Initially co-localisation of dextran (10 kDa) labelled with fluorophores Alexa 488 and 
Alexa 647 respectively was examined in A431 cells only to provide a good model for 
co-localisation using this technique. Cells were co-incubated with 0.1 mg/ml dextran10-
Alexa 488 (Dex-488) and dextran10-Alexa 647 (Dex-647) in medium containing or 
lacking 10 µM Cyt D for 1 hr, washed and then analysed as live cells by confocal 
microscopy. As expected, in control cells these two dextran probes were located in the 
same endocytic organelles, revealed as yellow structures somewhat concentrated in a 
perinuclear region (Figure 3.17A and B). The uptake of both probes was dramatically 
increased in Cyt D treated cells confirming that this effect is not due to any specific 
characteristic associated with Dex-647 (Figure 3.17C and D). Again in Cyt D-treated 
cells there was extensive co-localisation between the two probes in a perinuclear region.  
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Figure 3.17 Endosomal co-localisation of dextran10-Alexa 647 (Dex-647) and -Alexa 488 (Dex-488) 
in A431 cells. Control cells or cells pre-treated with 10 µM Cyt D were incubated with 0.1 mg/ml Dex-
647 and Dex-488 in the absence (A, B) or presence (C, D) of 10 µM Cyt D for 1 hr and washed with 
PBS. Cell associated fluorescence was analysed using confocal microscopy. Shown are single section 
images of fluorescence only (Dex-488 or Dex-647) and merges of fluorescence with or without DIC of 
the same cells. B and D represent zoomed images from different fields of view of A and C respectively. 
Scale bars 10 µm. 
 
A431 or HeLa cells were then first incubated with Dex-647 for 2 hr (pulse) to label 
endosomes and lysosomes. Following this dextran pulse, the medium was replaced with 
fresh dextran-free medium and the cells were further incubated for a 4 hr chase period. 
At the end of chase period, the internalised dextran would empty from the early and late 
endosomes and accumulate in lysosomes (Al-Taei et al., 2006). EGFP-R8 was then 
added to these cells that were further incubated for 1 hr before confocal microscopy. In 
both A431 (Figure 3.18A and B) and HeLa (Figure 3.18C and D) cells, a low extent of 
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co-localisation of the conjugates was observed. This suggested that in the 1 hr 
incubation very little EGFP-R8 had travelled to lysosomes or that any fraction that had 
reached the lysosomes had been degraded and was no longer fluorescent. The same 
experiment was then performed in cells incubated with 10 µM Cyt D after the chase 
period and immediately prior to the addition of EGFP-R8. As shown in Figure 3.19, Cyt 
D had no visible effects on the level of co-localisation of dextran and EGFP-R8 in 
either A431 (Figure 3.19A and B) or HeLa (Figure 3.19C and D) cells. This suggested 
but did not prove that Cyt D was not altering the intracellular traffic of EGFP-R8 in 
these cells to drive it into lysosomes.  
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Figure 3.18 Endosomal co-localisation of EGFP-R8 and dextran10-Alexa 647 (Dex-647) in A431 or 
HeLa cells. Cells were incubated with 0.1 mg/ml Dex-647 for 2 hr followed by 4 hr chase in fresh growth 
medium. EGFP-R8 (2 µM) was then added to A431 (A, B) or HeLa (C, D) cells for 1 hr. Cell associated 
fluorescence was analysed using confocal microscopy. Shown are single section images of fluorescence 
only (EGFP-R8 or Dex-647) and merges of fluorescence with or without DIC of the same cells. B and D 
represent zoomed images from different fields of view of A and C respectively. Scale bars 10 µm. 
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Figure 3.19 Endosomal co-localisation of EGFP-R8 and dextran10-Alexa 647 (Dex-647) in Cyt D 
treated A431 or HeLa cells. Cells were incubated with 0.1 mg/ml Dex-647 for 2 hr followed by a 4 hr 
chase in fresh growth medium. EGFP-R8 (2 µM) was then added to Cyt D-treated A431 (A, B) or HeLa 
(C, D) cells for 1 hr. Cell associated fluorescence was analysed using confocal microscopy. Shown are 
single section images of fluorescence only (EGFP-R8 or Dex-647) and merges of fluorescence with or 
without DIC of the same cells. B and D represent zoomed images from different fields of view of A and 
C respectively. Scale bars 10 µm. !
 
Control or Cyt D-treated A431 or HeLa cells were then simultaneously incubated with 
Dex-647 and EGFP-R8 for 1 hr before confocal microscopy. Co-incubation of the 
probes in control cells showed some co-localisation in both A431 (Figure 3.20A and B) 
and HeLa cells (Figure 3.20C and D). There were in both cell types, however, clear 
examples of structures containing only one probe. In Cyt D treated A431 cells there was 
as expected an extensive increase in fluorescence and this time co-localisation in 
punctate structures and large clusters were more clearly evident (Figure 3.21A and B). 
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Very faint signal of both EGFP-R8 and dextran was observed in Cyt D treated HeLa 
cells due to the inhibitory effects of Cyt D on the uptake of these cargos in this cell line 
(Figure 3.21C and D), which is consistent with the data previously shown in section 
3.2.3.  
 
Figure 3.20 Endosomal co-localisation of EGFP-R8 and dextran10-Alexa 647 (Dex-647) in A431 or 
HeLa cells. A431 (A, B) or HeLa (C, D) cells were co-incubated with 0.1 mg/ml Dex-647 and 2 µM 
EGFP-R8 in serum-free D-MEM for 1 hr. Cell associated fluorescence was analysed using confocal 
microscopy. Shown are single section images of fluorescence only (EGFP-R8 or Dex-647) and merges of 
fluorescence with or without DIC of the same cells. B and D represent zoomed images from different 
fields of view of A and C respectively. Scale bars 10 µm. 
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Figure 3.21 Endosomal co-localisation of EGFP-R8 and dextran10-Alexa 647 (Dex-647) in Cyt D 
treated A431 or HeLa cells. A431 (A, B) or HeLa (C, D) cells that pre-treated with 10 µM Cyt D for 15 
min, were co-incubated with 0.1 mg/ml Dex-647 and 2 µM EGFP-R8 in serum-free D-MEM for 1 hr. 
Cell associated fluorescence was analysed using confocal microscopy. Shown are single section images 
of fluorescence only (EGFP-R8 or Dex-647) and merges of fluorescence with or without DIC of the same 
cells. B and D represent zoomed images from different fields of view of A and C respectively. Scale bars 
10 µm. 
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3.3 Discussion 
Since the coining of the term CPPs almost twenty years ago, considerable efforts have 
been made to clarify their internalisation mechanisms. The majority of the early 
microscopy and flow cytometry studies on these peptides were conducted using fixation 
techniques and their internalisation appeared to be unaffected by low-temperature 
incubation or non-sensitive to endocytosis inhibitors. Therefore, the entry routes of 
CPPs were described as energy- and endocytosis- independent (Vivès et al., 1997). 
However, fixation was later found to cause artefact translocation of these peptides that 
were found to be strongly associated with the plasma membrane and upon fixation were 
accumulating in the nucleus (Lundberg and Johansson, 2002, Richard et al., 2003). 
Since then investigations on their mechanisms of membrane penetration and cell uptake 
were performed using live cell confocal microscopy or flow cytometry, in the absence 
of fixation and also including trypsinisation and washing with heparin. Flow cytometry 
is unlikely to provide information regarding the cellular location of fluorescent CPPs in 
individual cells and heterogeneity across the cell population. For these reasons almost 
all the studies here were performed by live cell confocal microscopy. It would however 
have been very interesting to compare the confocal data with flow cytometry analysis. 
Unfortunately time did not allow for this.    
Previously, the laboratory has predominantly focused on analysing the cellular uptake 
of CPP-fluorophore conjugates, but the availability of the plasmid encoding EGFP-R8 
allowed us to study uptake of this CPP fused to a much larger cargo. The conjugation of 
cargo to CPP makes the linkage between the two elements more stable and has been 
employed in a large number of studies in the field of drug delivery although non-
covalently complexed CPP-based delivery systems are more easily prepared and 
capable of bearing cargos at higher cargo/CPP ratios. BL21 (DE3) E.coli was selected 
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for this project to express EGFP-R8, and unsurprisingly leaky expression of this fusion 
protein in E.coli cell culture was observed prior to IPTG addition. To reduce basal level 
expression of the gene of interest, some E.coli strains such as BL21(DE3)pLysS have 
been designed to contain an additional gene encoding T7 lysozyme which inactivates 
the T7 promoter. This prevents background expression of T7 RNA polymerase from 
expressing the target gene prior to IPTG induction. This class of expression systems are 
suitable for expression of toxic proteins, but not ideal for non-toxic proteins like EGFP. 
The existence of the additional plasmid pLysS carrying gene sequence for T7 lysozyme 
may interfere with the level of expression achieved following IPTG induction. 
Following protein expression, methods were developed to optimise the purification of 
this CPP-protein conjugate from E. coli. This was initially achieved using a previously 
established protocol that resulted in high expression of the protein but there were 
concerns regarding some impurities that were eluted from the purification column and 
appearing on the gels. An optimisation approach was then initiated changing a number 
of purification variables such as salt, pH and imidazole concentration. Eventually a 
preparation of >99% purity was obtained and dialysed into cell culture medium. This 
EGFP-R8 preparation could then be directly applied to cells. Silver staining is rarely 
used to show purification of CPP-protein conjugates. We could not find a single paper 
in the literature showing silver stained gel that reveals impurities that are not apparent 
on Coomassie stained gels. The product obtained was deemed to be of sufficient purity 
to continue with cell uptake assays. One approach often used for further purification of 
proteins is size exclusion chromatography (Wang et al., 2010), but it was felt that purity 
was high from the optimised assay and that further purification was not necessary. The 
availability of this reagent allowed us to study its uptake in cell lines that were of 
particular interest in the laboratory due to the fact that they had major differences with 
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respects to actin organisation and also CPP uptake (Al Soraj et al., 2012). Additionally 
the uptake of the CPP-protein allowed us to study any differences in cell association and 
uptake of the same CPP attached to small (Alexa 488) and large cargo (EGFP). It 
should be noted that for this work we observed the fluorescence of the cargo without 
having information on the possibility that it is no longer attached to an intact CPP. It is 
possible that the peptide itself may get degraded after cell entry or even in the 
extracellular medium especially in the presence of serum proteases (Saar et al., 2005). 
The same is not true for EGFP as any degradation of the cargo would abolish the 
fluorescence.  
Macropinocytosis has been proposed to be a major contributing pathway in the 
internalisation of arginine-rich peptides such as R8 with or without the attachment to 
small molecular weight fluorophores or large protein cargo (El-Sayed et al., 2008, 
Nakase et al., 2004, Wadia et al., 2004a). The involvement of macropinocytosis in 
mediating CPP uptake was linked to the reorganisation of the actin cytoskeleton, a 
required process for this pathway to proceed. It should however be noted that actin 
activity has been shown for several other endocytic pathways such as clathrin-mediated 
endocytosis (CME) in mammalian cells in certain settings (Fujimoto et al., 2000, 
Mooren et al., 2012). In comparison with CME, the role of actin in clathrin-independent 
pathways including caveolae and flotillin-mediated pathways still remains less certain 
and less well-defined (Doherty and McMahon, 2009).   
The actin depolymerisation reagent Cyt D was the main tool used in this chapter to 
evaluate the role of actin cytoskeleton in the internalisation of R8 conjugates in two 
different cell lines HeLa and A431 cells. This reagent has been used to study actin 
assembly, endocytosis and most importantly phagocytosis, for over 40 years. 
! 125!
Initially we investigated the role of actin on R8 conjugate uptake using live cell 
confocal microscopy focusing on both the effects of the actin reagent was having on cell 
morphology, conjugate uptake and also subcellular distribution. The early studies 
confirmed previous flow cytometry data showing differential effects of Cyt D on 
cellular uptake of R8 and dextran, and extended these studies to look at EGFP-R8. 
Inhibition on R8 uptake by Cyt D in HeLa cells was previously observed by Futaki and 
co-workers (Nakase et al., 2004). They also suggested in the same study that the 
dramatic morphological changes induced by Cyt D in the cells were reversible and the 
decrease in R8-Texas Red internalisation was caused by actin disruption rather than 
necrosis, porosity and cell death (Nakase et al., 2004). In our studies, the EGFP-R8 
internalisation into HeLa cells was also suppressed by Cyt D. This observation was 
consistent with a previous report proposing the inhibitory effects of Cyt D on the uptake 
of Tat-protein conjugate in C2C12 mouse myoblasts (Tünnemann et al., 2006). Tat 
fusion proteins have been suggested to use macropinocytosis to enter into living cells 
(Wadia et al., 2004a). Therefore, actin disruption by Cyt D was expected to delay or 
impair the internalisation of Tat-protein cargo. As shown in studies performed by 
Tünnemann et al., Cyt D pre-incubation completely blocked the vesicular uptake of Tat-
protein, and the majority of the cargo was only plasma membrane-associated 
(Tünnemann et al., 2006).  
In contrast to R8, Cyt D did not show any effects on the uptake of the CME marker 
transferrin. To further investigate whether R8 was utilizing a pathway that was also 
used by dextran we performed the same Cyt D experiments using dextran10-Alexa 647, 
and inhibition was again observed in HeLa cells. This kind of Cyt D data using different 
endocytic probes has raised the profile of macropinocytosis as a potential uptake 
mechanism for different CPPs associated with many different types of cargos. It is 
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however worth noting that dextran is not solely a probe for macropinocytosis and can in 
fact enter cells via several different pathways including fluid phase uptake. The fact that 
fluid phase uptake has been difficult to analyse as a distinct process and that 
macropinocytosis can be constitutive and induced makes data interpretation very 
difficult when looking at uptake of probes such as dextran. 
Cyt D had little effect on the internalisation of R8 by A431 cells, and flow cytometry 
confirmed that this difference was apparent during time points 0-60 min but only 
statistically significant at 80 min (Al Soraj et al., 2012). Interestingly transferrin uptake 
was inhibited in suspension A431 cells incubated with another actin inhibitor 
jasplakinolide (see Chapter 4) but not in those grown on plates as we performed here 
(Fujimoto et al., 2000). Similarly, in this thesis transferrin uptake was unaffected by Cyt 
D in A431 and also HeLa cells. Uptake of EGFP-R8 and dextran10-Alexa 647 was 
inhibited by Cyt D in HeLa cells. However it was very surprised to see that their uptake 
in A431 cells was increased following actin disruption. The very different effects of 
actin disruption on R8 and EGFP-R8 uptake in A431 cells suggest their internalisation 
mechanisms are, at least, partially distinct. It may be the case that EGFP-R8 employs a 
pathway that is more similar to that used by dextran as both behaved similarly to the 
effects of Cyt D. 
From these data it appears that actin in A431 cells is acting as a hindrance to EGFP-R8 
and dextran endocytosis. There is some evidence to suggest that endocytosis in other 
cell types can be enhanced by actin disruption (Shurety et al., 1998, Lewis et al., 1998). 
These were all performed in different in vitro systems and some also employed other 
fluid phase markers such as horseradish peroxidase. The cellular uptake of other CPPs 
TP10 or pVec in HeLa cells was found to be evidently increased by Cyt D but generally 
it is regarded as an inhibitor of cationic-CPP uptake (Mäger et al., 2010, Wadia et al., 
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2004b). Such observations may suggest that the endocytic pathways involved in the 
uptake of a particular CPP conjugate are competing simultaneously with each other at 
different efficacies rather than being the involvement of only one specific pathway.  
In addition, a hypothesis on the compensation of different endocytic mechanisms was 
also proposed: when the rate-limiting pathway is dampened e.g. by inhibitors, another 
pathway(s) might be induced to a higher level. This hypothesis was also supported by 
data obtained from Säälik et al. They studied different endocytic pathways in uptake of 
transportan-protein conjugates and noted the involvement of the ﬂotillin-1, 
caveolar/caveosomal routes. Unexpectedly, flotillin-1 depletion using siRNA 
transfection resulted in a notable increase rather than decrease in the uptake of these 
transportan conjugates (Säälik et al., 2009). Those results imply the simultaneous 
involvement of more than one endocytic pathway in this process. It may be the case that 
when one rate-limiting pathway(s) is inhibited, uptake compensation by other routes 
might be stimulated. Of note here is that siRNA transfection is not a rapid process to 
shut down an endocytic pathway and when one endocytic protein is depleted and one 
endocytic pathway is inhibited other proteins can be upregulated to stimulate other 
pathway(s) before the uptake experiment is performed. The use of pharmacological 
inhibitors that are only placed on the cells for short periods of time does not allow for 
this compensation to occur. But the major problem with these agents is their lack of 
specificity. One recent study investigated the uptake of 22 different CPPs including R7 
and R9 in a wide range of cell lines and here they employed three different endocytosis 
inhibitors - chrorpromazine, nystatin, wortmannin and also chloroquine and heparin 
(Mueller et al., 2008). Unfortunately they did not include one that inhibited actin and 
based on the data presented in this thesis it would have been interesting to perform 
similar studies with Cyt D. 
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We then examined whether the EGFP-R8 and dextran (10 kDa) localised to the same 
vesicular compartments, in an attempt to obtain further information on the cellular 
uptake of both probes. Noted here is the fact that dextran is also a commonly used 
carrier for the uptake of drugs (Varshosaz, 2012) and it’s clear that more needs to be 
determined regarding its uptake into cells. Both HeLa and A431 cells (control and Cyt 
D-treated cells) showed very little co-localisation between dextran10-Alexa 647 and 
EGFP-R8 when they were separately incubated with cells. However the possibility 
exists that a fraction of EGFP-R8 reaches lysosomes within the incubation period. 
EGFP could therefore have been degraded and/or its fluorescence could have been pH-
quenched (Tsien, 1998). Alternatively they may be trafficked to different compartments 
inside the cells. There were however clear examples of the probes being located in the 
same organelle.  
Interestingly, these two probes (EGFP-R8 and dextran) showed a strikingly high level 
of co-localisation in Cyt D treated A431 cells after 1 hr co-incubation. This strongly 
suggests that these two cargos enter the same pathways when actin cytoskeleton is 
disrupted. However, the dextran probe used here was anionic, it may electrostatically 
associate with the highly positively charged R8 resulting in dimers, polymers or even 
aggregates that were too small to be observed using the microscopy techniques used 
here. The fact that Cyt D increased the uptake of both probes into punctate structures 
inside the cells highlighted this co-localisation even further.  
These studies provided very interesting data on the role rather than the dependence of 
actin for the uptake of two different R8 conjugates. This led to the design of 
experiments to further explore actin organisation in these two cell types and how this 
can be perturbed by inhibitors that interfere with actin in different ways. These data 
from these experiments are presented in the next results chapter. 
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Chapter 4: Examination of the effects of different actin 
inhibitors on actin architecture and the uptake of EGFP-R8 
 
4.1 Introduction  
As previously discussed in detail in the Introduction (Section 1.5), the health of all 
eukaryotic cells is absolutely dependent on a functional cytoskeleton as numerous 
cellular events rely on the duties of actin, microtubules, and intermediate filaments. 
Membrane traffic involves the packaging of materials into vesicular-like compartments 
that bud from and fuse with each other and travel along defined pathways to a variety of 
cellular destinations. These vesicles associate with the cytoskeleton that provide the 
necessary directionality to allow them to reach their final destination. Microtubules, 
often working in association with actin, are most often thought to regulate downstream 
traffic from the very early stages of endocytosis (Anitei and Hoflack, 2012), and 
comparatively little is known about the role of intermediate filaments. The starting point 
for endocytosis is the plasma membrane that undergoes reorganisation to form 
invaginations or protrusions that eventually results in the formation of a vesicular 
compartment containing a portion of the plasma membrane and accompanying 
extracellular medium. These starting steps of endocytosis, especially the formation of 
membrane protrusions for macropinocytosis/phagocytosis requires reorganisation of the 
actin network. Although the role of the actin cytoskeleton has been widely studied 
within the endocytosis remit, there is, to date, still little consensus as to exactly how, 
spatially and temporally actin filaments control endocytic processes (Fujimoto et al., 
2000, Mooren et al., 2012, Robertson et al., 2009).  
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Two independent studies published 10 years ago brought attention to the actin 
cytoskeleton in the uptake of cationic CPPs, and the possibility that they may in fact be 
promoting their own uptake by influencing the actin cytoskeleton (Nakase et al., 2004, 
Wadia et al., 2004). One endocytic pathway that is absolutely reliant on actin is 
macropinocytosis that when activated has the capacity to form large intracellular 
vesicles termed macropinosomes (Falcone et al., 2006, Jones, 2007, Kerr and Teasdale, 
2009, Lim and Gleeson, 2011). Classically this process is induced in response to growth 
factor activation such as epidermal growth factor (EGF) binding to the EGF receptor, 
initially leading to extensive actin-dependent ruffling on the plasma membrane. This 
induces a “gulping effect” manifest as an increased uptake of extracellular fluid 
(Haigler et al., 1979, Jones, 2007, Kerr and Teasdale, 2009). To what extent this occurs 
in the absence of growth factor activation - constitutive macropinocytosis - or indeed 
after the addition of artificial entities such as CPPs remains to be determined. Of 
interest are observations that some CPPs may induce plasma membrane effects similar 
to that seen upon growth factor activation (Nakase et al., 2004, Nakase et al., 2007), and 
that they also promote the uptake of 70 kDa Rhodamine-labelled dextran, a marker of 
fluid phase endocytosis (Wadia et al., 2004, Al Soraj et al., 2012, Åmand et al., 2008). 
4.1.1 Actin organising proteins and actin inhibitors 
As previously described in chapter 3, Cyt D induces the depolymerisation of 
filamentous actin by capping its barbed end that therefore blocks the incorporation of 
more monomeric actin at this site (Figure 4.1). In contrast to Cyt D, latrunculin B (Lat 
B), obtained from the marine sponge Latruncula magnifica binds to and complexes with 
actin monomers (Figure 4.1) at a molecular ratio of 1:1 and thereby prevents actin 
polymerisation (Spector et al., 1989). Jasplakinolide (JAS) is a natural cyclic peptide 
that was originally isolated from the marine sponge Jaspis johnstoni (Braekman et al., 
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1987), and has become another convenient and potent method for altering intracellular 
actin organisation. Unlike Cyt D and Lat B, JAS binds directly to filamentous actin 
(Figure 4.1) and induces stabilisation of the existing actin filaments to inhibit actin 
disassembly (Bubb et al., 1994, Visegrády et al., 2005, Bubb et al., 2000, Henquin et al., 
2012). However data obtained from in vivo experiments suggested that actin filaments 
were also disrupted by JAS (Senderowicz et al., 1995, Spector et al., 1999). The 
possible explanations for these in vivo effects have been described based on 
observations that this compound enhanced the rate of nucleation of filament assembly 
and then stimulated the polymerisation of actin filaments, and as a result decreased the 
cellular level of G-actin. Consequently, cellular monomeric actin was suggested to 
polymerise into amorphous masses and also the available G-actin was insufficient for 
actin remodelling into fibres (Krendel and Bonder, 1999, McGrath et al., 1998, Bubb et 
al., 2000).   
 
Figure 4.1 Actin inhibitors and their mechanism of action. Only those utilized in this chapter are 
shown. Cytochalasin D caps the barbed end of filamentous actin, thereby blocking further polymerization. 
Latrunculin B binds to and complexes with monomeric actin and inhibit its incorporation into actin 
filament. Jasplakinolide binds directly to the side of filamentous actin and prevents polymer disassembly. 
Y27632 inhibits the kinase activity of ROCKs and the Rho-ROCK signalling pathway that drives 
phosphorylation and activation of myosin. 
 
Members of the Ras-related small GTP-binding protein family Rho are known to act as 
molecular switches for a wide range of cellular processes. All these transform between 
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inactive, GDP-bound and active, GTP-bound forms (Figure 4.2). In mammals, 22 Rho 
GTPase variants have been identified, and most of these can be sub-grouped into Rac, 
Cdc42 and RhoA subfamilies (Ridley, 2006). Among these, Rac1, Cdc42 and RhoA are 
the best-studied members. Rho family members have been widely reported to 
participate in the regulation of actin polymerisation/depolymerisation and the formation 
of focal adhesions and stress fibres in response to extracellular signals (Ridley and Hall, 
1992, Tapon and Hall, 1997, Thumkeo et al., 2013). They are also critically involved in 
other cellular processes such as cytokinesis and nuclear transcription (reviewed in 
(Chircop, 2014, Rajakylä and Vartiainen, 2014).  
As previously mentioned, actin assembly and disassembly needs to be very tightly 
regulated and highly coordinated. The dynamics and regulation of actin is usually 
achieved through the concerted action of actin regulatory proteins whose activities are 
finely modulated by protein kinases. These include Rho-associated coiled-coil forming 
serine/threonine kinases ROCK I and II (Figure 4.2) that have been identified as 
important downstream effectors of RhoA through their interaction with its GTP-bound 
form (Ishizaki et al., 1996, Leung et al., 1995); ROCK I and II exhibit 90% identity in 
their kinase domain. A number of pharmacological inhibitors of the Rho-ROCK 
signalling cascade have been developed for research in the field of cell motility and 
adhesion. Among these inhibitors, the synthetic compound Y27632 [(+) -(R) - trans - 4 - 
(1-aminoethyl) - N - (4-pyridyl) cyclohexanecarboxamide dihydrochloride] (Figure 4.1) 
has been shown to inhibit the kinase activity of ROCKs by binding to their catalytic 
sites (Uehata et al., 1997, Ishizaki et al., 2000). Inhibition by Y27632 could be reversed 
by ATP binding to the same site in a competitive manner (Ishizaki et al., 2000). In 
addition to ROCK I and ROCK II, Y27632 also has inhibition effects on some other 
kinases including protein kinase C-related protein kinase 2 (PRK2) (Vincent and 
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Settleman, 1997). However, the inhibition by this compound on the ROCK family was 
suggested to be 100 times more potent than that on other kinases including protein 
kinase C and myosin light chain kinase (Ishizaki et al., 2000). Therefore Y27632 at low 
µM concentrations has been considered as a useful tool to assess the involvement and 
roles of the ROCKs in various cellular processes including actin organisation (Duess et 
al., 2016).  
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Figure 4.2 The roles of Rho family GTPases and their downstream effectors in the organisation of 
the actin cytoskeleton. The Rho GTPases are usually activated by guanine nucleotide exchange factors 
(GEFs), which release GDP and therefore allow for GTP binding. Their activity is down regulated by 
GTPase activated proteins (GAPs), which hydrolyse the bound GTP to GDP. The activated forms of Rho 
family members bind to and activate their downstream effectors including WASP/WAVE, which 
stimulate actin polymerisation via ARP2/3 complex, PAK1-3 and ROCK I and II, which have been 
shown to have indirect effects on actin dynamics/organisation, and consequently influence actin-involved 
membrane protrusions including filopodia and lamellipodia and also endocytosis (Ridley, 2006, Sit and 
Manser, 2011). PM: plasma membrane. 
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In addition to the Rho family and their downstream effectors mentioned in Figure 4.2, 
Src-family kinases (SFKs), a group of non-receptor tyrosine kinases also regulate the 
activity of a variety of actin regulatory proteins including nucleation promoting factor 
WASP (Torres and Rosen, 2006), the severing factor cofilin (Yoo et al., 2009) and the 
polymerisation promoting factor cortactin (Tehrani et al., 2007). The Src kinase family 
comprises nine closely related members including c-Src (Parsons and Parsons, 2004) 
that share a common domain structure including SH1-4. PP2 [4-amino-5-(4-chloro-
phenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine)] is a molecule that has been frequently 
used as a selective inhibitor for SFKs (Hanke et al., 1996, Frauenstein et al., 2015). It 
has been shown to have inhibitory effects on several Src members including c-Src, Lck, 
Hck and Fyn (Hanke et al., 1996). In contrast to those previous reports and despite its 
popular usage as a selective inhibition tool, PP2 has been recently shown to also inhibit 
many other kinases with similar binding affinities; these include Fyn-related kinase 
FRK and STE7 kinase family member MEK1 (Brandvold et al., 2012). The inhibition 
of Src kinase activity with PP2 has been shown to have similar effects on actin 
polymerisation as those produced by Cyt D, but not to disturb the organisation of 
cortical actin (Olivares et al., 2014).  
Aims  
For studies involving actin and CPPs it is useful to gain an initial insight into how actin 
is arranged within cell models that are under scrutiny. Our studies and other highlighted 
how this differs between different cell lines. This initial analysis for example could 
provide much needed supporting information on the effects of actin-modifying agents 
on cellular uptake of CPPs using both microscopy and flow cytometry as analytical 
tools. As previously discussed in Chapter 3, the cellular uptake of the CPP-protein 
conjugate EGFP-R8 and the fluid phase probe dextran in different cell models, HeLa 
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and A431, showed very different responses as a result when actin was disrupted with 
Cyt D. To study in more detail how actin is distributed in different cells (HeLa and 
A431 cells) with and without Cyt D, we attempted to optimise the existing confocal 
microscopy methods. Once in place it was hoped that these methods would shed further 
light on the putative effects of cationic CPPs on actin and how actin disruption by 
different chemical actin inhibitors influence the actin cytoskeleton to modify cellular 
levels of CPPs. 
The selected actin inhibitors were cytochalasin D (Cyt D), latrunculin B (Lat B), 
jasplakinolide (JAS), Y27632 and PP2 and based on data presented in Chapter 3 EGFP-
R8 was used as the CPP conjugate and for these analysis A431 cells were utilized as the 
in vitro model. It should be noted here that only Cyt D and JAS had previously been 
investigated in the laboratory and to our knowledge no CPP studies had been performed 
on Y27632 and PP2. 
4.2 Results  
4.2.1 Optimising microscopy based methods for analysing the actin architecture in 
HeLa and A431 cells  
To visualise the actin arrangement in these two cell lines the cells were seeded on 
coverslips as previously described in section 2.9.1 and cultured for 24 hr to reach a 
confluence of ~80–90 %. After removal of incubation medium, cells were fixed, stained 
for cell nuclei and polymerised actin and finally imaged by the confocal microscopy. 
Described below is the final method based on iterative analysis and discussion, and 
other details of experimental procedure have been described in section 2.9.2. 
All analysis was performed on the Leica SP5 confocal laser scanning microscope 
equipped with laser lines 405 Blue Diode (Excitation wavelength 405 nm) and Helium 
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Neon laser (Excitation wavelength 543 nm) for visualisation of Hoechst 33342 and Rh-
P respectively. All images presented here were obtained using a HCX PL APO 63× 1.4 
NA oil immersion objective with Leica Type F immersion oil. For multi-channel image 
acquisition, the channels were scanned in a sequential recording mode (two channels 
separately), which avoids spectral cross-talk caused by overlapping excitation and/or 
emission spectra of fluorophores. Although the scan time increases two fold, this 
ensures spectral separation of the two cell stains.  
The percentage of laser output was initially set quite low to avoid bleaching and 
saturation of the fluorescent signal. The signal-to-noise level was assessed on the basis 
of the image acquired, and the laser output intensity was adjusted accordingly. Emission 
(capture) bands ~420–500 nm (Hoechst 33342) and ~560–680 nm (Rh-P) were finally 
selected. Parameters “Gain” and “Off-set” of the individual photomultiplier tubes 
needed to be adjusted for each experiment in order to obtain optimal image acquisition 
avoiding saturation. “XYZ” was selected as the acquisition mode with image resolution 
(pixels/image) of 512×512. Pinhole size was set to 1 Airy Unit, and scan speed was set 
at 200 Hz. For both single sections and multiple projection images, the same optical 
section is scanned three times to generate a frame average image. To obtain a three-
dimensional actin distribution (Z-stack) the scanning was initiated at the glass–cell 
interface. Imaging through the cell body with a step size of 0.3 µm would ensure 
coverage of the whole cell volume. In HeLa cells this typically required approximately 
25–30 sections, as fixing causes the cells to flatten thus reducing the Z-axis depth and 
the number of optical sections that need to be imaged. Step size must be calculated 
according to the axial resolution of the microscope. Actin protrusions such as filopodia 
may extend above the obvious cell outline so ensure the imaging volume extends 
beyond the cell surface to capture these structures.  
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The obtained confocal images were analysed using Fiji, the open source platform for 
biological image analysis (Schindelin et al., 2012). Classically, images are shown as a 
maximum intensity projection through the entire stack and highlight the location of the 
nucleus (Figure 4.4 Max Proj). However, depth information regarding the localisation 
of the actin cytoskeleton is lost. Here, the data is presented in an alternative format to 
highlight differences in the actin cytoskeleton across the entire depth of the cell. The 
images shown in Figure 4.4 represent the following four cell profiles: 1. Max Proj 
representing maximum intensity projections through the entire cell volume of both 
Hoechst (blue) and Rh-P (red); 2. Basal, representing the three sections closest to the 
coverslip as a maximum intensity projection of Rh-P corresponding to the lower surface 
of the cell approximately 1.0 µm from the glass surface; 3. Cell Body and Apex (CBA), 
representing maximum Z-projection through the rest of the cell; 4. Merge, representing 
false colour merge of basal and CBA images highlighting in a single image the different 
actin structures found at the different sections of the cell. These cell regions 1-4 are 
illustrated in Figure 4.3. 
    
 
Figure 4.3 Illustrations of Cell Body and Apex (CBA) and Basal used in the confocal microscopy-
based analysis of this chapter. Basal represents the three sections closest to the coverslip as a maximum 
intensity projection of Rh-P corresponding to the lower surface of the cell approximately 1.0 µm from the 
glass surface. CBA represents maximum Z-projection through the rest of the cell. The dotted blue line 
represents the plasma membrane of the imaged cells.  
 
HeLa cells displayed classical filamentous actin (stress fibres) that was very apparent in 
the basal sections (Figure 4.4), whereas the CBA image displayed a more granulated 
Basal 
Cell Body  
and Apex 
(CBA) 
Cover Slip 
Nucleus   
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appearance highlighting actin structures near the top surface of the cells. However, in 
A431 cells generally very few stress fibres were observed (Figure 4.4) and the 
fluorescence was concentrated at the cell periphery especially at cell–cell contacts. This 
is where cortical actin is found and it remains to be determined what role it has, whether 
positive or negative, on endocytosis (Al Soraj et al., 2012, Ridley, 2011). The A431 
cells shown are confluent but clear projections are seen emanating from the plasma 
membrane, especially in the grey scale CBA image. 
 
Figure 4.4 The actin architecture in HeLa and A431 cells. HeLa and A431 cells fixed and stained with 
Rh-P and Hoechst 33342 were imaged by confocal microscopy as described in Section 4.2.1. The images 
shown represent: Maximum intensity projection (Max Proj.), Basal, Cell Body and Apex (CBA) and 
Merge images as defined in section 4.2.1. Scale bars 10 µm.  
 
4.2.2 Visualisation of the actin architecture in Cyt D-treated HeLa cells   
Here the cells were seeded on coverslips as previously described and cultured for 24 hr 
prior to analysis using the new imaging method described above. Cells were then 
washed with PBS and incubated with or without 1 or 10 µM Cyt D for 15 min in serum-
free D-MEM under tissue culture conditions (37˚C/5% CO2). After removal of 
incubation medium, cells were fixed, stained for cell nuclei and polymerised actin and 
finally imaged by confocal microscopy. 
The selected control cells in Figure 4.5 had very well defined stress fibres but also long 
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filopodia that are commonly observed in this cell line at <100% confluency. Actin 
labelling this way showed the dramatic effect that short Cyt D treatment had on the 
cells. Basal sections showed that actin stress fibres were almost completely 
disassembled with 1 µM Cyt D; less effect was observed on filopodia (Figure 4.5). In 
these cells, actin aggregated especially at the cell periphery and apical surface sections; 
this was particularly apparent at 10 µM Cyt D (Figure 4.5). The Cyt D effects on the 
actin cytoskeleton of A431 cells are shown and discussed in detail in section 4.2.6.   
 
Figure 4.5 Visualisation of the actin architecture in Cyt D-treated HeLa cells. HeLa cells on 
coverslips were treated either with diluent control, 1 or 10 µM Cyt D for 15 min before fixing and 
staining with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Scale bars 10 µm.  
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4.2.3 Visualisation of R8 effects on plasma membrane ruffling of serum-starved or 
non-starved HeLa cells  
To analyse plasma membrane dynamics in control or serum-starved cells treated with 
R8, HeLa cells were seeded and cultured for 24 hr under tissue culture conditions. For 
serum starvation the cells were washed with PBS and replaced with fresh D-MEM 
lacking serum. For control cells the old medium was replaced with fresh D-MEM 
supplemented with 10% FBS. Cells were then cultured under tissue culture conditions 
for 16 hr. Cells were washed again in PBS and then incubated with serum-free D-MEM 
containing 10 or 20 µM unlabelled R8 (Ac-RRRRRRRR-NH2) under tissue culture 
conditions for 2.5 min. After quickly washing the cells were fixed, labelled for the 
nucleus and actin and imaged by confocal microscopy as previously described in 
section 4.2.1. 
Analysis of these non-starved HeLa cells demonstrated that there was no clear effects 
on actin staining in cells treated with 10 µM R8. Membrane ruffling was, however, 
apparent in some cells treated with 20 µM R8 (Figure 4.6 right hand side). The arrow 
denotes the thin sheet-like lamellipodium at the leading edge of the cell that is clearly 
defined in the basal image. When the same experiment was performed in serum-starved 
HeLa cells (Figure 4.6 left hand side), there was a dramatic effect at both concentrations 
with single cells displaying very prominent splayed membrane sheets often covering 
several micrometres and also long filopodia emanating from them. At 20 µM the cells 
had severely altered morphologies, were spiculated and quite possibly in retraction. 
Incubating HeLa cells with 20 µM R8 in serum-containing medium is non-toxic but the 
data here suggests that adding the peptide at this concentration in serum-free medium to 
serum-starved cells could result in cytotoxicity. This could be confirmed by performing 
viability assays in non-treated and serum-starved cells incubated with different 
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concentrations of R8. 
 
Figure 4.6 R8 effects on plasma membrane ruffling of serum-starved or non-starved HeLa cells. 
Non-starved or serum-starved HeLa cells were incubated for 2.5 min with diluent control, 10 or 20 µM 
R8 before fixing and staining with Rh-P and Hoechst. Images were acquired as described in in section 
4.2.1. Large arrow denotes R8-induced lamellipodia structure on the leading edge of the cell. Small 
arrows in Merge image show R8-induced membrane protrusions/extensions in serum-starved cells. Scale 
bars 10 µm. 
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4.2.4 Visualisation of R8 or EGF effects on plasma membrane dynamics of serum-
starved A431 cells  
A431 cells express very high levels of the EGF receptor (EGFR) and it is well 
documented that addition of EGF to these cells causes extensive membrane ruffling and 
macropinocytosis (Jones, 2007, Al Soraj et al., 2012, Hewlett et al., 1994, Swanson and 
Watts, 1995). Serum-starved A431 cells, prepared as previously described in section 
2.9.5, were incubated for 2.5 min with EGF (50 nM) or R8 (20 µM) before fixation and 
staining for actin and the nucleus and then performing confocal microscopy. Extensive 
membrane reorganisation at the cell edges was observed in response to these short R8 
incubations (Figure 4.7) with clear display of the formation of lamellipodia (arrow) on 
the basal portion of the cells. EGF treatment, compared with R8, however, had a very 
different effect and seen in this figure were confluent cells with interdigitated ruffles 
that were most apparent on the apical portion of the cells. This data set clearly 
highlighted the different effects on cell morphology, and actin organisation caused by 
R8 vs EGF activation of EGFR.  
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Figure 4.7 Effects of R8 or EGF on plasma membrane dynamics of serum-starved A431 cells. 
Serum-starved A431 cells were incubated for 2.5 min with diluent control, 20 µM R8 or 50 nM EGF 
before fixing and staining with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. 
Arrow denotes R8-induced lamellipodia structure on the cell periphery. Scale bars 10 µm. 
 
4.2.5 Discussion: actin visualisation based on optimised confocal analysis   
Defining the exact role of the actin cytoskeleton in mediating endocytosis through 
different pathways is a significant challenge. The general consensus is that actin has an 
important role in organising the early stages of endocytosis but there is still much to 
learn. Actin has also been implicated in cell internalisation of CPPs. It is suggested that 
CPP variants such as octaarginine (R8) and the HIV Tat peptide induce actin-dependent 
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plasma membrane perturbation and enter via macropinocytosis (Nakase et al., 2004, 
Nakase et al., 2007). In this chapter a confocal microscopy technique was developed 
that allowed for high-resolution spatial characterisation of the actin cytoskeleton in 
untreated mammalian cells and those incubated with actin-disrupting agents and CPPs.  
Phalloidin binds to polymeric and oligomeric actin but not the monomeric form known 
as G-actin. Thus in contrast to observing total cellular actin, only organised structures 
were visualised in these studies using fluorescent phalloidin. The difference in actin 
organisation between these two cells lines (HeLa and A431 cells) was noted in this 
chapter (Figure 4.4) and further analysed in attempts to explain differences between 
these cells lines that we obtained when analysing the role of actin in cell uptake of CPPs 
R8 and HIV Tat, and especially the fluid phase marker dextran (Al Soraj et al., 2012). 
Between different cell lines, extensive differences in organisation/localisation pattern of 
actin, including a cortical actin ring close to the plasma membrane, thick actin 
bundles/stress fibres, small actin punctates and large actin aggregations have been noted 
(McKayed and Simpson, 2013). There are also differences between the way HeLa and 
A431 cells expand during tissue culture. A431 cells tend to grow in clusters and this is 
clearly reflected in the way the actin is organised especially at the cell periphery. As 
described these two cell lines also display very different endocytic characteristics when 
incubated with CPPs and endocytic probes (Al Soraj et al., 2012).  
Cyt D, as discussed in chapter 3, binds to actin filaments and prevents further filament 
assembly by monomeric actin. Other actin inhibitors are also available working directly 
or indirectly at different processes of assembly and disassembly. They can often provide 
supporting information to Cyt D experiments and may be used together as a cocktail 
(Peng et al., 2011). As shown in chapter 3, live cells were imaged then the effects of Cyt 
D on cell morphology could be clearly observed using bright field or Differential 
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Interference Contrast (DIC) microscopy. Endocytosis studies, including those analysing 
CPP uptake typically use Cyt D at 10 µM for longer pre-incubation times, but data in 
Figure 4.5 showed that the actin cytoskeleton in HeLa cells was significantly affected at 
1 µM with the appearance of large actin aggregates becoming more pronounced. Using 
these microscopy methods, visible effects on the actin cytoskeleton of A431 cells can be 
visualised at a Cyt D concentration of only 200 nM (data shown in section 4.2.6).  
Activation of epidermal growth factor receptor (EGFR) by EGF stimulates a number of 
signalling pathways including those involving GTPase Ras and kinase Src, and thereby 
induces the recruitment and activation of a variety of protein factors controlling and 
regulating actin dynamics at the plasma membrane (Krause and Gautreau, 2014). The 
first pathway is triggered by the activation of PI3K (phosphoinositide 3-kinase) by 
EGFR binding, which then results in the generation of PtdIns(3,4,5)P3. The produced 
PtdIns(3,4,5)P3 in turn activates GTPase Rac through GEFs and thus promotes the 
activity of their downstream effectors including WAVE and hence ARP2/3, leading to 
the actin-mediated membrane remodelling (Rossman et al., 2005). PtdIns(3,4,5)P3 can 
also directly bind to WAVE and relocate it to the plasma membrane (Oikawa et al., 
2004). The second activated cascade involves the activation of GTPase Ras, which 
activates certain kinases including the Ser/Thr kinase ERK that phosphorylate actin 
regulatory proteins such as WAVE (Mendoza et al., 2011). The third pathway is 
dependent on the kinase Src that activates a number of actin factors and enables them to 
initiate actin rearrangement (Olivares et al., 2014). Studies have shown that some CPPs 
cause membrane ruffling in cells akin to that observed upon growth factor stimulation. 
Noted in these studies is that the cells were previously starved of serum for periods 18-
24 hr (Nakase et al., 2004, Nakase et al., 2007). To investigate whether serum starvation 
is required to observe CPP-induced membrane ruffling, HeLa cells were incubated with 
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R8 (20 µM) as untreated cells or those starved of serum for 16 hr. The concentration of 
R8 used in this experiment was much higher than is usually used to demonstrate 
endocytic uptake of a fluorescent R8 conjugate and at these levels the peptide freely 
diffuses through the plasma membrane and into the cytosol (Watkins et al., 2009).  
Most notably in serum-starved cells lamellipodia were formed in response to this 
peptide highlighting that serum starvation sensitised the cells to the effects of this 
peptide. As lamellipodia are linked with cell motility it would be interesting to 
determine whether incubation with R8 influences cell migration. However, it is 
questionable as to whether these structures (Figure 4.6) are true lamellipodia or blebs or 
structures unique to cells incubated with this CPP. It is also unknown as to whether 
actin is actually required for them to form; they may simply be a product of the direct 
effects of the peptides on the membranes. Membrane blebs are formed when there is 
loss of actin interaction with the plasma membrane, often due to excess membrane, but 
that actin–membrane interaction is essential for lamellipodia to form (Ridley, 2011). 
These lamellipodia-like structures shown in Figure 4.6 can only clearly be observed in 
A431 cells that are not in contact with each other and it is documented that cell–cell 
contact inhibits the formation of these structures (Ridley, 2011). It remains to be 
determined exactly how much cell confluency influences the effects of CPPs on the 
plasma membrane of the cells studied here and others. We observed very little actin 
rearrangement in non-starved A431 cells similarly treated with R8 but extensive ruffling 
of the type observed in Figure 4.7 when they were incubated with EGF. As little as 1 hr 
serum starvation is sufficient for EGF to mediate macropinocytosis, measured as an 
increase in fluid phase endocytosis (Al Soraj et al., 2012). It remains to be determined 
as to whether this short starvation period also sensitises the plasma membrane of the 
cells to CPPs. The optimised microscopy technique allowing for separate analysis of 
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basal and apical profiles provided new information regarding the differential effects of 
R8 vs EGF on cells and can be used to analyse other CPPs but also other drug delivery 
vectors who may have similar effects - noted is that many of these including polyplexes 
and lipoplexes are cationic in nature.   
Cellular actin can now be microscopically visualised in tissue culture cells using a 
number of techniques and discovery of GFP allowed for live cell imaging analysis of 
this protein as a monomer and in organised structures (Ballestrem et al., 1998). 
Additionally a recent study revealing how microscopy development and new actin 
probes allows us to image actin action in live cells (Chen et al., 2014). The future 
clearly lies in supporting fixed cell analysis highlighted in this chapter with the capacity 
to monitor actin in live cells. The advent of super-resolution technology and new probes 
for visualisation of actin structures (Lukinavicius et al., 2014) will undoubtedly provide 
much needed new information on exactly why this protein is of such fundamental 
importance in cell physiology and how it impacts on the cellular uptake of CPPs. 
4.2.6 Effects of low Cyt D concentrations on the actin architecture and EGFP-R8 
uptake in A431 cells  
As shown by DIC/confocal microscopy in chapter 3, treatment with 10 µM Cyt D 
induced significant morphological alterations in both HeLa and A431 cells and also 
increased the cellular uptake of both EGFP-R8 and dextran in A431 cells. A previous 
report suggested that similar morphological changes observed by phase-contrast 
microscopy in HeLa cells were not due to cell death (Nakase et al., 2004). Cyt D of 
lower concentrations (20 nM-2 µM) were employed in this section in an attempt to 
minimise gross morphological effects on cells but to retain disruption of actin filaments.  
Cells were seeded on coverslips and cultured for 24 hr under tissue culture conditions 
prior to treatment with or without 20 nM-2 µM Cyt D for 30 min. Then cells were fixed 
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and labelled for the nucleus and actin and imaged by the optimised confocal microscopy 
method as previously described. Shown in Figure 4.8 are single sections through 6-10 
cells showing the overall distribution of the actin relative to the nucleus and images of 
2-3 cells from different z-regions. The figure clearly shows that Cyt D disrupts the 
organisation of the actin cytoskeleton in A431 cells in a concentration-dependent 
manner. The selected control cells showed diffused actin meshwork at both CBA and 
basal sections. Additionally a number of scattered F-actin specks in the cytoplasm were 
observed especially at basal section. Similar actin organisation was also exhibited in 
cells treated with 20 nM CytD, suggesting this concentration had little effects on the 
A431 actin architecture. When Cyt D concentration was increased to 200 nM, more 
actin specks started to appear in both CBA and basal sections and large patch of actin 
aggregates was present at the cell edges, which could be clearly seen in the CBA 
section. This large-scale actin disorganisation and intensive actin aggregation became 
more striking in cells treated with 2 µM Cyt D and were usually observed at the 
perinuclear region. These results suggested that by using this phalloidin labelling 
method, the concentration for Cyt D to have visible effects on actin organisation could 
be as low as 200 nM.  
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Figure 4.8 Cyt D effects on the actin architecture in A431 cells. Cells on coverslips were treated either 
with diluent control (0.1% DMSO), or with 20 nM to 2 µM Cyt D for 30 min before fixing and staining 
with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single sections show the 
overall distribution of the actin relative to the nucleus and highlight the effects of the compound on 6-10 
cells to give a better overview of the compound effects. Images below the black line show the actin 
arrangement of 2-3 cells (from other fields of view of single sections) from different z-regions. Scale bars 
10 µm.  
 
In the following experiments, the effect of Cyt D of the same concentrations as that 
used above was investigated with respects to the cellular uptake of EGFP-R8 in A431 
cells. Cells were cultured on 35 mm MatTek dishes and pre-treated with or without Cyt 
D of 20 nM-2 µM for 30 min. Then 2 µM of EGFP-R8 was loaded onto the cells in the 
continued presence or absence of Cyt D of relevant concentration for 1 hr. The cells 
were then washed three times with 0.5 mg/ml heparin in PBS to reduce plasma 
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membrane associated fluorescence and analysed by live cell imaging confocal 
microscopy. As demonstrated in Figure 4.9, Cyt D of 20 nM did not show any evident 
effects on EGFP-R8 uptake in terms of the internalisation level or the distribution of 
fluorescence throughout the cell. Although in the previous actin labelling experiments, 
Cyt D of 200 nM brought obvious alterations to the actin architecture in cells, here by 
live cell microscopy, its effects on EGFP-R8 uptake was hard to define. Unsurprisingly 
Cyt D at the higher concentration 2 µM dramatically enhanced the internalisation of this 
cargo into vesicular structures and affected the subcellular distribution of fluorescence. 
Instead of scattered cytoplasmic structures as shown in control cells, a large number of 
the observed green fluorescence was aggregated in small “island” structures, which 
were also found with 10 µM Cyt D (Figure 4.10). Using DIC microscopy (Figure 4.9; 
Merge), Cyt D of 2 µM caused very minor morphological changes in these cells and 
overall these results indicated that the increase of cargo uptake in A431 cells was due to 
the more subtle effects of this compound on the actin cytoskeleton rather than being due 
to gross morphological changes.  
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Figure 4.9 Effects of different concentration Cyt D on cell morphology and the cellular uptake of 
EGFP-R8 in A431 cells. Cells were incubated with 2 µM EGFP-R8 in the absence (control) or presence 
of 20 nM-2 µM Cyt D for 1 hr and washed with heparin. Cell associated fluorescence was analysed using 
confocal microscopy and shown are single projection images of fluorescence only (top rows) and merges 
of fluorescence and DIC of the same cells. C and D represent zoomed images from different fields of 
view of A and B. Scale bars 10 µm.    
 
To further confirm that the enhanced cellular uptake of EGFP-R8 in A431 cells by Cyt 
D treatment was mediated by endocytosis, rather than energy- and receptor- 
independent direct uptake through plasma membrane translocation, the same live-cell 
experiments were performed at 4°C and 37°C respectively. Cells plated on 35 mm 
MatTek dishes were pre-treated in the absence (Figure 4.10B and D) or presence 
(Figure 4.10A and C) of 10 µM Cyt D for 15 min. For control cells, 2 µM of EGFP-R8 
was then incubated with the cells for 1 hr at 4°C or 37°C. For Cyt D-treated cells, 2 µM 
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of EGFP-R8 was incubated with the cells in presence of 10 µM Cyt D for 1 hr at 4°C or 
37°C. The cells were then washed with heparin and analysed by live cell imaging 
confocal microscopy. 
Fluorescent vesicular structures were observed scattered in the cytoplasm of the control 
cells incubated with cargo at 37°C (Figure 4.10C) but not of that at 4°C (Figure 4.10A). 
This confirmed that the EGFP-R8 uptake by A431 cells was primarily mediated by 
endocytosis. Similarly in Cyt D-treated cells, there was very little evidence of EGFP 
fluorescence in cells treated at 4°C (Figure 4.10B), but clear vesicular labelling in cells 
incubated at 37°C (Figure 4.10D). Again the uptake of EGFP-R8 in Cyt D treated cells 
was dramatically enhanced (Figure 4.10D) compared with control cells (Figure 4.10C). 
This confirmed the absolute requirement for endocytosis in mediating the cellular entry 
of EGFP-R8 in this cell line in the absence of Cyt D and in the presence of Cyt D to 
cause this cell accumulation phenomenon.  
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Figure 4.10 Cellular uptake of EGFP-R8 in control or Cyt D-treated A431 cells at 4°C or 37°C. 
Cells were incubated with 2 µM EGFP-R8 in the absence (control) or presence of 10 µM Cyt D for 1 hr 
at 4°C or 37°C, washed with heparin and analysed using confocal microscopy and shown are single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Columns a-d represent zoomed images from different fields of view. Scale bars 10 µm.  
 
4.2.7 Effects of latrunculin B (Lat B) on the actin architecture and EGFP-R8 
uptake in A431 cells  
To identify the effects of Lat B on actin structures in A431 cells, cells were seeded on 
coverslips and cultured for 24 hr under tissue culture conditions, and then treated with 
0-1.0 µM Lat B for 30 min. Then cells were fixed and labelled for the nucleus and actin 
Control/4°C 
EGFP-R8 
10 µM Cyt D/4°C 
Control/37°C 
A
10 µM Cyt D/37°C 
B
C D
EGFP-R8 
EGFP-R8 EGFP-R8 
a b
c d
Merge Merge 
Merge Merge 
! 155!
and imaged by the optimised confocal microscopy method as previously described. 
Visible alterations in the actin organisation were detectable even at the lowest Lat B 
concentration of 0.1 µM (Figure 4.11). At this concentration, compared with control a 
larger number of small actin specks appeared at both the basal and CBA sections of the 
cells. At a Lat B concentration of 0.5 µM (Figure 4.11), actin specks/aggregations were 
extremely prominent especially at basal section, and also the cells started to round up 
and this was most noticeable in the CBA section. Figure 4.11 also shows that 1 µM Lat 
B caused a major disruption of the actin organisation and resulted in visualisation of 
large amorphous actin masses throughout the cells. Experiments were then performed in 
cells pre-incubated with 0.5 µM Lat B or 10 µM Cyt D that were then incubated with 
EGFP-R8. As expected, Cyt D treated cells had higher fluorescence compared with 
control cells and the same effects were also seen in Lat B treated cells that similarly 
accumulated the fluorescence in a perinuclear region (Figure 4.12). Thus the overall 
effects of these two agents was the same suggesting they influence the uptake of this 
CPP conjugate via a very similar if not identical mechanism of action. 
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Figure 4.11 Effects of Lat B on the actin architecture in A431 cells. Cells on coverslips were treated 
either with diluent control (0.1% DMSO) or 0.1-1.0 µM Lat B for 30 min before fixing and staining with 
Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single sections show the overall 
distribution of the actin relative to the nucleus and highlight the effects of the compound on 6-10 cells to 
give a better overview of the compound effects. Images below the black line show the actin arrangement 
of 4-5 cells (from other fields of view of single sections) from different z-regions. Scale bars 10 µm.  
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Figure 4.12 Effects of Lat B and Cyt D on the cellular uptake of EGFP-R8 in A431 cells. Cells were 
incubated with 2 µM EGFP-R8 in the absence (control) or presence of 0.5 µM Lat B or 10 µM Cyt D for 
1 hr and washed in heparin. Cell associated fluorescence was analysed using confocal microscopy and 
shown are single projection images of fluorescence only (top rows) and merges of fluorescence and DIC 
of the same cells. C/D represent zoomed images from different fields of view of A/B. Scale bars 10 µm.  
 
4.2.8 Effects of jasplakinolide (JAS) on the actin architecture and EGFP-R8 
uptake in A431 cells  
As described in Section 4.1.1 JAS is thought to stabilise actin fibres but has also been 
shown to affect actin assembly. Based on the similar effects of Cyt D and Lat B on actin 
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and EGFP-R8 uptake it was interesting to investigate whether similar effects would be 
observed with this agent. A431 cells grown on coverslips were treated with 
concentrations of JAS ranging from 0.2 to 4 µM for 45 min. Then cells were fixed with 
formaldehyde and labelled for the nucleus and actin and imaged by confocal 
microscopy as previously described for Cyt D and Lat B. Compared with control cells, 
no visible changes in actin organisation were observed in both basal and CBA sections 
of cells (Figure 4.13A) until the concentration of JAS reached 2 µM (Figure 4.13B). At 
this concentration, filamentous actin staining almost completely disappeared and only 
some small actin aggregates and large actin patches could be detected in a number of 
cells. At higher JAS concentration (4 µM) cellular F-actin staining was no longer visible 
(Figure 4.13C).  
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Figure 4.13 Effects of JAS on the actin architecture in A431 cells. Cells on coverslips were treated 
either with diluent control (0.1% DMSO) or 0.2-4.0 µM JAS for 45 min before fixing and staining with 
Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single sections in (A) show the 
overall distribution of the actin relative to the nucleus and highlight the effects of the compound on 6-8 
cells to give a better overview of the compound effects and images below the black line show the actin 
arrangement of 3-4 cells (from other fields of view of single sections) from different z-regions. Scale bars 
10 µm.  
 
EGFP-R8 uptake in JAS treated cells was studies as previously described. Cells were 
seeded on 35 mm MatTek dishes and pre-treated with or without 2-8 µM JAS for 45 
min. Then the cells were incubated for 1 hr with 2 µM of EGFP-R8 in the continued 
presence or absence of the appropriate concentration of the compound. The cells were 
then washed and analysed by live cell imaging confocal microscopy. The influence of 
JAS on the uptake of EGFP-R8 was evident at 2 µM, a concentration that, as previously 
shown, strongly disrupted the actin cytoskeleton. At this concentration, JAS increased 
cell fluorescence in vesicular structures and also altered their distribution in cytoplasm 
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from scattered to clustered. The same uptake experiment was also performed with a 
lower JAS concentration (0.8 µM) that showed little effects on cell morphology and the 
cellular uptake of EGFP-R8 (Appendix 3). As the JAS concentration was increased to 4 
or 8 µM, the enhancement in cargo uptake by this compound became more pronounced 
and strongly fluorescent clustered structures could be observed in most of the imaged 
cells (Figure 4.14). Thus though the effects of JAS on actin distribution was very 
different to that observed by Cyt D and Lat B, the overall effects of the three 
compounds on the uptake of EGFP-R8 was the same. 
 
Figure 4.14 Effects of JAS on the cellular uptake of EGFP-R8 in A431 cells. Cells were incubated 
with 2 µM EGFP-R8 in the absence (control) or presence of 2-8 JAS µM for 1 hr and washed thoroughly 
using heparin. Cell associated fluorescence was analysed using confocal microscopy and shown are single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
C/D represent zoomed images from different fields of view of A/B. Scale bars 10 µm.  
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4.2.9 Effects of Y27632 on the actin architecture and EGFP-R8 uptake in A431 
cells  
Y27632 is known to influence actin dynamics through its direct effects on ROCK 
proteins and thus indirectly through myosin (Figure 4.1). No studies had been 
previously been performed on this agent in the laboratory and initially different 
concentrations were tested for their putative effects on the actin structures in A431 cells 
using the methods described for the other actin inhibitors. Initially, concentrations 1 and 
10 µM were examined based on published observations (Ishizaki et al., 2000, Hoang et 
al., 2004). Figure 4.15 demonstrates that no visible changes in the organisation of the 
actin cytoskeleton were detected even at 10 µM. This concentration was used in 
previous studies showing effects on actin morphology (Darenfed et al., 2007). Higher 
concentrations of Y27632 (50 and 100 µM) (Figure 4.16) induced the formation of a 
large number of actin needles that were mostly running perpendicular to the plasma 
membrane (Figure 4.16Z). It should be noted that the cortical actin network was still 
evident in cells treated with these concentrations of Y27632. In contrast, upon treatment 
with Cyt D of lower concentrations the cortical actin in A431 cells was thinned out or 
even disappeared (Figure 4.8).  
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Figure 4.15 Effects of Y27632 (low concentrations) on the actin architecture in A431 cells. Cells on 
coverslips were treated either with diluent control (D-MEM) or Y27632 of 1 or 10 µM for 4 hr before 
fixing and staining with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single 
sections show the overall distribution of the actin relative to the nucleus and images shown below the 
black line provide information on the actin arrangement of cells (from other fields of view of single 
sections) from different z-regions. Scale bars 10 µm.  
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Figure 4.16 Effects of Y27632 (high concentrations) on the actin architecture in A431 cells. Cells on 
coverslips were treated either with diluent control (D-MEM) or 50, 100 µM of Y27632 for 4 hr before 
fixing and staining with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single 
sections show the overall distribution of the actin relative to the nucleus and highlight the effects of the 
compound on more cells to give a better overview of the compound effects and zoomed images show the 
actin arrangement of 3-4 cells from different z-regions. Scale bars 10 µm.  
 
The effects of Y27632 on the cellular uptake of EGFP-R8 was then investigated at 
various concentrations 1-100 µM. A431 cells seeded in 35mm MatTek dishes were pre-
treated with or without 1-100 µM Y27632 for 4 hr. EGFP-R8 (2 µM) was then 
incubated with the cells in the presence or absence of the appropriate concentration of 
Y27632 for 1 hr. The cells were then washed and analysed by live cell imaging confocal 
microscopy. Only minimal effects were observed in cells treated with low 
concentrations (1 and 10 µM) of this compound (Figure 4.17) and in comparison with 
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control cells, EGFP-R8 uptake was increased slightly in cells treated with 50 µM 
Y27632 but this increase was more apparent in cells exposed to 100 µM of this agent 
(Figure 4.18). Interestingly in contrast to the Cyt D treatment, the observed fluorescent 
vesicular structures in Y27632 treated cells distributed in a scattered manner, which was 
similar to the pattern in control cells. Moreover, unlike Cyt D and other actin disruptors 
previously used, Y27632 treatment did not show any significant morphological changes 
(Figure 4.17 and 4.18; Merge). 
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Figure 4.17 Effects of Y27632 (low concentrations) on the cellular uptake of EGFP-R8 in A431 
cells. Cells were incubated with 2 µM EGFP-R8 in the absence (control) or presence of 1 or 10 µM 
Y27632 for 4 hr and washed with heparin. Cell associated fluorescence was analysed using confocal 
microscopy and shown are single projection images of fluorescence only (top rows) and merges of 
fluorescence and DIC of the same cells. C/D represent zoomed images from different fields of view of 
A/B. Scale bars 10 µm. 
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Figure 4.18 Effects of Y27632 (high concentrations) on the cellular uptake of EGFP-R8 in A431 
cells. Cells were incubated with 2 µM EGFP-R8 in the absence (control) or presence of 50 or 100 µM 
Y27632 for 4 hr and washed with heparin. Cell associated fluorescence was analysed using confocal 
microscopy and shown are single projection images of fluorescence only (top rows) and merges of 
fluorescence and DIC of the same cells. C/D represent zoomed images from different fields of view of 
A/B. Scale bars 10 µm. 
 
4.2.10 Visualisation of EGFP-R8 effects on the actin dynamics of control or A431 
cells treated with actin inhibitors  
In the previous sections, the changes made by a range of actin inhibitors on actin 
arrangement in A431 cells were examined individually and concentrations showing 
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clear effects on actin and EGFP-R8 uptake were also identified. In this section further 
experiments were performed to investigate possible effects of EGFP-R8 on actin 
organisation in both control and compound-treated A431 cells. This was to determine 
whether EGFP-R8 influenced the actin cytoskeleton further to what was observed with 
the actin inhibitors. For these experiments cells on coverslips were pre-treated either 
with diluent control (0.1% DMSO or D-MEM) or the following concentrations of the 
actin inhibitors for the following times: 10 µM Cyt D for 15 min; 0.5 µM Lat B for 30 
min; 0.8 µM JAS for 45 min or 50 µM Y27632 for 4 hr. Control or compound treated 
cells were then incubated with 2 µM EGFP-R8 for 1 hr. Cells were then washed with 
heparin before fixing and staining with Rh-P and Hoechst and imaging by the optimised 
confocal microscopy method. EGFP-R8 at this concentration did not induce any visible 
changes to the actin arrangement in control cells (Figure 4.19A and B); both the cortical 
actin running beneath the plasma membrane observed in basal sections and the reticular 
actin network shown in CBA sections appeared in normal order. This CPP-conjugate 
also had minimal effects on the actin reorganisation in Cyt D treated cells identified by 
disruption of actin meshwork, loss of cortical actin and the presence of patchy actin 
aggregations at the perinuclear regions (Figure 4.19C and D). The same was true of Lat 
B and Y27632 treated cells (Figure 4.19E and F and Figure 4.20E and F) where EGFP-
R8 failed to have any notable effects.  
In order to visualise the F-actin staining by Rh-P in JAS treated cells, the concentration 
of JAS was reduced from 2 µM to 0.8 µM, this was due to the fact that at 2 µM JAS 
either significantly reduced actin staining or removed it altogether (Figure 4.13). The 
cortical actin network and the actin meshwork throughout the cell body were completed 
disrupted by 0.8 µM JAS and replaced by extensive actin aggregation (Figure 4.20 C 
and D). Again addition of EGFP-R8 had no visible contribution to this actin disruption. 
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These results indicated that the internalisation of EGFP-R8 did not evidently stimulate 
the reorganisation of the actin network in either control or compound-treated A431 
cells. 
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Figure 4.19 EGFP-R8 effects on the organisation of the actin architecture in control and A431 cells 
treated with Cyt D or Lat B. Cells on coverslips were pre-treated either with diluent control (0.1% 
DMSO), 10 µM Cyt D for 15 min or 0.5 µM Lat B for 30 min. Cells were then incubated with 2 µM 
EGFP-R8 in the continued absence (control) or presence of Cyt D or Lat B for 1 hr and washed with 
heparin before fixing and staining with Rh-P and Hoechst. Images were acquired as described in section 
4.2.1. Single sections show the overall distribution of the actin relative to the nucleus and images shown 
below the black line provide information on the actin arrangement of cells (from other fields of view of 
single sections) from different z-regions. Scale bars 10 µm.  
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Figure 4.20 EGFP-R8 effects on the organisation of the actin architecture in control and A431 cells 
treated with JAS or Y27632. Cells on coverslips were pre-treated either with diluent control (0.1% 
DMSO for JAS or D-MEM for Y27632), 0.8 µM JAS for 45 min or 50 µM Y27632 for 4 hr. Cells were 
then incubated with 2 µM EGFP-R8 in the absence (control) or presence of JAS or Y27632 for 1 hr and 
washed with heparin before fixing and staining with Rh-P and Hoechst. Images were acquired as 
described in section 4.2.1. Single sections show the overall distribution of the actin relative to the nucleus 
and images shown below the black line provide information on the actin arrangement of cells (from other 
fields of view of single sections) from different z-regions. Scale bars 10 µm.  
C
on
tr
ol
  
(+
)J
A
S 
/ (
-)E
G
FP
-R
8 
E
G
FP
-R
8 
(+
)J
A
S 
/ (
+)
E
G
FP
-R
8 
(+
)Y
27
63
2 
/ (
-)E
G
FP
-R
8 
(+
)Y
27
63
2 
/ (
+)
E
G
FP
-R
8 
A
 
B
 
C
 
D
 
E
 
F 
Si
ng
le
  
se
ct
io
n 
 
B
as
al
  
C
B
A
 
M
er
ge
 
! 171!
4.2.11 Effects of PP2 on the actin architecture and EGFP-R8 uptake in HeLa or 
A431 cells 
In view of the described link between actin dynamics and SFKs (Section 4.1.1) new 
investigations were performed investigating the actin cytoskeleton and EGFP-R8 uptake 
in HeLa and A431 cells incubated with the SFK inhibitor PP2. Here, cells were seeded 
on coverslips and cultured for 24 hr under tissue culture conditions, and treated with or 
without 1, 10 or 25 µM PP2 for 48 hr. Then cells were then fixed and labelled for the 
nucleus and actin and imaged by confocal microscopy as previously described. The 
higher concentrations of PP2 (10 and 25 µM) resulted in significant toxicity in HeLa 
cells and most of the cells had lifted either before the fixing procedure or did so during 
this process (data not shown). A431 cells were less sensitive to PP2 but at 25 µM, 
toxicity again became a major factor (data not shown). Inhibition of cell growth by PP2 
treatment at these concentrations was previously reported in a variety of cancer cell 
lines (Nam et al., 2002).   
As shown in Figure 4.21, 1 µM PP2 had no visible effects on the actin architecture of 
HeLa cells and long actin stress fibres or bundles were well maintained. However in 
A431 cells, at of 1 or 10 µM, the agent PP2 stimulated actin polymerisation into long 
filamentous bundles (Figure 4.22), observed predominantly in CBA sections. The 
effects of PP2 alone or in combination of PP2 and Cyt D (an actin depolymeriser) on 
the cellular uptake of EGFP-R8 in both HeLa and A431 cells was then investigated. 
Cells in 35mm MatTek dishes were pre-treated with or without PP2 (1 µM only for 
HeLa cells and 1 or 10 µM for A431 cells) for 48 hr. Some of the non-treated and PP2 
treated cells were further incubated with 10 µM Cyt D for an extra 15 min. Then EGFP-
R8 (2 µM) was added to the cells in the continued presence or absence of 10 µM Cyt D 
for 1 hr. The cells were then washed and analysed by live cell imaging confocal 
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microscopy. 
 
Figure 4.21 Effects of PP2 on the actin architecture in HeLa cells. Cells on coverslips were treated 
either with diluent control (0.1% DMSO) or PP2 of 1 µM for 48 hr before fixing and staining with Rh-P 
and Hoechst. Images were acquired as described in section 4.2.1. Single sections show the overall 
distribution of the actin relative to the nucleus and highlight the effects of the compound on more cells to 
give a better overview of the compound effects and images shown below the black line provide 
information on the actin arrangement of 2-3 cells (from other fields of view of single sections) from 
different z-regions. Scale bars 10 µm.  
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Figure 4.22 Effects of PP2 on the actin architecture in A431 cells. Cells on coverslips were treated 
either with diluent control (0.1% DMSO) or PP2 (1 or 10 µM) for 48 hr before fixing and staining with 
Rh-P and Hoechst. Images were acquired as described in section 4.2.1. Single sections show the overall 
distribution of the actin relative to the nucleus and images shown below the black line provide 
information on the actin arrangement of cells (from other fields of view of single sections) from different 
z-regions. Scale bars 10 µm.  
 
PP2 at 1 µM had no visible effects on the delivery of EGFP-R8 into HeLa cells 
regarding the efficiency of uptake and the distribution of internalised cargo (Figure 
4.23E-F). This was consistent with the observation on its effects on the actin 
cytoskeleton at this concentration (Figure 4.21). As already described in chapter 3, 10 
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µM Cyt D inhibited the uptake of EGFP-R8 by HeLa cells, however, this inhibition was 
prevented by the pre-treatment of the cells with 1 µM PP2 (Figure 4.23G-H). DIC also 
revealed clear morphological effects on the cells treated with Cyt D. A similar 
phenomenon was observed in A431 cells. In contrast to the striking increase of EGFP-
R8 uptake by Cyt D, PP2 at 10 µM did not noticeably influence EGFP-R8 uptake by 
A431 cells (Figure 4.24E-F). But again the pre-treatment of PP2 eliminated the Cyt D 
mediated enhancement of cargo uptake (Figure 4.24G-H). Thus the effects of Cyt D on 
EGFP-R8 uptake could be reversed in these two cell lines by prior incubation with PP2. 
 
Figure 4.23 Effects of PP2 alone and the combination of PP2 and Cyt D on the cellular uptake of 
EGFP-R8 in HeLa cells. Cells were cultured and pre-treated either with diluent control (0.01% DMSO) 
or 1 µM PP2 for 48 hr at 37°C/5% CO2. Cells were then incubated with or without 10 µM Cyt D for 15 
min prior to a further incubation with 2 µM EGFP-R8 for 1 hr in the continued presence or absence of 
Cyt D. Cells were then washed with heparin, and cell-associated fluorescence was analysed by confocal 
microscopy. Shown are representative single projection images of fluorescence only (top rows) and 
merges of fluorescence and DIC of the same cells. Shown in column B, D, F and H are zoomed images 
obtained from different fields of view of A, C, E and G respectively. Scale bars 10 µm.  
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Figure 4.24 Effects of PP2 alone and the combination of PP2 and Cyt D on the cellular uptake of 
EGFP-R8 in A431 cells. Cells were cultured and pre-treated either with diluent control (0.1% DMSO) or 
10 µM PP2 for 48 hr at 37°C/5% CO2. Cells were then incubated with or without 10 µM Cyt D for 15 min 
prior to a further incubation with 2 µM EGFP-R8 for 1 hr in the continued presence or absence of Cyt D. 
Cells were then washed with heparin, and cell-associated fluorescence was analysed by confocal 
microscopy. Shown are representative single projection images of fluorescence only (top rows) and 
merges of fluorescence and DIC of the same cells. Shown in column B, D, F and H represent zoomed 
images obtained from different fields of view of A, C, E and G respectively. Scale bars 10 µm.  
 
Further investigations into the effects of the combination of PP2 and Cyt D on the actin 
cytoskeleton in A431 cells were performed. For this, cells seeded on coverslips were 
cultured for 24 hr under tissue culture conditions and were pre-treated with or without 
10 µM PP2 for 48 hr. At the very end of the experiment, some of the non-treated and 
PP2 treated cells were further incubated with 10 µM Cyt D for 15 min. The cells were 
then washed, fixed and labelled for the nucleus and actin, and then imaged by confocal 
microscopy as previously described. As expected, Cyt D alone induced a dramatic 
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disruption of the actin organisation, while PP2 alone stimulated actin assembly into 
filament bundles and these structures were clearly observed in the CBA section (Figure 
4.25). Interestingly, the pre-incubation with PP2 failed to prevent Cyt D-mediated actin 
disruption, although, as previously shown, this compound abrogated the Cyt D-
mediated increase in EGFP-R8 uptake (Figure 4.25). 
 
 
 
Figure 4.25 Effects of the combination of PP2 and Cyt D on the actin cytoskeleton in A431 cells. 
Cells seeded on coverslips were cultured and pre-treated either with diluent control (0.1% DMSO) or 10 
µM PP2 for 48 hr at 37°C/5% CO2. They were then incubated with or without 10 µM Cyt D for 15 min 
prior to fixing and staining with Rh-P and Hoechst. Images were acquired as described in section 4.2.1. 
Single sections show the overall distribution of actin relative to the nucleus and images below the black 
line provide information on the actin arrangement of cells (from other fields of view of single sections) 
from different z-regions. Scale bars 10 µm. 
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4.2.12 Discussion on Section 4.2.6 to 4.2.11  
At present, one of the most commonly utilized approaches to study the role of actin 
organisation and dynamics in a range of cellular functions including endocytosis is via 
perturbation of actin architecture using pharmacological inhibitors. A number of natural 
compounds and synthetic products have been identified or developed to target the actin 
cytoskeleton directly or indirectly and to disrupt its arrangement and thus function. The 
most commonly used by a long margin are Cyt D, Lat B and JAS. But of interest to this 
thesis is the fact that they also have unique mechanisms of action and also that 
previously no comparative studies had been performed on their individual and 
combined effects on CPP uptake.  
Cyt D of high concentration (10 µM) was initially used in cultured cells to induce 
complete depolymerisation of actin cytoskeleton, although concentrations of 1-2 µM 
have also used for this purpose (Kolodney and Wysolmerski, 1992, Pelham and Wang, 
1999, Kasas et al., 2005, Pesen and Hoh, 2005). In this chapter it was identified the Cyt 
D induced increased uptake of EGFP-R8 in A431 cells was due to the effects of severe 
actin disorganisation on endocytosis rather than a general increase in plasma membrane 
permeability that could be caused by toxicity/necrosis. Lower concentrations of Cyt D 
were then tested and its disruption effects on actin could only be seen when the 
concentration reached 200 nM. However, visualisation of Cyt D effects on cellular 
uptake of EGFP-R8 required a higher concentration of 2 µM. The resulting actin 
visualisation experiments revealed that actin in HeLa cells was prominent in long 
filaments extending over several micro meters while cortical actin, associated with the 
plasma membrane is much more abundant in A431 cells. These major differences in 
actin organisation of these two cell lines has been previously reported by our group (Al 
Soraj et al., 2012). We therefore postulated that the observed difference in organisation 
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of the actin cytoskeleton between these two cell lines has significant influence on their 
sensitivity to Cyt D with respects to uptake of both dextran and EGFP-R8. Previously 
the group usually relied on acquiring single section images (wide field or confocal) of 
actin dynamics in fixed cells. In this thesis a significant effort was invested in 
optimising confocal microscopy based methods to visualise and highlight actin profiles 
at different sections of the cells. An optimised method was developed and published as 
He et al in Methods in Molecular Biology and the ruffling cell shown in Figure 4.6 at 10 
µM R8 was selected as the cover image for the 2015 volume of Cell Penetrating 
Peptides Methods and Protocols that also contains this publication (Figure 4.26). 
 
Figure 4.26 Cell Penetrating Peptides Methods and Protocols Volume showing a cell image 
presented in He et al 2015 (He et al., 2015).  
 
To further investigate the role of actin and especially cortical actin for endocytic EGFP-
R8 uptake in A431 cells, four other actin inhibitors, Lat B, JAS, Y27632 and PP2 were 
studied. Initially experiments were performed to assess their effects on actin using 
confocal fluorescence microscopy in fixed cells labelled with Rhodamine-Phalloidin. 
Similar to Cyt D, Lat B at 0.5 µM destroyed actin organisation, and a large number of 
amorphous actin aggregates were observed in treated cells. It should be noted that in Lat 
B treatment, the cortical actin network in a majority of the imaged cells was also 
disturbed. Based on results with Cyt D here and in Al Soraj et al (Al Soraj et al., 2012) 
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it was expected that treatment with this agent would increase EGFP-R8 uptake and 
indeed this is what happened. Time did not allow for similar analysis to be performed 
with this agent and others using dextran as an endocytic probe; but this data would 
further substantiate the similarities that we have observed with this probe and R8 
conjugates with respects to actin breakdown. JAS- and Y27632- treated cells also had 
increased levels of EGFP-R8 when the concentration was high enough to reveal clear 
evidence of actin breakdown. It should be noted here that high drug concentrations may 
also lead to cell death, which might in turn result in actin rearrangement. To minimise 
the possibility of cell death-induced actin reorganisation, viability assays might help 
determine the correct drug concentration to use. JAS is usually employed to stabilise 
pre-existing actin filaments and also to promote actin polymerisation (Bubb et al., 
1994). However in this chapter the effects of JAS were quite striking as it completely 
obliterated the actin architecture and at the higher levels actin staining altogether. It is 
known that after prolonged JAS treatment (1-24 hr), actin arrangement is significantly 
modified manifest as the formation of actin specks/patches and the disruption of 
filamentous actin (Braet et al., 1998, Senderowicz et al., 1995, Bubb et al., 2000, 
Sawitzky et al., 1999). Binding of JAS to F-actin is competitive with phalloidin (Bubb 
et al., 1994) and this is the likely reason for the disappearance of actin labelling at the 
higher concentrations. A decrease in actin labelling was also reported in JAS (1 µM) 
treated MDCK cells stained with FITC-phalloidin (Shurety et al., 1998). In order to 
avoid these visualisation difficulties, electron microscopy has been used as an 
alternative technique for observation of the effects of JAS on actin (Shaw and Tilney, 
1999).  
Rho signalling pathways critically participate in the regulation of actin reorganisation in 
a variety of systems, and downstream Rho effectors including ROCKs have been 
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reported to play a critical role in regulating actin dynamics (Sit and Manser, 2011, 
Riento and Ridley, 2003). Y27632 has been widely used as an inhibitor of ROCKs by 
competing with the ATP binding site (Ishizaki et al., 2000). After Y27632 treatment an 
altered distribution of filamentous actin has been reported in a variety of cell lines such 
as Swiss 3T3 cells, characterised by various phenotypes including the decrease or 
abolishment of the filamentous actin system (Ishizaki et al., 2000, Rao et al., 2001, Tee 
et al., 2015), the induction of long spiculate protrusions (Ishizaki et al., 2000) and the 
appearance of small circular actin structures (Svoboda et al., 2004). Intriguingly, at 
similar low micro molar concentrations that were commonly used in the studies 
mentioned above, Y27632 induced the reorganisation of actin into thick filament 
bundles underneath the plasma membrane of A431 cells; these interesting spiculated 
actin structures were found to be perpendicular with the membrane and oriented toward 
extracellular regions. The optimised methodology for visualising actin was a major 
factor in observing this phenomenon and these structures.  
Recent studies have confirmed the critical role of the SFK family in actin cytoskeleton 
dynamics/reorganisation via their phosphorylation and activation of a wide range of 
actin regulatory factors such as the actin polymerisation promoter cortactin that usually 
occurs in response to extracellular stimulation (Tehrani et al., 2007, Koivusalo et al., 
2009). Growth factor activated receptor tyrosine kinases (RTKs) such as EGFR and 
Platelet Derived Growth Factor Receptor (PDGFR) mediate extensive signalling to 
locally induce the formation of actin-rich dorsal membrane ruffles and globally promote 
cell migration and cell proliferation (Shah and Vincent, 2005, Reinecke and Caplan, 
2014). Src kinase family is a group of non-receptor tyrosine kinases (NRTKs) and acts 
directly downstream of RTKs and thus is involved in these cellular activities. Src family 
members have also been shown to regulate endocytosis via phosphorylating and 
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interaction with various components of the endocytic machinery including dynamin and 
actin-related cortactin (reviewed in (Lavoie et al., 2010).  
The Src kinases inhibitor PP2 was previously observed to significantly inhibit the 
invasion and proliferation of brain tumour cells (malignant glial cells) and induce a 
rapid disappearance of peripheral membrane ruffles and loss of lamellipodia at a 
concentration of 10 µM (Angers-Loustau et al., 2004). In our studies, the addition of 10 
µM PP2 stimulated the appearance of long actin fibres in A431 cells, but this agent was 
very toxic to HeLa cells at the same concentration. It should be noted that in contrast to 
the other actin influencing compounds used in the chapter, Src inhibition by PP2 did not 
disturb the cortical actin in A431 cells. Therefore it was somewhat unsurprising that the 
increase of EGFP-R8 uptake that was observed in A431 cells treated with the other 
actin inhibitors did not occur in cells incubated with PP2. Of particular interest was that 
the striking increase in EGFP-R8 uptake induced by Cyt D in the same cell line was 
diminished or even prevented by PP2 pre-treatment; this is interesting as the inhibition 
of Src kinase activity has previously been shown by other research group to prevent the 
Cyt D effects (Olivares et al., 2014). As reported in this study, inhibition of the SH3 
domain-dependent Src kinase association with other proteins by the microinjection of 
isolated cSrc-SH3 domain diminished both the disruption of the actin network and the 
increased neurotransmitter release in neuroendocrine chromaffin cells by Cyt D 
treatment, but the underlying reason for this was not mentioned and is still unknown. 
However, it should be noted that the link between these PP2 effects on actin 
arrangement/peptide uptake shown in this thesis and Src inhibition needs further 
characterisation. As noted in the introduction to this chapter, PP2 also inhibits other 
kinases such as FRK. The kinase activity of Src within a cell sample treated with PP2 in 
our cell model could be measured by Western blotting using Src phospho-specific 
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antibodies. Alternatively Src expression could be silenced using siRNA transfection and 
then Src depleted cells could be treated with Cyt D to assess whether the same effects 
are observed. 
Based on the results obtained from different actin inhibitors, the actin cytoskeleton and 
most probably the cortical network in A431 cells acts as a hindrance to the cellular 
uptake of EGFP-R8 and even endocytosis as a whole. This now needs to be further 
explored as classically the actin is deemed to support and promote endocytosis rather 
than hinder the process. Further attempts to separate the differential roles of cortical 
actin from the remaining actin cytoskeleton in mediating the uptake of CPP-protein 
cargo such as EGFP-R8 may further help us in defining their internalisation 
mechanisms. This may for example be achieved by using actin reagents in a different 
way. Studies have reported that low doses of Cyt D (50-100 nM) selectively 
destabilised the fine-mesh cortical filaments in endothelial cells while the larger 
filament bundles and stress fibres were unaffected by this treatment (Fels et al., 2012, 
Kronlage et al., 2015).  Lower concentrations of Cyt D could thus be tested with EGFP-
R8, R8-Alexa 488 and indeed other CPP conjugates that are thought to enter cells via 
the involvement of actin. Indeed other probes that enter cells via endocytosis, such as 
dextran, could be similarly investigated. 
Further analysis will highlight how these agents alone can give additional clues 
regarding the role of actin in endocytosis of CPP conjugates and their eventual 
intracellular fate. This is especially pertinent to the possibility that the CPP themselves, 
such as cationic R8, may either induce actin rearrangement to promote uptake via 
macropinocytosis or influence actin rearrangement in a manner similar to the chemical 
inhibitors that clearly induced endocytosis of EGFP-R8. As some of these actin-
disrupting agents have reverse effects on actin (polymerisation vs depolymerisation), 
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they might be used together as a cocktail to disrupt actin function but maintain cell 
morphology, thus causes less overall effects on cell architecture and integrity. In this 
chapter a major finding was that pre-treatment of HeLa and A431 cells with PP2 
desensitised them to the effects of Cyt D on EGFP-R8. Whatever the true mechanism of 
PP2 it is able to inhibit both the negative (HeLa) and positive effects (A431) of Cyt D 
on EGFP-R8 uptake. It is hypothesized that the same would be true for Lat B and JAS 
but this remains to be tested. A combination of JAS, Lat B and Y27632 as a 
pharmacological cocktail was reported to rapidly arresting actin dynamics within 
seconds and also preserve the existing actin architectures in a range of cell models. 
However, the responses to extracellular stimuli of the tested cells were retained (Peng et 
al., 2011). Unfortunately we failed to reproduce the preservation of actin cytoskeleton in 
either HeLa or A431 cells by loading these three dugs as a cocktail onto cells (data not 
shown). Future studies focusing on the potential tools/methods that can selectively 
disrupt the newly formed actin structures but preserve the pre-existing actin architecture 
would shed new light on the role of actin in mediating the endocytosis of CPPs or CPP 
conjugates.  
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Chapter 5: siRNA inhibition of endocytic pathways to 
investigate the cellular uptake mechanisms of the CPP-
protein conjugate EGFP-R8 
 
5.1 Introduction  
The studies performed in the previous two results chapters primarily used 
pharmacological inhibitors of the actin cytoskeleton to assess the role of actin in 
internalisation of CPP conjugates and well characterised endocytic probes in two 
different cell lines. However, as highlighted in this thesis and previously noted, the 
chemical actin inhibitors used here have their own limitations. They for example can 
cause severe and rapid morphological effects on cells and can induce cytotoxicity 
(Vercauteren et al., 2010, Ivanov, 2008). An alternative to chemical inhibition of 
endocytosis is that based on siRNA depletion of key endocytic proteins to selectively 
inhibit different endocytic pathways. This approach was used in our laboratory to 
investigate the roles of individual endocytic pathways and actin in the uptake of Alexa 
488 conjugates of HIV-Tat peptide and R8 (Al Soraj et al., 2012). This was the study 
that set the template for this PhD thesis with a view to further understanding how actin 
regulated CPP uptake when the peptide is attached to large protein cargo.  
Below, some of the identified endocytic pathways are described, as these were targets 
for studies performed in this chapter. It is important to note that other pathways have 
been described such as the CLIC-GEEC pathway that is thought to be involved in fluid 
phase uptake and endocytosis of GPI-linked proteins. This is a poorly described 
pathway as are others and these will not be described further in any great detail. 
! 185!
5.1.1 Clathrin-mediated endocytosis (CME) 
To date, the best-characterised endocytic pathway is CME (Figure 1.4) (McMahon and 
Boucrot, 2011). During this process, the highly conserved protein complex AP2 plays 
crucial roles especially in the formation and maturing of clathrin-coated vesicles on 
intracellular membranes. AP2 components are recruited to the plasma membrane, 
following the initiation of membrane invagination at the sites where the clathrin-coated 
vesicles will bud. It was previously thought that AP2 contributes to the initial 
generation of membrane curvature through binding to membrane-specific 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) and the cytoplasmic tails of 
transmembrane receptors (Ohno et al., 1995, Höning et al., 2005). However this concept 
on AP2 has been challenged by more recent research that suggested the essential 
requirement of a putative membrane nucleation complex for membrane curvature 
initiation (Stimpson et al., 2009, Henne et al., 2010). Upon arrival at the plasma 
membrane, the AP2 complexes directly recruit several types of receptors including 
EGFR (Huang et al., 2004) and TfR (Boucrot et al., 2010) through their α-subunit and 
µ2-subunit, and also bind to a number of cargo-specific adaptor proteins (using 
appendage domains), which then recruit other specific receptors to the AP2 hub (Collins 
et al., Kelly et al., 2008). Another crucial role for AP2 is to recruit clathrin from the 
cytosol to the plasma membrane to mediate the formation of coated vesicles; the 
depletion or absence of AP2 from cells has been suggested to abrogate the recruitment 
of clathrin and the consequent clathrin coat assembly and vesicle formation (Motley et 
al., 2003, Boucrot et al., 2010). Given the fact that AP2 acts as core component of the 
protein interaction network required for the formation of clathrin-coated vesicles, 
silencing expression of AP2 subunits such as the µ2 subunit and clathrin heavy and light 
chain through siRNA transfection has been often used as a tool to perturb the clathrin-
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mediated endocytic pathway (Ravikumar et al., 2010, Motley et al., 2003, Kolokoltsov 
et al., 2007).  
5.1.2 Caveolae-mediated endocytosis  
Caveolae are flask-shape membrane invaginations that bud from specialised 
glycosphingolipid- and cholesterol- enriched microdomains (rafts) and are defined by 
membrane proteins caveolins (caveolin-1 and muscle-specific caveolin-3) (Parton and 
del Pozo, 2013) and also cavins (Kovtun et al., 2015). Caveolae have been detected with 
high density in endothelial cells, adipocytes and skeletal muscle cells, whereas there is 
still no evidence for their presence in other cells types including commonly used cancer 
cell lines e.g. breast cancer MCF7 cells  (reviewed in (Rewatkar et al., 2015). Caveolin-
1 (or caveolin-3 in muscle cells) are essential structural components for caveolae 
formation and form oligomers, which are suggested to drive membrane curvature 
(Pelkmans and Zerial, 2005). From in vitro studies with cell lines, depletion of caveolin-
1 via siRNA targeting results in the absence of caveolae (Hill et al., 2008, Rewatkar et 
al., 2015) and hematopoietic cell lines do not express caveolin-1 and thus do not make 
caveolae (Van Deurs et al., 2006). As caveolae gained prominence as mediators of 
endocytosis, drug delivery researchers have attempted to inhibit uptake through this 
route either by depleting caveolin-1 expression with siRNA or using chemical agents 
such as nystatin and cyclodextrins that disrupt lipid rafts. These studies have suggested 
caveolae may play a role in uptake of spherical nucleic acid-conjugated gold 
nanoparticles (Choi et al., 2013), recombinant Tat-M13 phages (Kim et al., 2012) and 
other non-viral delivery vectors such as polyethylinimine (PEI)  (Gabrielson and Pack, 
2009). 
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5.1.3 Flotillin-mediated endocytosis  
Flotillins (1 and 2) are also found on lipid rafts and in 2006 flotillin-1 was proposed to 
regulate a distinct endocytic pathway (Glebov et al., 2006, Hansen and Nichols, 2009). 
To date, the flotillin-1-mediated endocytosis has been reported to provide cell entry for 
a variety of cargo molecules such as the GPI-anchored protein CD59, cholera toxin B 
subunit (CTxB) (Glebov et al., 2006), cationic polyplexes (Vercauteren et al., 2011) and 
CPP polyarginine (Payne et al., 2007). In addition to membrane trafficking processes, 
flotillins have also been revealed to function in several other cellular contexts including 
cell adhesion, signal transduction e.g. by receptor tyrosine kinases and regulation of the 
cortical cytoskeleton (Banning et al., 2014, Ludwig et al., 2010).  
Flotillins are expressed in all mammalian cells studied to date, and are thought to 
associate with specific cholesterol-enriched membrane microdomains constitutively 
through acylation, oligomerisation and cholesterol-binding (reviewed in (Meister and 
Tikkanen, 2014)). Studies of Frick et al. suggested that upon certain stimuli, flotillin-1 
and -2 located on the plasma membrane coassemble into higher-ordered oligomers to 
form flotillin-enriched microdomains that are distinct from those defined by caveolins. 
These oligomerised flotillins then recruit certain transmembrane cargo proteins such as 
EGFR into these newly generated microdomains to cluster them prior to endocytosis. 
These microdomains also exhibited some of the classical hallmarks of lipid rafts and 
showed the capacity to induce membrane curvature, the formation of membrane 
invaginations and thus membrane budding towards the cell interior (Frick et al., 2007).  
The distribution of flotillin microdomains and the flotillin functions during endocytosis 
are potentially regulated by tyrosine phosphorylation via certain Src family kinases 
(Neumann-Giesen et al., 2007, Riento et al., 2009). However, the exact role of flotillin-
positive microdomains in endocytic uptake has not been fully clarified.  
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5.1.4 Macropinocytosis  
Macropinocytosis is a process that cells can use to nonselectively engulf large amount 
of extracellular fluid containing nutrients. The most studied macropinocytosis process is 
that occurs in cells activated by growth factors such as EGF but there is also a belief 
that many cells types can perform constitutive macropinocytosis via membrane ruffling 
(Jones, 2007). Identified macropinocytosis regulators include the Na+/H+ exchanger, 
p21-actibvated kinase 1 (PAK-1) and a dynamic actin cytoskeleton to mediate the 
changes that occur on the plasma membrane. (Lim and Gleeson, 2011, Mercer and 
Helenius, 2012). The functional relationship between Na+/H+ exchange and 
macropinocytosis is not apparent. One possible mechanism is that the activity of Na+/H+ 
exchanger has influence on cytosolic pH and the pH changes could in turn lead to 
alterations in the signalling and/or actin reorganisation required for macropinocytosis 
(Koivusalo et al., 2010). PAK-1 is the best-characterized member of the PAK family of 
serine/threonine kinases that are activated by Rho family GTPases Rac 1 and Cdc42 
(Manser et al., 1994). It binds to the GTP-bound forms of Rac 1/Cdc42, and functions 
as downstream effector in several Rac- and Cdc42- regulated signalling events 
including the modulation of the actin cytoskeleton (Figure 4.1). Apart from the small 
GTPases, several other signalling proteins such as PAK interacting exchange factor 
(PIX) have been identified as key players in PAK activation (reviewed in (Rane and 
Minden, 2014). Upon activation, PAK-1 can phosphorylate a serine residue on the light 
chain of regulatory myosins, and thus stabilise filamentous actin and contribute to the 
formation of actin-rich structures such as dendritic spine in neuronal cells (Zhang et al., 
2005) or to some other actin-based functions such as membrane trafficking and cell 
migration (Kichina et al., 2010). However, in other cell types including fibroblasts, 
endothelial cells and epithelial cells, PAK-1 has been shown to have opposite effect on 
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actin structures (Sanders et al., 1999, Goeckeler et al., 2000). In these cell lines, PAK-1 
phosphorylates myosin light chain kinase (MLCK), blocking its kinase activity resulting 
in decreased phosphorylation of myosin light chain and the subsequent dissolution of 
stress fibres.  
PAK-1 has been shown to stimulate the formation of actin-rich dorsal membrane ruffles 
that were similar to those implicated in the process of macropinocytosis 
(Dharmawardhane et al., 1997, Edwards et al., 1999). Additionally, inhibition of 
endogenous PAK activity was reported to impede growth factor induced 
macropinocytosis (Liberali et al., 2008, Dharmawardhane et al., 2000) and the uptake of 
vaccinia virus by macropinocytosis (Mercer and Helenius, 2008). These data provide 
strong evidence for the direct regulatory role of PAK-1 in macropinocytosis, through its 
actin mediating activity. 
Rho GTPases, including Rac1 and Cdc42 are essential for appropriate organisation of 
actin cytoskeleton and in various endocytic pathways. These Rho family members have 
different roles in regulating actin dynamics. Specially, Rac1 promotes the formation of 
lamellipodia and membrane ruffles, whereas Cdc42 is primarily involved in the 
formation of filopodia, but both GTPases are required for at least some forms of 
endocytosis, especially macropinocytosis through their regulation of actin assembly 
factors like ARP2/3 complex and the ARP2/3 activator of WAVE and WASP (Figure 
4.1). For example, Cdc42 localised at the plasma membrane can bind to WASP, and the 
activated WASP in turn interacts with and activates the ARP2/3 complex, which then 
initiates the assembly of branched actin (Chesarone and Goode, 2009, Takenawa and 
Suetsugu, 2007). Mammalian diaphanous (mDia) proteins, which belong to the formin 
family, also act as downstream targets for Cdc42, and their activity is required to induce 
the polymerisation of unbranched actin filaments (Peng et al., 2003). Another actin 
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regulatory factor cofilin is known to stimulate actin disassembly and actin filament 
severing. There is still no valid evidence for the direct link between cofilin and Cdc42 
but Cdc42 was suggested to indirectly inhibit the activity of cofilin via LIM kinase 
(Wang et al., 2007). Several recent studies have revealed crosstalk regulation between 
Rac1 and Cdc42 in regulating actin dynamics (Yang et al., 2006, Steffen et al., 2013). 
These actin reorganisation events regulated by Cdc42 is the main force to drive 
membrane deformation and the subsequent vesicle formation required for 
macropinocytosis.  
Cdc42 was first identified in budding yeast, and loss of Cdc42 resulted in failure for 
budding and mating projection (Etienne-Manneville, 2004). In mammalian cells, in 
addition to macropinocytosis, fluid-phase endocytosis and clathrin-independent carrier 
pathway (CLIC-GEEC) have also been reported to rely on the involvement of Cdc42 
(Hansen and Nichols, 2009, Howes et al., 2010), and depletion of Cdc42 through RNA 
interference inhibited the endocytosis of transferrin in human HeLa cells (Balklava et 
al., 2007). 
Aims  
Previous studies shown in Chapter 3 and 4 have reported that actin 
disruption/reorganisation in A431 cells led to dramatic increase of cellular uptake of 
CPP conjugate EGFP-R8 and of the fluid-phase probe dextran, whereas the opposite 
effects were seen in HeLa cells. These observations were mainly based on the use of 
chemical inhibitors such as Cyt D. The aims of this chapter were to attempt to siRNA 
silence the expression of two proteins, PAK-1 and Cdc42 that have been implicated in 
regulating actin assembly and specifically macropinocytosis. These cells could then be 
tested for their ability to internalise EGFP-R8 compared with cells treated with 
chemicals that have been shown to inhibit macropinocytosis. A further aim was to 
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investigate the potential of siRNA sequences targeting CME, caveolae and flotillin 
pathways through silencing AP2µ2, caveolin-1 and flotillin-1 respectively to influence 
EGFP-R8 uptake. Together, these results in HeLa and A431 cells would then provide 
valuable information regarding the differences observed in their processing of CPPs and 
fluid phase probes and the roles of different endocytic pathways and specifically actin 
on the cellular uptake of this CPP-conjugate. 
5.2 Results 
5.2.1 Inhibition of caveolae-dependent endocytosis through siRNA depletion of 
caveolin-1  
The involvement of caveolae-dependent pathway in EGFP-R8 internalisation by HeLa 
or A431 cells was initially studied using siRNA transfection targeting caveolin-1. A 
validated sequence was investigated using a previously described method developed in 
the laboratory (Al Soraj et al., 2012).  
Briefly cells (HeLa or A431 cells) were seeded onto 12-well plates and transfected with 
100 nM siRNA for 48 hr. Cells were then lysed and aliquots of the cell lysate was 
separated by SDS-PAGE. Expression of caveolin-1 and tubulin was detected by 
Western blotting. In addition, siRNA against GFP (si-GFP) was employed as non-
targeting control siRNA.   
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Figure 5.1 siRNA-based caveolin-1 depletion from HeLa (A/C) and A431 (B/D) cells. A-B) 
Immunoblots for caveolin-1 and tubulin in untransfected cells or cells treated with Cav-1 targeting siRNA 
(si-Cav-1) or GFP control siRNA (si-GFP). C-D) Relative protein expression was quantified using 
ImageJ software by densitometry and normalised to tubulin loading control.  
 
The expression of caveolin-1 from the blots was normalised to tubulin loading control 
and the effectiveness of siRNA depletion of the target protein was quantified using 
ImageJ software. Figure 5.1 demonstrates effective depletion of the target protein from 
HeLa cells (Figure 5.1A) as ~92% reduction in caveolin-1 expression was observed 
(Figure 5.1C). The data in Figure 5.1B and D highlights that per µg of loaded protein 
that Cav-1 expression was higher in A431 cells and that silencing efficiency only 
reached ~38%.  As Cav-1 depletion using this siRNA sequence is well characterised in 
the laboratory (Al Soraj et al., 2012), this experiment confirming depletion of the 
protein in HeLa cells was only performed once before then conducting CPP uptake 
assays. Despite the fact that only partial silencing of Cav-1 expression was noted in 
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A431 cells it was determined that investigations were performed to observe any effects 
of this partial depletion on CPP uptake. 
Untransfected HeLa cells or cells transfected with control siRNA (si-GFP) or siRNA 
targeting caveolin-1 (si-Cav-1) for 48 hr as described above were washed and then 
incubated with 2 µM EGFP-R8 for 1 hr at 37°C/5% CO2. Cells were then washed three 
times with 0.5 mg/ml heparin solution and once with PBS prior to live cell imaging 
confocal microscopy. As shown in Figure 5.2, in comparison to si-GFP treatment, 
caveolin-1 depletion did not result in any obvious difference in EGFP-R8 uptake with 
respects to overall fluorescence intensity or intracellular distribution. This agrees with 
previous studies showing no effect of Cav-1 depletion on the cellular uptake of R8-
Alexa 488. Cav-1 studies in this cell line were not carried out further. This experiment 
was repeated and the fluorescence intensities from both experiments were then 
calculated using a fluorescence intensity quantification method recently developed in 
the laboratory (Moody et al., 2015) (see Appendix 4 for method details). As this 
represents an n=2 (due to time limitation), thus no statistical analysis could be 
performed but the data clearly shows that uptake of this protein is not heavily 
influenced by Cav-1 expression. 
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Figure 5.2 Effects of caveolin-1 depletion on the cellular uptake of EGFP-R8 in HeLa cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting caveolin-1 (si-
Cav-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells 
(bottom rows). Shown in Column A, B, and C are zoomed images of 5-8 cells from different fields of 
view. Scale bars 10 µm. Quantification data shown at bottom right represents the average fluorescence 
intensity +/- S.D. indicating intra-experimental variations from two independent experiments.   
 
Despite the fact that this siRNA targeting approach only partially reduced Cav-1 
expression in A431 cells, the same experiments were performed three times to 
investigate whether this loss influenced EGFP-R8 uptake. Confocal microscopy data 
shown in Figure 5.3 suggest that this depletion did also not influence EGFP-R8 uptake 
in this cell line. The calculated fluorescence intensity values for control cells and cells 
transfected with si-GFP or si-Cav-1 were compared and there was no significant 
difference in fluorescence values between these conditions.  
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Figure 5.3 Effects of caveolin-1 depletion on the cellular uptake of EGFP-R8 in A431 cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting caveolin-1 (si-
Cav-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence then was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are zoomed images of 5-8 cells from different fields of view. Scale bars 10 
µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- S.D. from 
three independent experiments (Exp 1-3; error bars indicate the intra-experimental variations) and the 
mean fluorescence intensity +/- S.D. of these three experiments (highlighted in green colour; error bars 
indicate the inter-experimental variations). Student’s independent T-Tests were performed to determine 
the significance of differences between two means. Statistical significance p=0.44.  
 
5.2.2 Inhibition of the flotillin endocytic pathway through siRNA depletion of 
flotillin-1  
Experiments, using the same methodology (section 2.5) were then conducted in order to 
deplete flotillin-1 from HeLa and A431 cells to assess the contribution of this protein 
and the pathway in regulating the internalisation of EGFP-R8. Here, a laboratory 
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control siRNA (si-GFP). The expression of flotillin-1 and GAPDH were finally detected 
by Western blotting and ECL and the relative intensities of the bands were quantified as 
described and normalised to the intensity of GAPDH as a loading control. Figure 5.4 
demonstrates that the expression of flotillin-1 was reduced by ~96% and ~70% 
respectively in HeLa and A431 cells.  
 
 
 
Figure 5.4 siRNA-based flotillin-1 depletion from HeLa (A/C) and A431 (B/D) cells. A-B) 
Immunoblots for flotillin-1 and GAPDH in untransfected cells or cells treated with flotillin-1 targeting 
siRNA (si-Flot-1) or GFP non-targeting control siRNA (si-GFP). C-D) Relative protein expression was 
quantified using ImageJ software and normalised to GAPDH loading control. 
 
These experiments were then repeated with HeLa and A431 cells gown in 35mm 
MatTek dishes that were then further incubated with 2 µM EGFP-R8 to assess whether 
depletion of flotillin-1 had any influence on uptake of this protein.  
Similar to results obtained with si-Cav-1 transfected cells there was, in both cell lines, 
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no obvious difference in EGFP-R8 uptake between control cells and those depleted on 
flotillin-1 (Figures 5.5-5.6). Quantification data from three independent experiments in 
A431 cells confirmed that there was no statistical difference between these experimental 
conditions but highlighted some variation in fluorescence intensity between separate 
individual experiments (Figure 5.6). From two separate experiments it is also clear that 
flotillin-1 is not a major regulator of the uptake of EGFP-R8 in HeLa cells (Figure 5.5). 
 
 
Figure 5.5 Effects of flotillin-1 depletion on the cellular uptake of EGFP-R8 in HeLa cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting flotillin-1 (si-
Flot-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are zoomed images of ~5 cells from different fields of view. Scale bars 10 
µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- S.D. 
indicating intra-experimental variations from two independent experiments.   
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Figure 5.6 Effects of flotillin-1 depletion on the cellular uptake of EGFP-R8 in A431 cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting flotillin-1 (si-
Flot-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence then was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are zoomed images of 5-8 cells from different fields of view. Scale bars 10 
µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- S.D. from 
three independent experiments (Exp 1-3; error bars indicate the intra-experimental variations) and the 
mean fluorescence intensity +/- S.D. of these three experiments (highlighted in green colour; error bars 
indicate the inter-experimental variations). Student’s independent T-Tests were performed to determine 
the significance of differences between two means. Statistical significance p=0.20. 
 
5.2.3 Inhibition of endocytic pathways regulated by PAK-1 through siRNA 
depletion of PAK-1  
PAK-1 is a well-characterised regulator of actin dynamics. It is also strongly linked 
with the functioning of macropinocytosis that has a strong requirement for actin 
reorganisation to accomplish the fluid engulfing and internalisation processes. Attempts 
were therefore made to silence the expression of this protein in HeLa and A431 cells 
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using the method described in section 2.5 and validated siRNA (Al Soraj et al., 2012).   
 
 
 
Figure 5.7 siRNA-based PAK-1 depletion from HeLa (A/C) and A431 (B/D) cells. A-B) Immunoblots 
for PAK-1 and GAPDH in untransfected cells or cells treated with PAK-1 targeting siRNA (si-PAK-1) or 
GFP non-targeting control siRNA (si-GFP). C-D) Relative protein expression was quantified using 
ImageJ software and normalised to GAPDH loading control. 
 
Results in Figure 5.7 showed that PAK-1 expression was reduced by ~87% in the si-
PAK-1 treated HeLa cells (Figure 5.7A and C), and by ~63% in the si-PAK-1 treated 
A431 cells (Figure 5.7B and D). Here it should be noted that there was also some 
silencing of PAK-1 with the control transfection using si-GFP; the reason for this is 
unknown. This method was then used to test the functionality of these cells for uptake 
of EGFP-R8 using live cell imaging confocal microscopy as described above for si-
Cav-1 and si-Flot-1 transfected cells. 
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Figure 5.8 Effects of PAK-1 depletion on the cellular uptake of EGFP-R8 in HeLa cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting PAK-1 (si-
PAK-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are zoomed images of ~5 cells from different fields of view. Scale bars 10 
µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- S.D. 
indicating intra-experimental variations from two independent experiments.   
 
In both HeLa and A431 cells there was no noticeable difference in EGFP-R8 uptake 
between si-PAK-1 treated and control cells (Figure 5.8-5.9). Statistical analysis from 
data obtained in A431 cells showed that any difference was not statistically significant. 
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Figure 5.9 Effects of PAK-1 depletion on the cellular uptake of EGFP-R8 in A431 cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting PAK-1 (si-
PAK-1) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence then was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are representative zoomed images of 5-8 cells from different fields of 
view. Scale bars 10 µm. Quantification data shown at bottom right represents the average fluorescence 
intensity +/- S.D. from three independent experiments (Exp 1-3; error bars indicate the intra-experimental 
variations) and the mean fluorescence intensity +/- S.D. of these three experiments (highlighted in green 
colour; error bars indicate the inter-experimental variations). Student’s independent T-Tests were 
performed to determine the significance of differences between two means. Statistical significance 
p=0.16. 
  
5.2.4 Inhibition of endocytic pathways regulated by Cdc42 through siRNA 
depletion of Cdc42  
As one of the upstream regulators of PAK-1 activity, Cdc42 functions in the regulation 
of actin remodelling and in various endocytic pathways. To investigate whether EGFP-
R8 uptake is affected by Cdc42-mediated pathways, Cdc42 expression in HeLa and 
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A431 cells was depleted using siRNA prior to cellular uptake assays. Prior to this thesis 
no Cdc42 silencing had been attempted in the laboratory. Two MWG/Eurofin custom 
siRNAs were purchased and tested and one gave very good silencing of this protein 
(>90%) in both cell lines (Figure 5.10). In contrast to other experiments the control 
siRNA appeared to increase Cdc42 expression levels. 
 
 
Figure 5.10 siRNA-based Cdc42 depletion from HeLa (A/C) and A431 (B/D) cells. A-B) 
Immunoblots for Cdc42 and tubulin in untransfected cells or cells treated with Cdc42 targeting siRNA 
(si-Cdc42) or GFP non-targeting control siRNA (si-GFP). C-D) Relative protein expression was 
quantified using ImageJ software and normalised to tubulin loading control. 
 
These cells were then tested for their ability to internalise EGFP-R8. From initial 
analysis of the cells by DIC microscopy it was clear that Cdc42 depletion resulted in 
morphological changes (Figure 5.11-5.12). A proportion of HeLa cells were elongated 
and these are highlighted with white arrows in the Figure 5.11. A more complex 
observation was seen in A431 cells that also adopted an elongated shape (a typical 
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example is shown in the bottom left image of Figure 5.12). Additionally the formation 
of long cell protrusions akin to long filopodia, were also observed in some of these 
cells. Interestingly, cells imaged in some other regions were a lot more circular in 
appearance than control cells (see bottom middle image of Figure 5.12). For both cell 
lines the total fluorescence intensity was quantified from separate experiments (n=2 for 
HeLa and n=3 for A431) to show that depletion of Cdc42 did not result in major 
differences in cellular uptake of EGFP-R8. Statistical analysis from data obtained in 
A431 cells showed that any difference was not statistically significant. It should be 
highlighted that the rounded A431 were characterised by having low fluorescence 
(Figure 5.12) that was more polar in localisation compared to the very scattered 
fluorescence in control and si-GFP treated cells. 
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Figure 5.11 Effects of Cdc42 depletion on the cellular uptake of EGFP-R8 in HeLa cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting Cdc42 (si-
Cdc42) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C and D are zoomed images of ~5 cells from different fields of view. Scale 
bars 10 µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- 
S.D. indicating intra-experimental variations from two independent experiments.   
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Figure 5.12 Effects of Cdc42 depletion on the cellular uptake of EGFP-R8 in A431 cells. 
Untransfected cells and cells transfected with control siRNA (si-GFP) or siRNA targeting Cdc42 (si-
Cdc42) were incubated for 1 hr with 2 µM EGFP-R8 at 37°C/5% CO2, and washed with heparin. Cell-
associated fluorescence then was analysed by confocal microscopy and shown are representative single 
projection images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. 
Shown in Column A, B, and C are zoomed images of 5-8 cells from different fields of view. Scale bars 10 
µm. Quantification data shown at bottom right represents the average fluorescence intensity +/- S.D. from 
three independent experiments (Exp 1-3; error bars indicate the intra-experimental variations) and the 
mean fluorescence intensity +/- S.D. of these three experiments (highlighted in green colour; error bars 
indicate the inter-experimental variations). Student’s independent T-Tests were performed to determine 
the significance of differences between two means. Statistical significance p=0.08. 
 
As previously shown by DIC microscopy, si-Cdc42 transfected HeLa and A431 cells 
had visible morphological changes compared to control cells and this was most 
pronounced in A431 cells. To further investigate whether these cell shape alterations are 
related to or mediated by actin cytoskeleton rearrangements, untransfected A431 cells 
or cells incubated with either control siRNA (si-GFP) or siRNA targeting Cdc42 (si-
Cdc42) at 37°C/5% CO2 for 72 hr were fixed and labelled for the nucleus and F-actin, 
and imaged by the confocal microscopy method described in chapter 4. The cells were 
incubated for 72 hr rather than 48 hr to maximise the possibility of clearly seeing 
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morphological/actin effects. In Figure 5.13, two typical phenotypes of actin 
cytoskeleton organisation are shown side by side for each experimental condition - 
untransfected cells, si-GFP and si-Cdc42 treated cells. A fraction of imaged cells were 
observed to assemble pronounced long actin fibres (Figure 5.13 B, D and F), 
particularly noticeable in the basal cell region. In other cells (Figure 5.13 A, C and E) 
these structures were absent but both phenotypes highlighted the cortical actin that has 
been described in chapter 4. The F-actin distribution in si-Cdc42 treated cells did not 
exhibit detectable alterations, compared with those of control cells.  
 
Figure 5.13 Effects of Cdc42 depletion on the actin architecture in A431 cells. Untransfected cells 
and cells transfected with control siRNA (si-GFP) or siRNA targeting Cdc42 (si-Cdc42) were fixed and 
stained with Rh-P. Images were acquired as described in section 4.3.1. Scale bars 10 µm. 
 
In chapter 4 A431 cells pre-treated with PP2 did not respond to Cyt D with respects to 
EGFP-R8 uptake. Experiments were then prepared to investigate whether si-Cdc42 
transfected cells were responsive to Cyt D effects. Cells were cultured and untransfected 
or transfected with siRNA targeting Cdc42 (si-Cdc42) for 48 hr at 37°C/5% CO2. Some 
of these cells were further incubated with 10 µM Cyt D for 15 min prior to addition of 2 
µM EGFP-R8 for 1 hr in the continued presence of 10 µM Cyt D. The cells were then 
washed with heparin, and cell-associated fluorescence was analysed by live cell 
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imaging confocal microscopy. As shown in Figure 5.14 and as expected, Cyt D 
treatment alone dramatically enhanced the EGFP-R8 uptake by A431 cells. Cells 
transfected with si-Cdc42 were equally responsive to this drug (Figure 5.14 A-B). This 
was irrespective of their shape. 
 
 
Figure 5.14 Effects of Cdc42 depletion alone and the combination of Cdc42 depletion and Cyt D on 
the cellular uptake of EGFP-R8 in A431 cells. Cells were cultured and untransfected or transfected 
with siRNA targeting Cdc42 (si-Cdc42) for 48 hr at 37°C/CO2. Cells were then incubated with or without 
10 µM Cyt D for 15 min prior to incubation with 2 µM EGFP-R8 for 1 hr in the presence or absence of 
Cyt D. Cells were then washed with heparin, and cell-associated fluorescence was analysed by confocal 
microscopy. Shown are representative single projection images of fluorescence only (top rows) and 
merges of fluorescence and DIC of the same cells. Shown in column A and B are images obtained from 
two different fields of view, and in column E are zoomed images from a different field of view of C/D. 
Scale bars 10 µm.  
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5.3 Discussion 
The overall aim of this chapter was to support data obtained in chapters 3 and 4 via the 
development of alternative techniques to study the cellular uptake of CPP-protein 
conjugates. For clear reasons EGFP was used as a model cargo that allowed for direct 
analysis of fluorescence inside cells using live cell confocal microscopy. This was the 
preferred method here over flow cytometry that had previously been used to detail the 
cellular uptake of Alexa 488 conjugated R8 used here and also HIV-Tat (Al Soraj et al., 
2012). Microscopy allows researchers the added benefit of seeing the localisation of 
CPPs and cargos inside cells and also highlighted in this study is the high degree of 
heterogeneity in cell phenotype of fluorescence seen within a single experiment within a 
single population. Ideally flow cytometry and microscopy should be used in tandem but 
this requires more time that was not available for this thesis. 
 A large number of investigations on internalisation mechanisms of CPPs attached to 
small or large cargos have been made, and the vast majority of these studies have relied 
on the use of chemical inhibitors of endocytosis. Their inherent lack of specificity 
makes data interpretation very difficult and this is why the laboratory invested time to 
develop molecular, siRNA targeting strategies, not to totally replace inhibitor work but 
to supplement research performed with these agents. In this chapter, a number of 
different siRNA sequences were used as an attempt to block pathways regulated by 
AP2µ2, caveolin-1, flotillin-1, PAK-1 and Cdc42, and therefore to evaluate the 
involvement of these pathways in the cellular uptake of EGFP-R8. However 
optimisation of all siRNA-based silencing was not performed for this PhD project due 
to time constraints; this includes the inability to silence >50% expression of Cav-1 in 
A431 cells. This raises the concern that some negative data from CPP uptake assays 
may be due to the fact that there was insufficient depletion of a protein to mediate a 
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cellular effect on endocytosis.  
Initially, several attempts using a siRNA sequence were carried out to deplete the 
expression of AP2µ2 subunit that forms part of the AP2 complex that is vital for CME. 
Unfortunately these experiments were unsuccessful due to the poor quality of the 
purchased AP2µ2 antibodies that gave multiple bands by Western blotting (data not 
shown). Towards the end of my experimental period Dr Paul Moody in the laboratory 
was able to characterise AP2µ2 silencing in HeLa cells (Moody et al., 2015). This 
approach will now be of significant interest to test this very important pathway in 
cellular uptake of EGFP-R8. 
The siRNA sequence employed in this section to target caveolin-1 successfully depleted 
caveolin-1 expression in HeLa cells. However, this depletion had no detectable effects 
on EGFP-R8 internalisation. HeLa cells have been reported to utilize caveolar 
endocytosis to internalise different cargos including lipoplexes (Rejman et al., 2005) 
and nanoparticles (Bohmer and Jordan, 2015). In a separate study depletion of caveolin-
1 in this cell line via siRNA targeting was found to reduce the uptake of a transportan-
streptavidin conjugate by up to 50% and interestingly flotillin-1 depletion increased 
transportan mediated uptake of the same cargo (Säälik et al., 2009). For these types of 
experiments it should not be overlooked that inhibition of a particular pathway may 
activate other pathway(s), which then act as compensatory mechanism(s) to perform 
cargo internalisation. Caveolin-1 depletion has been reported to increase the levels of 
activated Cdc42 at the plasma membrane (Doherty and McMahon, 2009), and 
stimulated the Cdc42-dependent fluid phase endocytosis in epithelial ovarian hamster 
cells (Cheng et al., 2010). An efficient siRNA transfection usually requires at least 24 hr 
to achieve effective depletion of a protein and in this time the inhibition of one targeted 
pathway may lead to an up-regulation in the activity of an alternative endocytic 
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pathway. One of the advantages of using pharmacological inhibitors is that the agent 
only needs to be added to cells for a short period of time to mediate an effect on 
endocytosis. The problem is that this effect is unlikely to be confined to one endocytic 
pathway.  
Pharmacological inhibitors also affect all cells in the experimental population and 
effects seen with siRNA transfections will only be obvious if the transfection efficiency 
is high. This was not the case in A431 cells incubated with si-Cav-1 and it still remains 
to be determined whether caveolae play an important role in EGFP-R8 uptake in this 
cell line.  
Although flotillin-1 expression was successfully depleted in both HeLa and A431 cells, 
the lack of this endocytic protein did not exhibit notable effects on EGFP-R8 
internalisation in these two cell types. It indicates that the cargo EGFP-R8 does not use 
flotillin-mediated endocytic pathway for cell entry in these cells. This finding was 
consistent with our previously published studies where flotillin-1 knockdown with 
siRNA showed no effects on the cellular uptake of Alexa 488 conjugates of HIV-Tat or 
R8 (Al Soraj et al., 2012). A major obstacle underlying the investigations of flotillin-
mediated pathway is the lack of specific and easy available probes to label this pathway 
inside cells and also the lack of specific chemical inhibitors to perturb this entry route. 
To date in addition to flotillin itself, only a limited number of molecules including anti-
CD59 antibody have been reported to employ this pathway to enter into cells (Glebov et 
al., 2006).   
It should also be mentioned that both caveolin-1 and flotillin-1 may be regulating the 
integrity of the plasma membrane via organising lipid rafts to where they both reside. 
Silencing the expression of these proteins may therefore have effects beyond their roles 
in mediating endocytic effects as the cells may have very different plasma membrane 
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organisation. The very same is likely to be true in cells incubated with cholesterol 
sequestering drugs such as methyl β-cyclodextrin that is often used in CPP and other 
drug delivery research to target endocytosis mediating from lipid rafts (Kaplan et al., 
2005, Li et al., 2012, Lim et al., 2013). Great care should be given to interpreting this 
data. 
The siRNA-mediated depletion of the macropinocytosis regulator PAK-1 was shown to 
reduce the internalisation of R8-Alexa 488 and HIV-Tat by up to 50% in A431 cells (Al 
Soraj et al., 2012). Growth factor induced entry (i.e. macropinocytosis) of the fluid 
phase probe dextran into the same cell line was also shown in another study to be 
inhibited by endogenous PAK-1 silencing (Liberali et al., 2008), indicating that the 
PAK-1 activity is required for macropinocytic uptake. A recent study examining the 
molecular mechanisms of the cell entry of Herpes simplex virus1 suggested that the 
virus internalisation by HeLa cells was dependent on PAK-1 activity either for 
macropinocytosis or for the reorganisation of local cortical actin cytoskeleton allowing 
for passage through the plasma membrane and the actin cortex (Devadas et al., 2014). In 
contrast to these earlier observations, we found that cellular entry of EGFP-R8 was 
unaffected in PAK-1 depleted cells. The reason for this CPP PAK-1 discrepancy is 
unknown but may be due to differences in cargo (Alexa 488 vs EGFP) and/or 
methodology (flow cytometry vs confocal microscopy) and/or a higher level of PAK-1 
silencing. Further mention to this is given in the final discussion.  
As previously discussed in Section 5.1, Cdc42 plays a crucial role in regulating actin 
remodelling, thereby controlling cell migration, invasion and morphology (Heasman 
and Ridley, 2008). This GTPase is mainly responsible for promoting filopodia 
formation, and two models including convergent elongation and tip nucleation have 
been suggested to underlie this (Mellor, 2010, Mattila and Lappalainen, 2008). The tip 
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nucleation model involves the formin family of proteins, which stimulate nucleation and 
the subsequent assembly of linear actin filaments that are required to generate cellular 
actin structures such as filopodia (Yang and Svitkina, 2011). Upon activation, active 
Cdc42 can bind to and stimulate the formin family members mDia2 and formin-like 
protein 3, which in turn induce the formation and extension of filopodia (Wakayama et 
al., 2015). In a recently published study, the increased activation of Cdc42 
(constitutively activated by the Cdc42 GEF Dock10 protein) in HeLa cells induced a 
morphological transition from polygonal elongated to non-polygonal but more rounded 
cell shape, with the accompany of inducible formation of filopodia (Ruiz-Lafuente et 
al., 2015). This is consistent with the proposed role of Cdc42 for filopodia formation. 
Moreover, this report on the loss of morphological elongation was consistent with a 
previous study by Gadea and coworkers (Gadea et al., 2008), where siRNA-mediated 
Dock10 knockdown resulted in a decreased level of activated Cdc42 and thereby a 
morphology alteration from rounded to elongated in amoeboid cells. This cell 
elongation also occurred in a population of our si-Cdc42 treated HeLa and A431 cells. 
Therefore, these observations together confirm the role of Cdc42 for the maintenance of 
normal cell shape that requires the coordination of membrane remodelling and actin 
cytoskeleton dynamics at the cell edge. It should be noted that in migrating cells, Cdc42 
also contributes to the regulation of the polarity of microtubules through a distinct 
pathway from that modulating actin cytoskeleton (Cau and Hall, 2005). 
An unusual observation discovered in this thesis was the rounding of A431 cells 
transfected with siRNA targeting Cdc42. This did not extend across the total cell 
population and may only be observed in cells at a certain stage in cell division. These 
cells also appeared to have decreased EGFP-R8 fluorescence and it remains to be 
determined whether this is a due to their position in the cell cycle or the fact that they 
! 213!
were depleted of Cdc42. By labelling cells with rhodamine-phalloidin it was expected 
that actin effects would be highlighted but this was not the case as it was impossible to 
identify differences between control and si-Cdc42 treated cells. This suggests that the 
effects are subtle and that alternative microscopy systems such as super resolution 
systems may be required to observe them. It should be noted here that the siRNA 
approach used here was very efficient at depleting Cdc42 (>90%) thus criticisms 
regarding poor silencing (e.g. caveolin-1 in A431 cells) do not really apply.  
In a collaborative study with our group Cdc42 depletion impaired the internalisation of 
glycol chitosan nanogels (Pereira et al., 2015) and similar effects again in HeLa cells 
were noted for uptake studies characterising the cellular uptake of silica-coated iron 
oxide nanoparticles (Bohmer and Jordan, 2015) and the entry of vaccine into bladder 
cancer cells (Redelman-Sidi et al., 2013). This highlighted the involvement of actin 
dynamics in these events and most probably macropinocytosis. Additionally, in HeLa 
cells depleted of Cdc42, dextran uptake through clathrin-independent fluid phase 
endocytosis was markedly reduced (Francis et al., 2015). However, our data obtained 
from cells with loss of Cdc42 expression implied that the endocytic route(s) regulated 
by Cdc42 were not necessarily implicated in EGFP-R8 uptake. Moreover, the role of 
macropinocytosis in EGFP-R8 internalisation could not be confirmed from results 
presented in this chapter.   
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Chapter 6: General discussion 
 
It has been more than twenty years since the identification of the first cell penetrating 
peptide (CPP) (Derossi et al., 1994). This was penetratin and this peptide represents one 
of the most studied CPPs in the literature as studies on this peptide now span twenty-
two years (Gartziandia et al., 2016). A growing number of reports on the capacity of 
CPPs to deliver a wide range of cargos from small molecular entities to macromolecules 
including large bioactive complexes into the cell interior reflect the continued interest in 
them for therapeutic/clinical applications.  It should be noted, however, that despite this 
great effort the number of CPP delivery systems that have made it from bench to 
clinical trial is disappointingly low and none of these have made it all the way to 
market.  
A major issue that contributes to this poor translation to clinic is the lack of detailed 
knowledge on the membrane translocation mechanisms that CPPs or CPP-cargos 
employ. Most of the known CPPs, especially those attached to large cargo such as 
proteins (Säälik et al., 2009) or being part of nanoparticle formulations (Khalil et al., 
2006, Torchilin, 2008) are assumed to rely on endocytic pathways to enter into cells. 
For some CPPs that are attached to small cargos, non-endocytic direct translocation has 
been clearly shown to mediate their cellular entry (Duchardt et al., 2007, Tünnemann et 
al., 2006, Jones and Sayers, 2012). All known endocytic pathways are accompanied by 
cell cortex remodelling during the internalisation processes; by membrane invagination 
(e.g. CME and caveolar endocytosis) or membrane protrusion (e.g. macropinocytosis). 
The literature highlights the very strong link between endocytic pathways and actin and 
describes how the actin cytoskeleton associates with components of the endocytic 
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machinery during endocytosis (Qualmann et al., 2000, Roth, 2007, Taylor et al., 2012). 
For example, actin regulators such as ARP2/3 and N-WASP are observed to relocate to 
clathrin-coated vesicles to facilitate CME (Merrifield et al., 2004). Overall, with the 
exception of macropinocytosis that involves extensive actin reorganisation, there is little 
consensus in the literature regarding the exact role of the actin network for endocytic 
processes (Mooren et al., 2012). The strong link between CPPs and actin has been 
described in Chapter 3 and 4, and was a major focus of the previous studies in our 
laboratory (Al Soraj et al., 2012) leading up to the thesis presented here. Further 
information on this poorly characterised link would hopefully contribute to CPP 
knowledge with respects to mechanisms of action of cell entry.  
A major focus of this PhD project was to perform comparative analysis of the reliance 
on actin of the internalisation of CPP-conjugates R8-Alexa 488 and EGFP-R8 into two 
different cell lines HeLa and A431 cells that had been previously shown to have major 
differences in uptake profiles of R8-Alexa 488. Two major questions were asked with 
respects to elucidating how these CPP conjugates comparatively rely on, or influence 
actin dynamics to gain access into cells.  
Previous work in the laboratory had focused on CPP-fluorophores and this project 
initially developed and optimised a protein purification protocol to obtain EGFP-R8 of 
high yield and also of high purity from E.coli cultures. This was developed and the final 
product achieved a purity of >99% allowing us to confidently study its mechanism(s) of 
cell entry.  
As well as studying CPPs the thesis was also interested in studying the uptake of 
dextran, a well characterised probe that enters cells via a non receptor process (fluid 
phase uptake) and also by macropinocytosis (Jones, 2007). As CPPs have also been 
shown to enter via these pathways dextran represents a good endocytic model for 
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parallel studies with the two selected R8 conjugates. As noted, previous studies 
performed in the laboratory demonstrated a major difference in the results obtained in 
dextran uptake in HeLa and A431 cells when actin was disrupted with Cyt D (Al Soraj 
et al., 2012).  
To extend the previous work that the laboratory had performed on both CPPs and 
dextran with Cyt D, a variety of other actin inhibitors including Lat B and JAS working 
via different mechanisms were utilized in this thesis and the results were compared with 
those obtained with Cyt D. In HeLa cells, Cyt D reduced the cellular uptake of both 
CPP conjugates (R8-Alexa 488 and EGFP-R8) and dextran, but had little effects on the 
internalisation of CME marker transferrin (TF). Similar to the case in HeLa cells, entry 
of TF in A431 cells was unaffected by Cyt D. Although this drug did not exert notable 
influence on the uptake level of R8-Alexa 488 in A431 cells, it altered the distribution 
of labelled punctate structures from scattered to clustered. It is only by using 
microscopy based technologies that these subtle changes are observed as flow 
cytometry would generally not be able to provide this level of information. By contrast, 
the internalisation of both EGFP-R8 and dextran into vesicles in A431 cells was 
dramatically enhanced by Cyt D, and a vast majority of these fluorescent vesicles were 
observed to aggregate in perinuclear regions rather than be scattered throughout the 
cytoplasm in control cells. This data was unexpected and had not been previously 
shown. It was also absent form a very large study on twenty-two different CPPs in four 
cell lines (including HeLa, but not A431 cells) using a number of endocytosis inhibitors 
where no data on actin-dependent uptake was presented (Mueller et al., 2008). This 
study did, however, highlight the different responses of the four cell lines to the chosen 
endocytic inhibitors and also major differences in peptide uptake in the absence of 
drugs. 
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CME mediated TF uptake in both cell cells, under the experimental conditions used in 
this project, did not appear to be sensitive to actin disruption and again the involvement 
of actin in TF endocytosis is known to be cell line dependent (Fujimoto et al., 2000). In 
this thesis uptake of the two CPP conjugates and dextran in HeLa cells, by endocytosis, 
required a functional actin system. In A431 cells, EGFP-R8 and R8-Alexa 488 seemed 
to utilize different uptake mechanisms (possibly endocytic pathways) to gain access to 
the cells and uptake characteristics of dextran very closely resembled that of EGFP-R8. 
However, the low degree of co-localisation obtained after simultaneous incubation of 
EGFP-R8 and dextran indicated that more than one endocytic routes were utilized by 
this CPP conjugate. It should be mentioned that dextran as a fluid phase probe also has 
the capacity to enter cells via multiple pathways. The same co-incubation experiment 
was then performed in Cyt D treated A431 cells. This study quite dramatically 
highlighted the increased uptake of both probes and this time they were very strongly 
co-localised. The underlying mechanism involved in this process still remains unclear. 
It should be noted that the dextran used in this project is anionic and additional 
experiments using neutral dextran could be performed to minimise the potential 
electrostatic interactions between anionic dextran and cationic R8 in the extracellular 
environment and thus avoid their co-internalisation as complexes into the same 
endocytic vesicles.    
The striking difference between these two cell lines in response to Cyt D with respects 
to uptake of both EGFP-R8 and dextran may lie in their difference in actin cytoskeleton 
as previously noted (Al Soraj et al., 2012) and also shown in this thesis. Actin in HeLa 
cells is prominent in long filaments while cortical actin, associated with the plasma 
membrane is much more abundant in A431 cells. Therefore, in this thesis, the 
interesting increased EGFP-R8 uptake in A431 cells by Cyt D was further investigated; 
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noting that actin is usually regarded as a promoter of endocytosis. Like Cyt D, two other 
actin-targeting reagents, JAS and Lat B directly interact with actin and modify the actin 
cytoskeleton as described in Section 4.1. Initially, the effects of these three agents on 
actin were analysed using confocal fluorescence microscopy in fixed A431 cells 
labelled with rhodamine-phalloidin. At certain concentrations, all these three drugs 
showed pronounced disruption of the actin cytoskeleton: they caused the actin 
reorganisation into amorphous masses and thinned out or even completely destroyed the 
cortical actin meshwork. Confirming data shown for Cyt D, a marked increase in uptake 
of EGFP-R8 was also observed in cells treated with Lat B or JAS. The plasma 
membrane tension of mammalian cells is mainly maintained by actin network, and 
reduced membrane tension resulted from actin disruption may actually favor the 
formation of invaginations during the step of endocytosis initiation (Greene and Gao, 
2009). Additionally the cortical actin network located immediately beneath the plasma 
membrane is tightly associated with the membrane via linking proteins such as cortactin 
(Weed and Parsons, 2001, Cao et al., 2010), and may facilitate membrane invagination 
and the subsequent scission by providing the mechanical force that is required for 
membrane deformation (Kaksonen et al., 2006). Studies have also shown that the 
cortical actin network could function as a physical barrier for exocytosis in chormaffin 
cells as the transient and focal disruption of actin cytoskeleton underneath the plasma 
membrane facilitated these secretion processes (Cheek and Burgoyne, 1986, Trifaró and 
Vitale, 1993, Jog et al., 2007, Johnson et al., 2012). These previous findings together 
with data in this thesis suggest that this tight mesh of actin is a general barrier to 
membrane trafficking events close to the plasma membrane. 
The other two chemical inhibitors Y27632 and PP2 do not directly interact with actin 
filaments and influence the actin cytoskeleton in A431 cells via inhibition of ROCKs 
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and Src kinases respectively. The formation of a large number of actin needles that were 
mostly running perpendicular to the plasma membrane was clearly shown in cells 
treated with Y27632 of relatively high concentrations and in contrast to the previously 
discussed actin disruptors, the cortical actin network was still evident in these drug 
treated cells. In addition to its effects on actin organisation, Y27632 also increased the 
internalisation of EGFP-R8 into vesicular structures. But unlike those observed in Cyt 
D or Lat B or JAS treated cells, these fluorescent punctate structures were found to 
distribute throughout the cytoplasm in a scattered fashion. These observations obtained 
in cells treated with Y27632 would appear to challenge our hypothesis regarding the 
role of cortical actin in endocytosis. However it may well be that this drug was able to 
interfere with cortical actin but in a manner that did not allow for easy identification 
using confocal microscopy. 
Previous studies, mainly from the Futaki laboratory have shown that cationic CPPs such 
as R8 influence actin arrangement and that this is linked to the possibility that this 
influences peptide uptake into cells – induction of macropinocytosis (Nakase et al., 
2004, Nakase et al., 2007). The effects of EGFP-R8 (2 µM) on the actin architecture of 
control cells or cells treated with different actin drugs were also investigated to 
determine whether CPP effects on actin could influence the ability of these drugs to 
disrupt the cytoskeleton. This was not observed, initially the data shows that EGFP-R8 
itself at this concentration did not induce visible actin rearrangement that would be 
expected to either inhibit or promote uptake via macropinocytosis. Therefore, actin 
reorganisation/disruption caused by these actin inhibitors working directly or indirectly 
is the major factor governing this enhanced uptake. These studies allowed for repeating 
some of the earlier studies shown for R8 and this was performed whilst developing the 
microscopy assay for visualising actin that was later published (He et al., 2015). It was 
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discovered that the capacity of this CPP to modify actin is highly dependent on the state 
of the cells and that serum-starved cells were much more sensitive than control cells. 
This explains why so many studies on macropinocytosis as a cellular event and as a 
putative response to CPPs are done in serum-starved cells. Caution should however, be 
given to interpreting the data from these studies as they are done in highly stressed cells. 
The results from studies using the Src kinase inhibitor PP2 were surprising and very 
interesting. PP2 did not cause marked changes in actin arrangement in HeLa cells, 
whereas in A431 cells, actin filaments became very apparent and the drug also 
stimulated actin assembly into filamentous bundles. This may be due to the effects of 
this drug on the Raf-MEK-ERK signalling cascade. The activation of Raf-1, a 
cytoplasmic serine/threonine protein kinase, involves interaction with active Ras (Ras-
GTP) that recruits the protein, in an autoinhibited state, from the cytosol to the plasma 
membrane and activates it (Marshall, 1995, Desideri et al., 2015). Raf-1 has also been 
localised to endosomes (Rizzo et al., 2000, McKay et al., 2011) and efficient activation 
of this protein also requires additional phosphorylation on tyrosine residues by Src 
kinases and serine residues by PAKs (Tran and Frost, 2003). Activated Raf-1 has been 
reported to bind to mitogen and extracellular signal-regulated kinase (MEKs) and 
trigger the phosphorylation and activation of these MEKs and also the extracellular 
signal-regulated kinases (ERKs) (Pritchard et al., 2004). Together these as the Raf-
MEK-ERK pathway have a role in regulating actin remodelling (Nussinov and Jang, 
2014). A number of published studies have demonstrated that the constitutive activation 
of Src by v-Src kinase overexpression lead to a loss of actin stress fibres and other 
alterations in cytoskeletal architecture, and that v-Src-induced actin disruptions were 
linked to the activation of MEK and ERK, and the subsequent inhibition of Rho 
GTPases and their downstream effector ROCKs (Pawlak and Helfman, 2002, Fincham 
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et al., 1999, Mayer et al., 1999, Pullikuth and Catling, 2007, Guarino, 2010). As 
previously discussed in Chapter 4, the activation of ROCKs by Rho is involved in the 
formation and stabilisation of actin stress fibres via interactions with a variety of 
substrates such as LIMK. Considering these together, it is possible that the 
pharmacological inhibition of Src kinases by PP2 induced a sequential inhibition of Raf, 
MEKs and then ERKs and in turn stimulated ROCK-mediated actin assembly into 
fibres. PP2, like Y27632 had not previously been studied in our laboratory and exerted 
no visible influence on EGFP-R8 uptake in HeLa or A431 cells. However, we were 
very surprised to observe that pre-incubation of this inhibitor in A431 cells abrogated or 
completely abolished the Cyt D mediated increase in cellular uptake of this R8 protein 
conjugate. Importantly the drug was unable to prevent Cyt D mediated actin disruption. 
The underlying mechanisms governing these surprising findings are unknown but 
suggest that further cell biology analysis should be performed with PP2 and other actin 
inhibitors to shed more light on how actin regulates endocytosis and other cellular 
functions.  
In other CPP studies Cyt D alone is used to highlight the role of actin in cell uptake, but 
based on the results presented in this thesis there is certainly an argument for looking at 
more actin modifiers to get a higher level of understanding as summarised for R8 
conjugates, TF and dextran in Figure 6.1.  
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Figure 6.1 Summary of the effects of different actin inhibitors on the actin cytoskeleton and the 
cellular uptake of CPP conjugates and endocytic probes. Cortical actin is represented as a thick red 
line that is associated with the plasma membrane. 
 
Supplementation of inhibitor studies with siRNA-based targeting of endocytic proteins 
and pathways were performed in the last results chapter, in some cases using 
uncharacterised siRNA and cell models. There was no strong evidence showing that 
caveolin-1 or flotillin-1 mediated endocytic pathways were implicated in the EGFP-R8 
uptake by both HeLa and A431 cells. Caveolar endocytosis was reported to be involved 
in internalisation of transportan-avidin complexes into HeLa cells (Säälik et al., 2009), 
but there is no strong data to suggest that this CPP and R8 share identical uptake 
F-actin  
R8-Alexa 488 EGFP-R8 TF-Alexa 647  Dex-Alexa 647  
HeLa 
Control Cyt D-treated  
Internalization  Inhibited Internalization  Increased Internalization  
A431 
Control Cyt D-treated  
A431 control Lat B-treated A431  JAS-treated A431   
(low concentrations) 
JAS-treated A431   
(high concentrations) 
Y27632-treated A431  PP2-treated A431  PP2 PP2+Cyt D 
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mechanisms. As PAK-1 is such an important regulator of actin it was rather surprising 
to observe that si-PAK-1 treated cells had a visibly normal actin phenotype, and that 
EGFP-R8 uptake seemed to be independent of PAK-1 expression. This may be seen as 
evidence that macropinocytosis does not regulate uptake of EGFP-R8 in these studied 
cells. PAK-1 and Cdc42 function in actin organisation is linked and the depletion of 
Cdc42 from HeLa cells resulted in morphological changes (elongation), which is in 
agreement with earlier observations from different laboratories (described in section 
5.3). Some rather unusual morphological alterations were detected in our si-Cdc42 
treated A431 cells with cell rounding and the formation of filopodia-like structures 
being observed; the latter was unexpected based on the described role of this GTPase in 
promoting filopodia formation (Chapter 5). These global effects on cells were not 
reflected in any observable changes on actin cytoskeleton that was visualised by 
rhodamine-phalloidin staining. Cdc42 is a well-established actin regulator, but in 
contrast to PAK-1, it may not be essential for macropinocytosis (Amstutz et al., 2008, 
Koivusalo et al., 2010). In line with observations of an apparently normal actin 
arrangement in these cells, EGFP-R8 uptake was not evidently affected by Cdc42 
depletion.  
The importance of the actin cytoskeleton in endocytic processes cannot be 
underestimated and this PhD project provides new insights into the role(s) of actin for 
the endocytic uptake of R8 conjugates. We should no longer assume that proper actin 
assembly is required for R8 uptake in all cell lines. In our hands, as Alexa 488 
conjugates, R8 and HIV-Tat peptide behave very similarly (Fretz et al., 2007, Al Soraj 
et al., 2012) and we suggest here that similar effects would be seen with HIV-Tat when 
actin is directly disrupted. Remaining to be seen are data from experiments using other 
more complex CPPs such as penetratin that are likely to use different uptake 
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mechanisms. Interpretation of data on EGFP-R8 uptake following actin 
disruption/reorganisation is clearly dependent on several factors including the choice of 
cell line (tissue), the mechanism of actin interfering agent and the nature of the attached 
cargo. It is very likely that in HeLa cells, this protein cargo employs 
macropinocytosis/fluid phase uptake to enter into the cell interior. However, for A431 
cells, the situation is more complex because of the way these cells and quite possibly 
others arrange the actin to serve its multiple functions including endocytosis. For future 
CPP development, the work presented in this thesis further highlights that 
characterisation of cell uptake is needed in more than one cell model to provide a better 
understanding of their potential as drug delivery vectors for delivering therapeutics to 
different tissues. 
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Appendix 1: The original SDS-PAGE gel that formed the 
template for Figure 3.2.  
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Appendix 2: The effects of cytochalasin D (Cyt D) on 
internalisation of dextran (40 kDa) labeled with FITC (FITC-
Dex40) in A431 and published as Figure 8F in (Al Soraj et al., 2012). 
A431 cells seeded on tissue culture plates were washed twice with PBS at room 
temperature then pre-incubated at 37°C/5% CO2 for 15 min in serum-free D-MEM in the 
absence (control) or presence of 10 µM Cyt D. The media was removed and fresh serum-
free D-MEM containing 5.0 mg/ml FITC-Dex40 (Sigma-Aldrich, Dorset, UK) as well as 
10 µM Cyt D was added and the cells were further incubated for 0–80 min at 37°C/5% 
CO2. The plates were then placed on ice to inhibit further uptake and washed twice with 
ice-cold PBS followed by a 1 min incubation in ice-cold acid wash (0.2 M acetic acid, 0.2 
M NaCl, pH 2.0) to remove remaining surface label. Cells were then washed three times 
with PBS at room temperature, prior to trypsinisation for 4 min at 20°C. The cell 
suspension was then washed with ice-cold PBS, before measuring cell-associated 
fluorescence (10,000 gated cells) by flow cytometry on a Becton Dickinson FACScalibur 
analyser.  
 
Appendix Figure 2. The effects of cytochalasin D (Cyt D) on internalisation of dextran (40 kDa) labeled 
with FITC (FITC-Dex40) in A431 cells. Cells were pre-incubated in the absence (Cont) or presence of 10 
µM Cyt D prior to incubation with FITC-Dex40 for the indicated time points. The cells were then trypsinised 
and analysed by flow cytometry. Data represent the geometric means ± S.D. from three separate experiments. 
Statistical analysis for comparing control cells with treated cells was performed using the Student's t-test. ** 
p<0.01, compared with controls. The cellular uptake of this probe in A431 cells was markedly increased 
following actin disruption by Cyt D.  
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Appendix 3: Effects of 0.8 µM JAS on the cellular uptake of 
EGFP-R8 in A431 cells. 
 
Appendix Figure 3. Effects of JAS on the cellular uptake of EGFP-R8 in A431 cells. Cells (control and 
those pre-treated with 0.8 µM JAS for 45 min) were incubated with 2 µM EGFP-R8 in the continued absence 
(control) or presence of 0.8 µM JAS for 1 hr and washed three times with heparin and once with PBS. Cell 
associated fluorescence was analysed using live-cell confocal microscopy and shown are single projection 
images of fluorescence only (top rows) and merges of fluorescence and DIC of the same cells. B/D represent 
zoomed images from different fields of view of A/C. Scale bars 10 µm.  
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Appendix 4: Calculation of fluorescence intensities (Moody et al., 
2015). 
Images to be analysed by this quantification method were acquired by live cell confocal 
microscopy. Single chosen images were analysed using an ImageJ script without manual 
intervention. Fluorescence intensity was calculated for each channel except the DIC 
channel. Pixels with intensity greater than an ImageJ Li (Li and Lee, 1993) threshold were 
considered as “fluorescent”, and the mean intensity of these fluorescent pixels was 
calculated. Pixels having intensity below a Li threshold and being spatially separated by at 
least 5 pixels from any pixel above this threshold were labelled as “Background”. Then the 
mean background intensity was calculated. The corrected intensity was then calculated by 
subtracting the mean background intensity value from the mean fluorescence intensity 
value. For each experimental sample, corrected intensity values were calculated for at least 
ten images (≥100 cells in total), and the average of these values was then calculated as 
shown in Chapter 5.  
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